1
|
Brown E, Jr GAF, Shelton A, Johnson T, Chen C, Shaheen S, Holden TL, Dao VA, Bien JYE, King D, Vitzthum L, Kirilcuk N, Morris A, Kin C, Dawes A, Sheth V, Chang DT, Pollom E. A Technology-Informed Approach to Clinical Trial Equity. Int J Radiat Oncol Biol Phys 2023; 117:e8. [PMID: 37786184 DOI: 10.1016/j.ijrobp.2023.06.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Despite efforts to increase participation of diverse communities in clinical trials, ethnic/racial minorities remain underrepresented. One such determinant may be lack of access to a comprehensive cancer center that conducts clinical research. Historically, our institution has had low accrual from rural regions further away from our cancer center, with Hispanic or Latino (HL) patients (pts) being especially underrepresented in our clinical research. In this study, we explored the impact of a clinical trial that allowed pts to receive chemotherapy (chemo) with their local oncologist. We hypothesize that allowing pts to receive chemo locally will lead to higher rates of enrollment from populations under-represented in clinical trials. MATERIALS/METHODS We conducted a study for pts with rectal cancer to undergo short-course radiation followed by 4 months of chemo with the option to pursue watch and wait if pts achieve a clinical complete response. Radiation was administered at our institution while pts could receive standard-of-care chemo closer to home with their local oncologist. For pts who received chemo locally, the research coordinator and co-investigators held video visits with the pts prior to each chemo infusion to review adverse events (AE), labs, and chemo dosing. We compared demographic data of pts on this trial with that of pts enrolled across all adult therapeutic oncologic clinical trials over the same time period at our institution. Distance to our institution was calculated based on pts' primary residence zip code. Protocol compliance with AE reporting for pts who received chemo locally was assessed by chart review. RESULTS Between May 2020 and January 2023, 24/35 enrolled pts completed both radiation and chemo on trial. 13/24 pts (54%) received chemo locally. Of the 24 pts, 16 were White (67%), 7 Asian (29%), 1 Native Hawaiian/ Pacific Islander (4%). Of all enrolled patients, 4 were HL (16.7%), compared to our institutional average of 16.5%. All enrolled HL pts received their chemo locally. The average distance traveled by non-HL pts from their home to our institution was 87.7 miles (range 5.1 - 308). In contrast, HL pts traveled an average of 147.8 miles (range 110 - 249), 68% further than their non-HL counterparts. There was 100% compliance with AE reporting among those pts who received their chemo locally. CONCLUSION Although the percentage of HL participation in our study was consistent with our institutional average, all HL pts enrolled on the trial received treatment locally and lived substantially further from our institution than non-HL. By allowing pts to receive this part of treatment locally, we provided pts who live further away an opportunity to engage in clinical research without the associated financial and time toxicities related with traveling for treatment. By decentralizing clinical trials and leveraging telemedicine, we can promote the participation of under-represented groups in clinical trials.
Collapse
Affiliation(s)
- E Brown
- Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
| | - G A Fisher Jr
- Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
| | - A Shelton
- Department of Surgery, Stanford University School of Medicine, Palo Alto, CA
| | - T Johnson
- Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
| | - C Chen
- Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
| | - S Shaheen
- Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
| | - T L Holden
- Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
| | - V A Dao
- Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
| | - J Y E Bien
- Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA
| | - D King
- Department of Medical Oncology/Hematology, Northwell Health Cancer Institute, New Hyde Park, NY
| | - L Vitzthum
- Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
| | - N Kirilcuk
- Department of Surgery, Stanford University School of Medicine, Palo Alto, CA
| | - A Morris
- Department of Surgery, Stanford University School of Medicine, Palo Alto, CA
| | - C Kin
- Department of Surgery, Stanford University School of Medicine, Palo Alto, CA
| | - A Dawes
- Department of Surgery, Stanford University School of Medicine, Palo Alto, CA
| | - V Sheth
- Department of Radiology, Stanford University School of Medicine, Palo Alto, CA
| | - D T Chang
- Department of Radiation Oncology, Michigan Medicine, Ann Arbor, MI
| | - E Pollom
- Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
| |
Collapse
|
2
|
O'Donoghue B, Sexton S, Lyne JP, Roche E, Mifsud N, Brown E, Renwick L, Behan C, Clarke M. Socio-demographic and clinical characteristics of migrants to Ireland presenting with a first episode of psychosis. Ir J Psychol Med 2023; 40:336-342. [PMID: 33632349 DOI: 10.1017/ipm.2020.132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
OBJECTIVES When presenting with a first episode of psychosis (FEP), migrants can have different demographic and clinical characteristics to the native-born population and this was examined in an Irish Early Intervention for Psychosis service. METHODS All cases of treated FEP from three local mental health services within a defined catchment area were included. Psychotic disorder diagnoses were determined using the SCID and symptom and functioning domains were measured using validated and reliable measures. RESULTS From a cohort of 612 people, 21.1% were first-generation migrants and there was no difference in the demographic characteristics, diagnoses, symptoms or functioning between migrants and those born in the Republic of Ireland, except that migrants from Africa presented with less insight. Of those admitted, 48.6% of admissions for migrants were involuntary compared to 37.7% for the native-born population (p = 0.09). CONCLUSIONS First-generation migrants now make up a significant proportion of people presenting with a FEP to an Irish EI for psychosis service. Broadly the demographic and clinical characteristics of migrants and those born in the Republic of Ireland are similar, except for less insight in migrants from Africa and a trend for a higher proportion of involuntary admissions in the total migrant group.
Collapse
Affiliation(s)
- B O'Donoghue
- Orygen, Melbourne, Australia
- Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
| | - S Sexton
- Linndara, Child and Adolescent Mental Health Services, Health Service Executive, Kildare, Ireland
| | - J P Lyne
- Wicklow Mental Health Services, Newcastle Hospital, Greystones, Co. Wicklow, Ireland
- Royal College of Surgeons in Ireland, 123 St Stephens Green, Dublin 2, Ireland
| | - E Roche
- Cluain Mhuire Mental Health Services, Newtownpark Avenue, Blackrock, Co Dublin, Ireland
| | - N Mifsud
- Orygen, Melbourne, Australia
- Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
| | - E Brown
- Orygen, Melbourne, Australia
- Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia
| | - L Renwick
- Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine and Health, University of Manchester, England, UK
| | - C Behan
- DETECT Early Intervention for Psychosis Service, Blackrock, Co Dublin, Ireland
| | - M Clarke
- DETECT Early Intervention for Psychosis Service, Blackrock, Co Dublin, Ireland
- Department of Psychiatry, University College Dublin, Dublin, Ireland
| |
Collapse
|
3
|
Maltez N, Hughes M, Brown E, Hickey V, Shea B, Herrick AL, Proudman S, Merkel PA, Pauling JD. Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review. Semin Arthritis Rheum 2023; 61:152208. [PMID: 37202251 DOI: 10.1016/j.semarthrit.2023.152208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 04/17/2023] [Accepted: 04/19/2023] [Indexed: 05/20/2023]
Abstract
BACKGROUND Raynaud's phenomenon (RP) is a cardinal feature of SSc and is associated with significant disease-related morbidity that impacts on quality of life. The assessment of SSc-RP is challenging. The aim of this scoping review was to evaluate the outcome domains studied and outcome measures used in clinical studies of SSc-RP. METHODS Embase, MEDLINE, and the Cochrane Central Register of Controlled Trials were used to identify randomized control trials (RCTs), quasi-randomized studies, case-control studies, prospective and retrospective cohort studies, case series, and cross-sectional studies of adult participants with SSc-associated RP, written in English. A minimum of 25 participants for studies of imaging modalities and 40 participants for questionnaire-based studies was required for inclusion. Basic laboratory and genetic studies were excluded. No limitations were imposed based on intervention, comparator, or study setting. Study characteristics and primary and secondary target domains in each study were recorded. RESULTS 58 studies (24 randomized clinical trials) were included in the final analysis. The commonest domains captured were severity of attacks (n=35), frequency of attacks (n=28), and duration of attacks (n=19). Objective assessments of digital perfusion were also commonly used in studies of SSc-RP. CONCLUSION The outcome domains and the associated outcomes used to assess the impact of SSc-RP in research studies are broad and have varied across studies. The results of this study will inform the OMERACT Vascular Disease in Systemic Sclerosis Working Group to establish a core set of disease domains encompassing the impact of RP in SSc.
Collapse
Affiliation(s)
- Nancy Maltez
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
| | - Michael Hughes
- Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK; Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | | | | | - Beverley Shea
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Ariane L Herrick
- Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - Susanna Proudman
- Discipline of Medicine, University of Adelaide and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia
| | - Peter A Merkel
- Division of Rheumatology, Department of Medicine, Division of Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA
| | - John D Pauling
- North Bristol NHS Trust, Bristol, UK; Bristol Medical School, University of Bristol, Bristol, UK
| |
Collapse
|
4
|
Hughes M, Maltez N, Brown E, Hickey V, Shea B, Pauling JD, Proudman S, Merkel PA, Herrick AL. Domain reporting in Systemic Sclerosis-Related Digital Ulcers: An OMERACT Scoping Review. Semin Arthritis Rheum 2023; 61:152220. [PMID: 37236843 DOI: 10.1016/j.semarthrit.2023.152220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 04/20/2023] [Accepted: 04/26/2023] [Indexed: 05/28/2023]
Abstract
BACKGROUND Digital ulcers (DUs) are a major cause of pain and disability in patients with systemic sclerosis (SSc). The aim of this scoping review was to evaluate the outcome domains used in studies of SSc-associated DUs. METHODS Electronic databases (EMBASE, MEDLINE and the Cochrane Library) were searched for articles written (1947 onwards) in English relating to SSc-DUs. A minimum of 15 participants for studies of imaging and 25 participants for questionnaire-based studies was required for inclusion. Information on all primary and secondary domains was extracted. RESULTS 4869 manuscripts were identified, of which 40 met the eligibility criteria and were included in the synthesis. Most studies were randomized controlled trials (n=13), or prospective (n=12)/retrospective (n=8) observational studies. Interventions included oral or intravenous drugs (n=25), topical/local treatments (n=5), and surgical interventions (n=2). Approximately half the studies assessed either the count/number of DUs (n=23) and/or improvement in DUs (n=20). Functional impact of DUs was examined in 25% (n=10) of studies. Other domains were related to complications of DUs (n=7), pain (n=6), health-related quality of life (n=4), microvascular assessment/pathophysiology (n=4), global assessment of DUs (n=2), and histopathology (n=1). CONCLUSION This scoping review identified a broad range of disease-related domains used to study SSc-DUs. There is significant heterogeneity in these domains. These data will inform the ongoing work of the OMERACT Vascular Disease in Systemic Sclerosis Working Group to define a core set of disease broad domains to capture the burden of DUs in SSc.
Collapse
Affiliation(s)
- Michael Hughes
- Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK; Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
| | - Nancy Maltez
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | | | | | - Beverley Shea
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - John D Pauling
- North Bristol NHS Trust, Bristol, UK; Bristol Medical School, University of Bristol, Bristol, UK
| | - Susanna Proudman
- Discipline of Medicine, University of Adelaide and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia
| | - Peter A Merkel
- Division of Rheumatology, Department of Medicine, Division of Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA
| | - Ariane L Herrick
- Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| |
Collapse
|
5
|
Brown E, Whiteley W, Kale P. Incorporating Palliative Care Services in the Advanced Heart Failure Clinic. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
6
|
Brown E, Whiteley W, Kale P. Human Papilloma Virus Associated Malignancies in Heart Transplant Recipients. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
7
|
Hespe CM, Brown E, Rychetnik L. Learning from the implementation of a quality improvement intervention in Australian general practice: a qualitative analysis of participants views of a CVD preventive care project. BMC Prim Care 2022; 23:79. [PMID: 35421935 PMCID: PMC9011978 DOI: 10.1186/s12875-022-01692-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 04/04/2022] [Indexed: 11/23/2022]
Abstract
Background Quality improvement collaborative projects aim to reduce gaps in clinical care provided in the healthcare system. This study evaluated the experience of key participants from a Quality Improvement Program (QPulse) that focussed on cardiovascular disease assessment and management. The study goal was to identify critical barriers and factors enabling the implementation of a quality improvement framework in Australian general practice. Methods This qualitative study examined in-depth semi-structured interviews with nineteen purposively-selected participants of the QPulse project. Interviewees were from General Practices and the local supporting organisation, a Primary Health Network. Interviews were analysed thematically using the Complex Systems Improvement framework, focusing on five domains: strategy, culture, structure, workforce and technology. Results Despite reported engagement with QPulse objectives to improve cardiovascular preventive care, implementation barriers associated with this program were considerable for all interviewees. Adoption of the quality improvement process was reliant on designated leadership, aligned practice culture, organised systems for clear communication, tailored education and utilisation of clinical audit and review processes. Rather than practice size and location, practice culture and governance alignment to quality improvement predicted successful implementation. Financial incentives for both general practice and the Primary Health Network were also identified as prerequisites for systematised quality improvement projects in the future, along with individualised support and education for each general practice. Technology was both an enabler and a barrier, and the Primary Health Network was seen as key to assisting the successful utilisation of the available tools. Conclusions Implementation of Quality Improvement programs remains a potential tool for achieving better health outcomes in General Practice. However, enablers such as financial incentives, individualised education and support provided via a supporting organisation, and IT tools and support are crucial if the full potential of Quality Improvement programs are to be realised in the Australian healthcare setting. Trial registration ACTRN12615000108516, UTN U1111-1163–7995. Supplementary Information The online version contains supplementary material available at 10.1186/s12875-022-01692-0.
Collapse
|
8
|
Oya M, Armstrong A, Thiery-Vuillemin A, Shore N, Procopio G, Arslan Ç, Mehra N, Parnis F, Brown E, Constans Schlurmann F, Joung J, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Desai C, Del Rosario P, Clarke N, Saad F. 157O Biomarker analysis and updated results from the phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
9
|
Yost J, Brown E, Winders T, Jaffee H, Klein S, Martinez E, Silvera T, Malawer E. EPINEPHRINE AUTOINJECTOR UTILIZATION AND ACCESS IN A NATIONALLY REPRESENTATIVE FOOD-ALLERGIC ADULT SAMPLE. Ann Allergy Asthma Immunol 2022. [DOI: 10.1016/j.anai.2022.08.527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
10
|
Saad F, Armstrong A, Thiery-Vuillemin A, Oya M, Shore N, Procopio G, Arslan C, Mehra N, Parnis F, Brown E, Constans Schlurmann F, Joung J, Sugimoto M, Sartor O, Liu YZ, Poehlein C, Desai C, Del Rosario P, Clarke N. 1357O Biomarker analysis and updated results from the Phase III PROpel trial of abiraterone (abi) and olaparib (ola) vs abi and placebo (pbo) as first-line (1L) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
11
|
Kouli O, Murray V, Bhatia S, Cambridge WA, Kawka M, Shafi S, Knight SR, Kamarajah SK, McLean KA, Glasbey JC, Khaw RA, Ahmed W, Akhbari M, Baker D, Borakati A, Mills E, Thavayogan R, Yasin I, Raubenheimer K, Ridley W, Sarrami M, Zhang G, Egoroff N, Pockney P, Richards T, Bhangu A, Creagh-Brown B, Edwards M, Harrison EM, Lee M, Nepogodiev D, Pinkney T, Pearse R, Smart N, Vohra R, Sohrabi C, Jamieson A, Nguyen M, Rahman A, English C, Tincknell L, Kakodkar P, Kwek I, Punjabi N, Burns J, Varghese S, Erotocritou M, McGuckin S, Vayalapra S, Dominguez E, Moneim J, Salehi M, Tan HL, Yoong A, Zhu L, Seale B, Nowinka Z, Patel N, Chrisp B, Harris J, Maleyko I, Muneeb F, Gough M, James CE, Skan O, Chowdhury A, Rebuffa N, Khan H, Down B, Fatimah Hussain Q, Adams M, Bailey A, Cullen G, Fu YXJ, McClement B, Taylor A, Aitken S, Bachelet B, Brousse de Gersigny J, Chang C, Khehra B, Lahoud N, Lee Solano M, Louca M, Rozenbroek P, Rozitis E, Agbinya N, Anderson E, Arwi G, Barry I, Batchelor C, Chong T, Choo LY, Clark L, Daniels M, Goh J, Handa A, Hanna J, Huynh L, Jeon A, Kanbour A, Lee A, Lee J, Lee T, Leigh J, Ly D, McGregor F, Moss J, Nejatian M, O'Loughlin E, Ramos I, Sanchez B, Shrivathsa A, Sincari A, Sobhi S, Swart R, Trimboli J, Wignall P, Bourke E, Chong A, Clayton S, Dawson A, Hardy E, Iqbal R, Le L, Mao S, Marinelli I, Metcalfe H, Panicker D, R HH, Ridgway S, Tan HH, Thong S, Van M, Woon S, Woon-Shoo-Tong XS, Yu S, Ali K, Chee J, Chiu C, Chow YW, Duller A, Nagappan P, Ng S, Selvanathan M, Sheridan C, Temple M, Do JE, Dudi-Venkata NN, Humphries E, Li L, Mansour LT, Massy-Westropp C, Fang B, Farbood K, Hong H, Huang Y, Joan M, Koh C, Liu YHA, Mahajan T, Muller E, Park R, Tanudisastro M, Wu JJG, Chopra P, Giang S, Radcliffe S, Thach P, Wallace D, Wilkes A, Chinta SH, Li J, Phan J, Rahman F, Segaran A, Shannon J, Zhang M, Adams N, Bonte A, Choudhry A, Colterjohn N, Croyle JA, Donohue J, Feighery A, Keane A, McNamara D, Munir K, Roche D, Sabnani R, Seligman D, Sharma S, Stickney Z, Suchy H, Tan R, Yordi S, Ahmed I, Aranha M, El Sabawy D, Garwood P, Harnett M, Holohan R, Howard R, Kayyal Y, Krakoski N, Lupo M, McGilberry W, Nepon H, Scoleri Y, Urbina C, Ahmad Fuad MF, Ahmed O, Jaswantlal D, Kelly E, Khan MHT, Naidu D, Neo WX, O'Neill R, Sugrue M, Abbas JD, Abdul-Fattah S, Azlan A, Barry K, Idris NS, Kaka N, Mc Dermott D, Mohammad Nasir MN, Mozo M, Rehal A, Shaikh Yousef M, Wong RH, Curran E, Gardner M, Hogan A, Julka R, Lasser G, Ní Chorráin N, Ting J, Browne R, George S, Janjua Z, Leung Shing V, Megally M, Murphy S, Ravenscroft L, Vedadi A, Vyas V, Bryan A, Sheikh A, Ubhi J, Vannelli K, Vawda A, Adeusi L, Doherty C, Fitzgerald C, Gallagher H, Gill P, Hamza H, Hogan M, Kelly S, Larry J, Lynch P, Mazeni NA, O'Connell R, O'Loghlin R, Singh K, Abbas Syed R, Ali A, Alkandari B, Arnold A, Arora E, Azam R, Breathnach C, Cheema J, Compton M, Curran S, Elliott JA, Jayasamraj O, Mohammed N, Noone A, Pal A, Pandey S, Quinn P, Sheridan R, Siew L, Tan EP, Tio SW, Toh VTR, Walsh M, Yap C, Yassa J, Young T, Agarwal N, Almoosawy SA, Bowen K, Bruce D, Connachan R, Cook A, Daniell A, Elliott M, Fung HKF, Irving A, Laurie S, Lee YJ, Lim ZX, Maddineni S, McClenaghan RE, Muthuganesan V, Ravichandran P, Roberts N, Shaji S, Solt S, Toshney E, Arnold C, Baker O, Belais F, Bojanic C, Byrne M, Chau CYC, De Soysa S, Eldridge M, Fairey M, Fearnhead N, Guéroult A, Ho JSY, Joshi K, Kadiyala N, Khalid S, Khan F, Kumar K, Lewis E, Magee J, Manetta-Jones D, Mann S, McKeown L, Mitrofan C, Mohamed T, Monnickendam A, Ng AYKC, Ortu A, Patel M, Pope T, Pressling S, Purohit K, Saji S, Shah Foridi J, Shah R, Siddiqui SS, Surman K, Utukuri M, Varghese A, Williams CYK, Yang JJ, Billson E, Cheah E, Holmes P, Hussain S, Murdock D, Nicholls A, Patel P, Ramana G, Saleki M, Spence H, Thomas D, Yu C, Abousamra M, Brown C, Conti I, Donnelly A, Durand M, French N, Goan R, O'Kane E, Rubinchik P, Gardiner H, Kempf B, Lai YL, Matthews H, Minford E, Rafferty C, Reid C, Sheridan N, Al Bahri T, Bhoombla N, Rao BM, Titu L, Chatha S, Field C, Gandhi T, Gulati R, Jha R, Jones Sam MT, Karim S, Patel R, Saunders M, Sharma K, Abid S, Heath E, Kurup D, Patel A, Ali M, Cresswell B, Felstead D, Jennings K, Kaluarachchi T, Lazzereschi L, Mayson H, Miah JE, Reinders B, Rosser A, Thomas C, Williams H, Al-Hamid Z, Alsadoun L, Chlubek M, Fernando P, Gaunt E, Gercek Y, Maniar R, Ma R, Matson M, Moore S, Morris A, Nagappan PG, Ratnayake M, Rockall L, Shallcross O, Sinha A, Tan KE, Virdee S, Wenlock R, Donnelly HA, Ghazal R, Hughes I, Liu X, McFadden M, Misbert E, Mogey P, O'Hara A, Peace C, Rainey C, Raja P, Salem M, Salmon J, Tan CH, Alves D, Bahl S, Baker C, Coulthurst J, Koysombat K, Linn T, Rai P, Sharma A, Shergill A, Ahmed M, Ahmed S, Belk LH, Choudhry H, Cummings D, Dixon Y, Dobinson C, Edwards J, Flint J, Franco Da Silva C, Gallie R, Gardener M, Glover T, Greasley M, Hatab A, Howells R, Hussey T, Khan A, Mann A, Morrison H, Ng A, Osmond R, Padmakumar N, Pervaiz F, Prince R, Qureshi A, Sawhney R, Sigurdson B, Stephenson L, Vora K, Zacken A, Cope P, Di Traglia R, Ferarrio I, Hackett N, Healicon R, Horseman L, Lam LI, Meerdink M, Menham D, Murphy R, Nimmo I, Ramaesh A, Rees J, Soame R, Dilaver N, Adebambo D, Brown E, Burt J, Foster K, Kaliyappan L, Knight P, Politis A, Richardson E, Townsend J, Abdi M, Ball M, Easby S, Gill N, Ho E, Iqbal H, Matthews M, Nubi S, Nwokocha JO, Okafor I, Perry G, Sinartio B, Vanukuru N, Walkley D, Welch T, Yates J, Yeshitila N, Bryans K, Campbell B, Gray C, Keys R, Macartney M, Chamberlain G, Khatri A, Kucheria A, Lee STP, Reese G, Roy choudhury J, Tan WYR, Teh JJ, Ting A, Kazi S, Kontovounisios C, Vutipongsatorn K, Amarnath T, Balasubramanian N, Bassett E, Gurung P, Lim J, Panjikkaran A, Sanalla A, Alkoot M, Bacigalupo V, Eardley N, Horton M, Hurry A, Isti C, Maskell P, Nursiah K, Punn G, Salih H, Epanomeritakis E, Foulkes A, Henderson R, Johnston E, McCullough H, McLarnon M, Morrison E, Cheung A, Cho SH, Eriksson F, Hedges J, Low Z, May C, Musto L, Nagi S, Nur S, Salau E, Shabbir S, Thomas MC, Uthayanan L, Vig S, Zaheer M, Zeng G, Ashcroft-Quinn S, Brown R, Hayes J, McConville R, French R, Gilliam A, Sheetal S, Shehzad MU, Bani W, Christie I, Franklyn J, Khan M, Russell J, Smolarek S, Varadarassou R, Ahmed SK, Narayanaswamy S, Sealy J, Shah M, Dodhia V, Manukyan A, O'Hare R, Orbell J, Chung I, Forenc K, Gupta A, Agarwal A, Al Dabbagh A, Bennewith R, Bottomley J, Chu TSM, Chu YYA, Doherty W, Evans B, Hainsworth P, Hosfield T, Li CH, McCullagh I, Mehta A, Thaker A, Thompson B, Virdi A, Walker H, Wilkins E, Dixon C, Hassan MR, Lotca N, Tong KS, Batchelor-Parry H, Chaudhari S, Harris T, Hooper J, Johnson C, Mulvihill C, Nayler J, Olutobi O, Piramanayagam B, Stones K, Sussman M, Weaver C, Alam F, Al Rawi M, Andrew F, Arrayeh A, Azizan N, Hassan A, Iqbal Z, John I, Jones M, Kalake O, Keast M, Nicholas J, Patil A, Powell K, Roberts P, Sabri A, Segue AK, Shah A, Shaik Mohamed SA, Shehadeh A, Shenoy S, Tong A, Upcott M, Vijayasingam D, Anarfi S, Dauncey J, Devindaran A, Havalda P, Komninos G, Mwendwa E, Norman C, Richards J, Urquhart A, Allan J, Cahya E, Hunt H, McWhirter C, Norton R, Roxburgh C, Tan JY, Ali Butt S, Hansdot S, Haq I, Mootien A, Sanchez I, Vainas T, Deliyannis E, Tan M, Vipond M, Chittoor Satish NN, Dattani A, De Carvalho L, Gaston-Grubb M, Karunanithy L, Lowe B, Pace C, Raju K, Roope J, Taylor C, Youssef H, Munro T, Thorn C, Wong KHF, Yunus A, Chawla S, Datta A, Dinesh AA, Field D, Georgi T, Gwozdz A, Hamstead E, Howard N, Isleyen N, Jackson N, Kingdon J, Sagoo KS, Schizas A, Yin L, Aung E, Aung YY, Franklin S, Han SM, Kim WC, Martin Segura A, Rossi M, Ross T, Tirimanna R, Wang B, Zakieh O, Ben-Arzi H, Flach A, Jackson E, Magers S, Olu abara C, Rogers E, Sugden K, Tan H, Veliah S, Walton U, Asif A, Bharwada Y, Bowley D, Broekhuizen A, Cooper L, Evans N, Girdlestone H, Ling C, Mann H, Mehmood N, Mulvenna CL, Rainer N, Trout I, Gujjuri R, Jeyaraman D, Leong E, Singh D, Smith E, Anderton J, Barabas M, Goyal S, Howard D, Joshi A, Mitchell D, Weatherby T, Badminton R, Bird R, Burtle D, Choi NY, Devalia K, Farr E, Fischer F, Fish J, Gunn F, Jacobs D, Johnston P, Kalakoutas A, Lau E, Loo YNAF, Louden H, Makariou N, Mohammadi K, Nayab Y, Ruhomaun S, Ryliskyte R, Saeed M, Shinde P, Sudul M, Theodoropoulou K, Valadao-Spoorenberg J, Vlachou F, Arshad SR, Janmohamed AM, Noor M, Oyerinde O, Saha A, Syed Y, Watkinson W, Ahmadi H, Akintunde A, Alsaady A, Bradley J, Brothwood D, Burton M, Higgs M, Hoyle C, Katsura C, Lathan R, Louani A, Mandalia R, Prihartadi AS, Qaddoura B, Sandland-Taylor L, Thadani S, Thompson A, Walshaw J, Teo S, Ali S, Bawa JH, Fox S, Gargan K, Haider SA, Hanna N, Hatoum A, Khan Z, Krzak AM, Li T, Pitt J, Tan GJS, Ullah Z, Wilson E, Cleaver J, Colman J, Copeland L, Coulson A, Davis P, Faisal H, Hassan F, Hughes JT, Jabr Y, Mahmoud Ali F, Nahaboo Solim ZN, Sangheli A, Shaya S, Thompson R, Cornwall H, De Andres Crespo M, Fay E, Findlay J, Groves E, Jones O, Killen A, Millo J, Thomas S, Ward J, Wilkins M, Zaki F, Zilber E, Bhavra K, Bilolikar A, Charalambous M, Elawad A, Eleni A, Fawdon R, Gibbins A, Livingstone D, Mala D, Oke SE, Padmakumar D, Patsalides MA, Payne D, Ralphs C, Roney A, Sardar N, Stefanova K, Surti F, Timms R, Tosney G, Bannister J, Clement NS, Cullimore V, Kamal F, Lendor J, McKay J, Mcswiggan J, Minhas N, Seneviratne K, Simeen S, Valverde J, Watson N, Bloom I, Dinh TH, Hirniak J, Joseph R, Kansagra M, Lai CKN, Melamed N, Patel J, Randev J, Sedighi T, Shurovi B, Sodhi J, Vadgama N, Abdulla S, Adabavazeh B, Champion A, Chennupati R, Chu K, Devi S, Haji A, Schulz J, Testa F, Davies P, Gurung B, Howell S, Modi P, Pervaiz A, Zahid M, Abdolrazaghi S, Abi Aoun R, Anjum Z, Bawa G, Bhardwaj R, Brown S, Enver M, Gill D, Gopikrishna D, Gurung D, Kanwal A, Kaushal P, Khanna A, Lovell E, McEvoy C, Mirza M, Nabeel S, Naseem S, Pandya K, Perkins R, Pulakal R, Ray M, Reay C, Reilly S, Round A, Seehra J, Shakeel NM, Singh B, Vijay Sukhnani M, Brown L, Desai B, Elzanati H, Godhaniya J, Kavanagh E, Kent J, Kishor A, Liu A, Norwood M, Shaari N, Wood C, Wood M, Brown A, Chellapuri A, Ferriman A, Ghosh I, Kulkarni N, Noton T, Pinto A, Rajesh S, Varghese B, Wenban C, Aly R, Barciela C, Brookes T, Corrin E, Goldsworthy M, Mohamed Azhar MS, Moore J, Nakhuda S, Ng D, Pillay S, Port S, Abdullah M, Akinyemi J, Islam S, Kale A, Lewis A, Manjunath T, McCabe H, Misra S, Stubley T, Tam JP, Waraich N, Chaora T, Ford C, Osinkolu I, Pong G, Rai J, Risquet R, Ainsworth J, Ayandokun P, Barham E, Barrett G, Barry J, Bisson E, Bridges I, Burke D, Cann J, Cloney M, Coates S, Cripps P, Davies C, Francis N, Green S, Handley G, Hathaway D, Hurt L, Jenkins S, Johnston C, Khadka A, McGee U, Morris D, Murray R, Norbury C, Pierrepont Z, Richards C, Ross O, Ruddy A, Salmon C, Shield M, Soanes K, Spencer N, Taverner S, Williams C, Wills-Wood W, Woodward S, Chow J, Fan J, Guest O, Hunter I, Moon WY, Arthur-Quarm S, Edwards P, Hamlyn V, McEneaney L, N D G, Pranoy S, Ting M, Abada S, Alawattegama LH, Ashok A, Carey C, Gogna A, Haglund C, Hurley P, Leelo N, Liu B, Mannan F, Paramjothy K, Ramlogan K, Raymond-Hayling O, Shanmugarajah A, Solichan D, Wilkinson B, Ahmad NA, Allan D, Amin A, Bakina C, Burns F, Cameron F, Campbell A, Cavanagh S, Chan SMZ, Chapman S, Chong V, Edelsten E, Ekpete O, El Sheikh M, Ghose R, Hassane A, Henderson C, Hilton-Christie S, Husain M, Hussain H, Javid Z, Johnson-Ogbuneke J, Johnston A, Khalil M, Leung TCC, Makin I, Muralidharan V, Naeem M, Patil P, Ravichandran S, Saraeva D, Shankey-Smith W, Sharma N, Swan R, Waudby-West R, Wilkinson A, Wright K, Balasubramanian A, Bhatti S, Chalkley M, Chou WK, Dixon M, Evans L, Fisher K, Gandhi P, Ho S, Lau YB, Lowe S, Meechan C, Murali N, Musonda C, Njoku P, Ochieng L, Pervez MU, Seebah K, Shaikh I, Sikder MA, Vanker R, Alom J, Bajaj V, Coleman O, Finch G, Goss J, Jenkins C, Kontothanassis A, Liew MS, Ng K, Outram M, Shakeel MM, Tawn J, Zuhairy S, Chapple K, Cinnamond A, Coleman S, George HA, Goulder L, Hare N, Hawksley J, Kret A, Luesley A, Mecia L, Porter H, Puddy E, Richardson G, Sohail B, Srikaran V, Tadross D, Tobin J, Tokidis E, Young L, Ashdown T, Bratsos S, Koomson A, Kufuor A, Lim MQ, Shah S, Thorne EPC, Warusavitarne J, Xu S, Abigail S, Ahmed A, Ahmed J, Akmal A, Al-Khafaji M, Amini B, Arshad M, Bogie E, Brazkiewicz M, Carroll M, Chandegra A, Cirelli C, Deng A, Fairclough S, Fung YJ, Gornell C, Green RL, Green SV, Gulamhussein AHM, Isaac AG, Jan R, Jegatheeswaran L, Knee M, Kotecha J, Kotecha S, Maxwell-Armstrong C, McIntyre C, Mendis N, Naing TKP, Oberman J, Ong ZX, Ramalingam A, Saeed Adam A, Tan LL, Towell S, Yadav J, Anandampillai R, Chung S, Hounat A, Ibrahim B, Jeyakumar G, Khalil A, Khan UA, Nair G, Owusu-Ayim M, Wilson M, Kanani A, Kilkelly B, Ogunmwonyi I, Ong L, Samra B, Schomerus L, Shea J, Turner O, Yang Y, Amin M, Blott N, Clark A, Feather A, Forrest M, Hague S, Hamilton K, Higginbotham G, Hope E, Karimian S, Loveday K, Malik H, McKenna O, Noor A, Onsiong C, Patel B, Radcliffe N, Shah P, Tye L, Verma K, Walford R, Yusufi U, Zachariah M, Casey A, Doré C, Fludder V, Fortescue L, Kalapu SS, Karel E, Khera G, Smith C, Appleton B, Ashaye A, Boggon E, Evans A, Faris Mahmood H, Hinchcliffe Z, Marei O, Silva I, Spooner C, Thomas G, Timlin M, Wellington J, Yao SL, Abdelrazek M, Abdelrazik Y, Bee F, Joseph A, Mounce A, Parry G, Vignarajah N, Biddles D, Creissen A, Kolhe S, K T, Lea A, Ledda V, O'Loughlin P, Scanlon J, Shetty N, Weller C, Abdalla M, Adeoye A, Bhatti M, Chadda KR, Chu J, Elhakim H, Foster-Davies H, Rabie M, Tailor B, Webb S, Abdelrahim ASA, Choo SY, Jiwa A, Mangam S, Murray S, Shandramohan A, Aghanenu O, Budd W, Hayre J, Khanom S, Liew ZY, McKinney R, Moody N, Muhammad-Kamal H, Odogwu J, Patel D, Roy C, Sattar Z, Shahrokhi N, Sinha I, Thomson E, Wonga L, Bain J, Khan J, Ricardo D, Bevis R, Cherry C, Darkwa S, Drew W, Griffiths E, Konda N, Madani D, Mak JKC, Meda B, Odunukwe U, Preest G, Raheel F, Rajaseharan A, Ramgopal A, Risbrooke C, Selvaratnam K, Sethunath G, Tabassum R, Taylor J, Thakker A, Wijesingha N, Wybrew R, Yasin T, Ahmed Osman A, Alfadhel S, Carberry E, Chen JY, Drake I, Glen P, Jayasuriya N, Kawar L, Myatt R, Sinan LOH, Siu SSY, Tjen V, Adeboyejo O, Bacon H, Barnes R, Birnie C, D'Cunha Kamath A, Hughes E, Middleton S, Owen R, Schofield E, Short C, Smith R, Wang H, Willett M, Zimmerman M, Balfour J, Chadwick T, Coombe-Jones M, Do Le HP, Faulkner G, Hobson K, Shehata Z, Beattie M, Chmielewski G, Chong C, Donnelly B, Drusch B, Ellis J, Farrelly C, Feyi-Waboso J, Hibell I, Hoade L, Ho C, Jones H, Kodiatt B, Lidder P, Ni Cheallaigh L, Norman R, Patabendi I, Penfold H, Playfair M, Pomeroy S, Ralph C, Rottenburg H, Sebastian J, Sheehan M, Stanley V, Welchman J, Ajdarpasic D, Antypas A, Azouaghe O, Basi S, Bettoli G, Bhattarai S, Bommireddy L, Bourne K, Budding J, Cookey-Bresi R, Cummins T, Davies G, Fabelurin C, Gwilliam R, Hanley J, Hird A, Kruczynska A, Langhorne B, Lund J, Lutchman I, McGuinness R, Neary M, Pampapathi S, Pang E, Podbicanin S, Rai N, Redhouse White G, Sujith J, Thomas P, Walker I, Winterton R, Anderson P, Barrington M, Bhadra K, Clark G, Fowler G, Gibson C, Hudson S, Kaminskaite V, Lawday S, Longshaw A, MacKrill E, McLachlan F, Murdeshwar A, Nieuwoudt R, Parker P, Randall R, Rawlins E, Reeves SA, Rye D, Sirkis T, Sykes B, Ventress N, Wosinska N, Akram B, Burton L, Coombs A, Long R, Magowan D, Ong C, Sethi M, Williams G, Chan C, Chan LH, Fernando D, Gaba F, Khor Z, Les JW, Mak R, Moin S, Ng Kee Kwong KC, Paterson-Brown S, Tew YY, Bardon A, Burrell K, Coldwell C, Costa I, Dexter E, Hardy A, Khojani M, Mazurek J, Raymond T, Reddy V, Reynolds J, Soma A, Agiotakis S, Alsusa H, Desai N, Peristerakis I, Adcock A, Ayub H, Bennett T, Bibi F, Brenac S, Chapman T, Clarke G, Clark F, Galvin C, Gwyn-Jones A, Henry-Blake C, Kerner S, Kiandee M, Lovett A, Pilecka A, Ravindran R, Siddique H, Sikand T, Treadwell K, Akmal K, Apata A, Barton O, Broad G, Darling H, Dhuga Y, Emms L, Habib S, Jain R, Jeater J, Kan CYP, Kathiravelupillai A, Khatkar H, Kirmani S, Kulasabanathan K, Lacey H, Lal K, Manafa C, Mansoor M, McDonald S, Mittal A, Mustoe S, Nottrodt L, Oliver P, Papapetrou I, Pattinson F, Raja M, Reyhani H, Shahmiri A, Small O, Soni U, Aguirrezabala Armbruster B, Bunni J, Hakim MA, Hawkins-Hooker L, Howell KA, Hullait R, Jaskowska A, Ottewell L, Thomas-Jones I, Vasudev A, Clements B, Fenton J, Gill M, Haider S, Lim AJM, Maguire H, McMullan J, Nicoletti J, Samuel S, Unais MA, White N, Yao PC, Yow L, Boyle C, Brady R, Cheekoty P, Cheong J, Chew SJHL, Chow R, Ganewatta Kankanamge D, Mamer L, Mohammed B, Ng Chieng Hin J, Renji Chungath R, Royston A, Sharrad E, Sinclair R, Tingle S, Treherne K, Wyatt F, Maniarasu VS, Moug S, Appanna T, Bucknall T, Hussain F, Owen A, Parry M, Parry R, Sagua N, Spofforth K, Yuen ECT, Bosley N, Hardie W, Moore T, Regas C, Abdel-Khaleq S, Ali N, Bashiti H, Buxton-Hopley R, Constantinides M, D'Afflitto M, Deshpande A, Duque Golding J, Frisira E, Germani Batacchi M, Gomaa A, Hay D, Hutchison R, Iakovou A, Iakovou D, Ismail E, Jefferson S, Jones L, Khouli Y, Knowles C, Mason J, McCaughan R, Moffatt J, Morawala A, Nadir H, Neyroud F, Nikookam Y, Parmar A, Pinto L, Ramamoorthy R, Richards E, Thomson S, Trainer C, Valetopoulou A, Vassiliou A, Wantman A, Wilde S, Dickinson M, Rockall T, Senn D, Wcislo K, Zalmay P, Adelekan K, Allen K, Bajaj M, Gatumbu P, Hang S, Hashmi Y, Kaur T, Kawesha A, Kisiel A, Woodmass M, Adelowo T, Ahari D, Alhwaishel K, Atherton R, Clayton B, Cockroft A, Curtis Lopez C, Hilton M, Ismail N, Kouadria M, Lee L, MacConnachie A, Monks F, Mungroo S, Nikoletopoulou C, Pearce L, Sara X, Shahid A, Suresh G, Wilcha R, Atiyah A, Davies E, Dermanis A, Gibbons H, Hyde A, Lawson A, Lee C, Leung-Tack M, Li Saw Hee J, Mostafa O, Nair D, Pattani N, Plumbley-Jones J, Pufal K, Ramesh P, Sanghera J, Saram S, Scadding S, See S, Stringer H, Torrance A, Vardon H, Wyn-Griffiths F, Brew A, Kaur G, Soni D, Tickle A, Akbar Z, Appleyard T, Figg K, Jayawardena P, Johnson A, Kamran Siddiqui Z, Lacy-Colson J, Oatham R, Rowlands B, Sludden E, Turnbull C, Allin D, Ansar Z, Azeez Z, Dale VH, Garg J, Horner A, Jones S, Knight S, McGregor C, McKenna J, McLelland T, Packham-Smith A, Rowsell K, Spector-Hill I, Adeniken E, Baker J, Bartlett M, Chikomba L, Connell B, Deekonda P, Dhar M, Elmansouri A, Gamage K, Goodhew R, Hanna P, Knight J, Luca A, Maasoumi N, Mahamoud F, Manji S, Marwaha PK, Mason F, Oluboyede A, Pigott L, Razaq AM, Richardson M, Saddaoui I, Wijeyendram P, Yau S, Atkins W, Liang K, Miles N, Praveen B, Ashai S, Braganza J, Common J, Cundy A, Davies R, Guthrie J, Handa I, Iqbal M, Ismail R, Jones C, Jones I, Lee KS, Levene A, Okocha M, Olivier J, Smith A, Subramaniam E, Tandle S, Wang A, Watson A, Wilson C, Chan XHF, Khoo E, Montgomery C, Norris M, Pugalenthi PP, Common T, Cook E, Mistry H, Shinmar HS, Agarwal G, Bandyopadhyay S, Brazier B, Carroll L, Goede A, Harbourne A, Lakhani A, Lami M, Larwood J, Martin J, Merchant J, Pattenden S, Pradhan A, Raafat N, Rothwell E, Shammoon Y, Sudarshan R, Vickers E, Wingfield L, Ashworth I, Azizi S, Bhate R, Chowdhury T, Christou A, Davies L, Dwaraknath M, Farah Y, Garner J, Gureviciute E, Hart E, Jain A, Javid S, Kankam HK, Kaur Toor P, Kaz R, Kermali M, Khan I, Mattson A, McManus A, Murphy M, Nair K, Ngemoh D, Norton E, Olabiran A, Parry L, Payne T, Pillai K, Price S, Punjabi K, Raghunathan A, Ramwell A, Raza M, Ritehnia J, Simpson G, Smith W, Sodeinde S, Studd L, Subramaniam M, Thomas J, Towey S, Tsang E, Tuteja D, Vasani J, Vio M, Badran A, Adams J, Anthony Wilkinson J, Asvandi S, Austin T, Bald A, Bix E, Carrick M, Chander B, Chowdhury S, Cooper Drake B, Crosbie S, D Portela S, Francis D, Gallagher C, Gillespie R, Gravett H, Gupta P, Ilyas C, James G, Johny J, Jones A, Kinder F, MacLeod C, Macrow C, Maqsood-Shah A, Mather J, McCann L, McMahon R, Mitham E, Mohamed M, Munton E, Nightingale K, O'Neill K, Onyemuchara I, Senior R, Shanahan A, Sherlock J, Spyridoulias A, Stavrou C, Stokes D, Tamang R, Taylor E, Trafford C, Uden C, Waddington C, Yassin D, Zaman M, Bangi S, Cheng T, Chew D, Hussain N, Imani-Masouleh S, Mahasivam G, McKnight G, Ng HL, Ota HC, Pasha T, Ravindran W, Shah K, Vishnu K S, Zaman S, Carr W, Cope S, Eagles EJ, Howarth-Maddison M, Li CY, Reed J, Ridge A, Stubbs T, Teasdaled D, Umar R, Worthington J, Dhebri A, Kalenderov R, Alattas A, Arain Z, Bhudia R, Chia D, Daniel S, Dar T, Garland H, Girish M, Hampson A, Kyriacou H, Lehovsky K, Mullins W, Omorphos N, Vasdev N, Venkatesh A, Waldock W, Bhandari A, Brown G, Choa G, Eichenauer CE, Ezennia K, Kidwai Z, Lloyd-Thomas A, Macaskill Stewart A, Massardi C, Sinclair E, Skajaa N, Smith M, Tan I, Afsheen N, Anuar A, Azam Z, Bhatia P, Davies-kelly N, Dickinson S, Elkawafi M, Ganapathy M, Gupta S, Khoury EG, Licudi D, Mehta V, Neequaye S, Nita G, Tay VL, Zhao S, Botsa E, Cuthbert H, Elliott J, Furlepa M, Lehmann J, Mangtani A, Narayan A, Nazarian S, Parmar C, Shah D, Shaw C, Zhao Z, Beck C, Caldwell S, Clements JM, French B, Kenny R, Kirk S, Lindsay J, McClung A, McLaughlin N, Watson S, Whiteside E, Alyacoubi S, Arumugam V, Beg R, Dawas K, Garg S, Lloyd ER, Mahfouz Y, Manobharath N, Moonesinghe R, Morka N, Patel K, Prashar J, Yip S, Adeeko ES, Ajekigbe F, Bhat A, Evans C, Farrugia A, Gurung C, Long T, Malik B, Manirajan S, Newport D, Rayer J, Ridha A, Ross E, Saran T, Sinker A, Waruingi D, Allen R, Al Sadek Y, Alves do Canto Brum H, Asharaf H, Ashman M, Balakumar V, Barrington J, Baskaran R, Berry A, Bhachoo H, Bilal A, Boaden L, Chia WL, Covell G, Crook D, Dadnam F, Davis L, De Berker H, Doyle C, Fox C, Gruffydd-Davies M, Hafouda Y, Hill A, Hubbard E, Hunter A, Inpadhas V, Jamshaid M, Jandu G, Jeyanthi M, Jones T, Kantor C, Kwak SY, Malik N, Matt R, McNulty P, Miles C, Mohomed A, Myat P, Niharika J, Nixon A, O'Reilly D, Parmar K, Pengelly S, Price L, Ramsden M, Turnor R, Wales E, Waring H, Wu M, Yang T, Ye TTS, Zander A, Zeicu C, Bellam S, Francombe J, Kawamoto N, Rahman MR, Sathyanarayana A, Tang HT, Cheung J, Hollingshead J, Page V, Sugarman J, Wong E, Chiong J, Fung E, Kan SY, Kiang J, Kok J, Krahelski O, Liew MY, Lyell B, Sharif Z, Speake D, Alim L, Amakye NY, Chandrasekaran J, Chandratreya N, Drake J, Owoso T, Thu YM, Abou El Ela Bourquin B, Alberts J, Chapman D, Rehnnuma N, Ainsworth K, Carpenter H, Emmanuel T, Fisher T, Gabrel M, Guan Z, Hollows S, Hotouras A, Ip Fung Chun N, Jaffer S, Kallikas G, Kennedy N, Lewinsohn B, Liu FY, Mohammed S, Rutherfurd A, Situ T, Stammer A, Taylor F, Thin N, Urgesi E, Zhang N, Ahmad MA, Bishop A, Bowes A, Dixit A, Glasson R, Hatta S, Hatt K, Larcombe S, Preece J, Riordan E, Fegredo D, Haq MZ, Li C, McCann G, Stewart D, Baraza W, Bhullar D, Burt G, Coyle J, Deans J, Devine A, Hird R, Ikotun O, Manchip G, Ross C, Storey L, Tan WWL, Tse C, Warner C, Whitehead M, Wu F, Court EL, Crisp E, Huttman M, Mayes F, Robertson H, Rosen H, Sandberg C, Smith H, Al Bakry M, Ashwell W, Bajaj S, Bandyopadhyay D, Browlee O, Burway S, Chand CP, Elsayeh K, Elsharkawi A, Evans E, Ferrin S, Fort-Schaale A, Iacob M, I K, Impelliziere Licastro G, Mankoo AS, Olaniyan T, Otun J, Pereira R, Reddy R, Saeed D, Simmonds O, Singhal G, Tron K, Wickstone C, Williams R, Bradshaw E, De Kock Jewell V, Houlden C, Knight C, Metezai H, Mirza-Davies A, Seymour Z, Spink D, Wischhusen S. Evaluation of prognostic risk models for postoperative pulmonary complications in adult patients undergoing major abdominal surgery: a systematic review and international external validation cohort study. Lancet Digit Health 2022; 4:e520-e531. [PMID: 35750401 DOI: 10.1016/s2589-7500(22)00069-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2021] [Revised: 01/07/2022] [Accepted: 04/06/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Stratifying risk of postoperative pulmonary complications after major abdominal surgery allows clinicians to modify risk through targeted interventions and enhanced monitoring. In this study, we aimed to identify and validate prognostic models against a new consensus definition of postoperative pulmonary complications. METHODS We did a systematic review and international external validation cohort study. The systematic review was done in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched MEDLINE and Embase on March 1, 2020, for articles published in English that reported on risk prediction models for postoperative pulmonary complications following abdominal surgery. External validation of existing models was done within a prospective international cohort study of adult patients (≥18 years) undergoing major abdominal surgery. Data were collected between Jan 1, 2019, and April 30, 2019, in the UK, Ireland, and Australia. Discriminative ability and prognostic accuracy summary statistics were compared between models for the 30-day postoperative pulmonary complication rate as defined by the Standardised Endpoints in Perioperative Medicine Core Outcome Measures in Perioperative and Anaesthetic Care (StEP-COMPAC). Model performance was compared using the area under the receiver operating characteristic curve (AUROCC). FINDINGS In total, we identified 2903 records from our literature search; of which, 2514 (86·6%) unique records were screened, 121 (4·8%) of 2514 full texts were assessed for eligibility, and 29 unique prognostic models were identified. Nine (31·0%) of 29 models had score development reported only, 19 (65·5%) had undergone internal validation, and only four (13·8%) had been externally validated. Data to validate six eligible models were collected in the international external validation cohort study. Data from 11 591 patients were available, with an overall postoperative pulmonary complication rate of 7·8% (n=903). None of the six models showed good discrimination (defined as AUROCC ≥0·70) for identifying postoperative pulmonary complications, with the Assess Respiratory Risk in Surgical Patients in Catalonia score showing the best discrimination (AUROCC 0·700 [95% CI 0·683-0·717]). INTERPRETATION In the pre-COVID-19 pandemic data, variability in the risk of pulmonary complications (StEP-COMPAC definition) following major abdominal surgery was poorly described by existing prognostication tools. To improve surgical safety during the COVID-19 pandemic recovery and beyond, novel risk stratification tools are required. FUNDING British Journal of Surgery Society.
Collapse
|
12
|
Becker C, As-Sanie S, Abrao M, Brown E, Arjona Ferreira J, Wagman R, Wang F, Perry J, Johnson N, Giuduce L. O-305 SPIRIT long-term extension study: two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain. Hum Reprod 2022. [DOI: 10.1093/humrep/deac105.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Study question
To assess the long-term efficacy and safety of once-daily Relugolix combination therapy (Relugolix-CT) in the treatment of endometriosis-associated pain over two years.
Summary answer
Relugolix-CT previously demonstrated sustained improvement of endometriosis-associated pain and was generally well tolerated over 52 weeks. Research is ongoing: two-year results will be reported.
What is known already
SPIRIT 1&2 were international, Phase 3, replicate, randomized, double-blind, placebo-controlled studies of Relugolix-CT (relugolix 40mg, estradiol 1mg, norethisterone acetate 0.5mg) in premenopausal women with moderate-to-severe endometriosis-associated pain, which were followed by the open-label, 80-week, long-term extension. 52-week results showed sustained improvement in dysmenorrhea and non-menstrual pelvic pain (NMPP) with 84.8% and 73.3% of responders, respectively. Efficacy was evidenced by reductions in dysmenorrhea (82.8%,) NMPP (62.9%,) proportion of women using opioids, and improvements in function. Relugolix-CT was generally well tolerated. Bone mineral density (BMD) assessment showed minimal initial decline (<1%) from baseline followed by stabilization from Week 24 to 52.
Study design, size, duration
Women who completed the 24-week pivotal studies (SPIRIT 1&2) were eligible to enroll in an 80-week open-label, single-arm, long-term extension study of safety and efficacy, representing up to 104 weeks of treatment in total. All women enrolled in the long-term extension study received once-daily oral Relugolix-CT. Analyses were performed based on the initial randomized treatment groups in pivotal studies: Relugolix-CT, delayed Relugolix-CT (relugolix 40mg alone for 12 weeks, then Relugolix-CT for 12 weeks), or placebo.
Participants/materials, setting, methods
Primary endpoints are proportion of dysmenorrhea and NMPP responders at Weeks 52 and 104 based on daily Numerical Rating Scale (NRS) scores (0=no pain, 10=worst pain imaginable) and analgesic use. Responders are women who achieved a predefined, clinically meaningful reduction from baseline in NRS score and no increase in analgesic use. Secondary efficacy endpoints include change in Endometriosis Health Profile-30 pain domain scores, use of opioids/analgesics. Safety endpoints include adverse events and BMD (percent change).
Main results and the role of chance
Of 1251 randomized patients in SPIRIT 1&2, 1044 (83.4%) completed the pivotal studies; 802 (76.8%) enrolled in the long-term extension, and 681 (84.9%) completed 52 weeks of treatment. Baseline demographics and clinical characteristics of the long-term extension population were consistent with those of the pivotal study population. The study remains ongoing at the time of writing. Efficacy and safety data with Relugolix-CT for up to Week 104, will be presented at the scientific session of the 2022 congress.
Limitations, reasons for caution
The study was conducted as an open-label study without a control group over the 80 weeks of the extension period.
Wider implications of the findings
Through 52 weeks of treatment, Relugolix-CT demonstrated sustained improvement of dysmenorrhea, NMPP, function, and reduced need for opiates in women with endometriosis-associated pain. No new safety concerns were identified, and treatment was associated with BMD loss <1%. Data from 104 weeks of treatment will be presented at the 2022 congress.
Trial registration number
NCT03654274
Collapse
Affiliation(s)
- C Becker
- University of Oxford, Nuffield Department of Women's and Reproductive Health, Headington- Oxford , United Kingdom
| | - S As-Sanie
- University of Michigan Medical Center, Obstetrics and Gynecology , Michigan, U.S.A
| | - M.S Abrao
- São Paulo University , Ob/Gyn, São Paulo, Brazil
| | - E Brown
- Medi-Sense- Inc.-, Medi-Sense- Inc .-, Atlanta- Georgia, U.S.A
| | | | - R.B Wagman
- Myovant Sciences Inc., Myovant Sciences Inc ., Brisbane- California, U.S.A
| | - F Wang
- Myovant Sciences Inc., Myovant Sciences Inc ., Brisbane- California, U.S.A
| | - J.S Perry
- Myovant Sciences Inc., Myovant Sciences Inc ., Brisbane- California, U.S.A
| | - N Johnson
- University of Adelaide, Robinson Research Institute , Adelaide, Australia
| | - L.C Giuduce
- University of California San Francisco, Department of Obstetrics- Gynecology and Reproductive Sciences , San Francisco- California, U.S.A
| |
Collapse
|
13
|
Pathmanathan K, Mubin M, Sevilla C, Zaman M, Chan R, Hussain M, Brown E, McDevitt G, Khan R, Nandi A, Mukherjee B, Obiechina N. 970 FRAILTY IS INVERSELY CORRELATED WITH SERUM ALBUMIN IN ACUTE HIP FRACTURE. Age Ageing 2022. [DOI: 10.1093/ageing/afac126.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Introduction
Frailty and sarcopenia have been shown to significantly increase the risk of falls, traumatic hip fractures and all-cause mortality in the elderly. The assessment of frailty using a validated clinical frailty scale such as that proposed by Rockwood et al., therefore, continues to remain an important step in determining post-operative prognosis in patients undergoing hip fracture surgery. The purpose of this study was to examine the relationship between frailty and serum albumin—an independent biochemical predictor of survival in hip fracture patients (1).
Method
This retrospective cross-sectional study analysed 190 patients, aged above 60 years, admitted to Queen’s Hospital Burton (QHB) between the 1st January and 28th December 2019 with a newly diagnosed hip fracture. Pre-operative serum albumin levels (g/L) and Rockwood clinical frailty scores (rCFS) were recorded from electronic medical records (EMR). Using the SPSS 27 statistical package, Pearson’s correlation co-efficient and linear regression analysis were carried out using these variables.
Results
A total of 190 patients were included in the study (57 male, 133 female). Mean patient age was 82.2 ± 8.47 years. More than 50% of patients had a Rockwood CFS ≥5. Mean serum albumin (g/L) was 37.3 ± 6.56. A statistically significant inverse correlation was demonstrated between pre-operative serum albumin levels and Rockwood CFS (r = −0.243, p < 0.001).
Conclusion
This study showed how serum albumin, a negative acute phase reactant and marker of chronic malnutrition, is inversely associated with frailty in hip fracture patients and the important role of Rockwood CFS and pre-operative serum albumin levels in the prognostication of hip fractures in the elderly. References 1) Bohl D, Shen M, Hannon C, Fillingham Y, Darrith B, Della Valle C. Serum Albumin Predicts Survival and Postoperative Course Following Surgery for Geriatric Hip Fracture. Journal of Bone and Joint Surgery. 2017;99(24):2110–2,118.
Collapse
Affiliation(s)
- K Pathmanathan
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - M Mubin
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - C Sevilla
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - M Zaman
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - R Chan
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - M Hussain
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - E Brown
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - G McDevitt
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - R Khan
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - A Nandi
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - B Mukherjee
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| | - N Obiechina
- Department of Elderly Medicine; University Hospitals Derby and Burton NHS Foundation Trust
| |
Collapse
|
14
|
Jain A, Brown E, Htay H, Pawlak M, Chirumarry S, Gadi V, Singh S, Lim J, Gow S, Chen B, Jamaluddin S, Wang Y, Gori M, Venkataraya S, Foo M. POS-689 APPLICATION OF AN ADVANCED ULTRAFILTRATION MANAGEMENT SYSTEM USING AWAK SORBENT-BASED PERITIONEAL DIALYSIS IN A PORCINE MODEL. Kidney Int Rep 2022. [DOI: 10.1016/j.ekir.2022.01.723] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
15
|
Walsh CL, Tafforeau P, Wagner WL, Jafree DJ, Bellier A, Werlein C, Kühnel MP, Boller E, Walker-Samuel S, Robertus JL, Long DA, Jacob J, Marussi S, Brown E, Holroyd N, Jonigk DD, Ackermann M, Lee PD. Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography. Nat Methods 2021; 18:1532-1541. [PMID: 34737453 PMCID: PMC8648561 DOI: 10.1038/s41592-021-01317-x] [Citation(s) in RCA: 64] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Accepted: 10/05/2021] [Indexed: 12/24/2022]
Abstract
Imaging intact human organs from the organ to the cellular scale in three dimensions is a goal of biomedical imaging. To meet this challenge, we developed hierarchical phase-contrast tomography (HiP-CT), an X-ray phase propagation technique using the European Synchrotron Radiation Facility (ESRF)'s Extremely Brilliant Source (EBS). The spatial coherence of the ESRF-EBS combined with our beamline equipment, sample preparation and scanning developments enabled us to perform non-destructive, three-dimensional (3D) scans with hierarchically increasing resolution at any location in whole human organs. We applied HiP-CT to image five intact human organ types: brain, lung, heart, kidney and spleen. HiP-CT provided a structural overview of each whole organ followed by multiple higher-resolution volumes of interest, capturing organotypic functional units and certain individual specialized cells within intact human organs. We demonstrate the potential applications of HiP-CT through quantification and morphometry of glomeruli in an intact human kidney and identification of regional changes in the tissue architecture in a lung from a deceased donor with coronavirus disease 2019 (COVID-19).
Collapse
Affiliation(s)
- C L Walsh
- Department of Mechanical Engineering, University College London, London, UK.
- Centre for Advanced Biomedical Imaging, University College London, London, UK.
| | - P Tafforeau
- European Synchrotron Radiation Facility, Grenoble, France.
| | - W L Wagner
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
- German Lung Research Centre (DZL), Translational Lung Research Centre Heidelberg (TLRC), Heidelberg, Germany
| | - D J Jafree
- Developmental Biology and Cancer Programme, Great Ormond Street Institute of Child Health, University College London, London, UK
- UCL MB/PhD Programme, Faculty of Medical Sciences, University College London, London, UK
| | - A Bellier
- French Alps Laboratory of Anatomy (LADAF), Grenoble Alpes University, Grenoble, France
| | - C Werlein
- Institute of Pathology, Hannover Medical School, Hannover, Germany
| | - M P Kühnel
- Institute of Pathology, Hannover Medical School, Hannover, Germany
- German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany
| | - E Boller
- European Synchrotron Radiation Facility, Grenoble, France
| | - S Walker-Samuel
- Centre for Advanced Biomedical Imaging, University College London, London, UK
| | - J L Robertus
- Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, UK
- National Heart and Lung Institute, Imperial College London, London, UK
| | - D A Long
- Developmental Biology and Cancer Programme, Great Ormond Street Institute of Child Health, University College London, London, UK
| | - J Jacob
- Centre for Medical Image Computing, University College London, London, UK
- UCL Respiratory, University College London, London, UK
| | - S Marussi
- Department of Mechanical Engineering, University College London, London, UK
| | - E Brown
- Centre for Advanced Biomedical Imaging, University College London, London, UK
| | - N Holroyd
- Centre for Advanced Biomedical Imaging, University College London, London, UK
| | - D D Jonigk
- Institute of Pathology, Hannover Medical School, Hannover, Germany.
- German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany.
| | - M Ackermann
- Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Institute of Pathology and Department of Molecular Pathology, Helios University Clinic Wuppertal, University of Witten-Herdecke, Wuppertal, Germany.
| | - P D Lee
- Department of Mechanical Engineering, University College London, London, UK.
| |
Collapse
|
16
|
Gensheimer M, Gee H, Von Eyben R, Shirato H, Taguchi H, Wong S, Brown E, Nguyen N, Liang R, Maxim P, Wakelee H, Neal J, Das M, Loo B, Diehn M. A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR). Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
17
|
Seligmann J, Fisher D, Brown L, Adams R, Graham J, Quirke P, Richman S, Butler R, Domingo E, Blake A, Braun M, Collinson F, Jones R, Brown E, De Winton E, Humphies T, Kaplan R, Wilson R, Seymour M, Maughan T. 382O Inhibition of WEE1 is effective in TP53 and RAS mutant metastatic colorectal cancer (mCRC): A randomised phase II trial (FOCUS4-C) comparing adavosertib (AZD1775) with active monitoring. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.904] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
18
|
Mulcahy M, Salem R, Mahvash A, Pracht M, Montazeri A, Bandula S, Hermann K, Brown E, Zuckerman D, Wilson G, Kim TY, Weaver A, Ross P, Harris W, Johnson M, Sofocleous C, Padia S, Lewandowski R, Garin E, Sinclair P. LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.2095] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
19
|
Hydes T, Brown E, Hamid A, Bateman AC, Cuthbertson DJ. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Clin Ther 2021; 43:1505-1522. [PMID: 34400007 DOI: 10.1016/j.clinthera.2021.07.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 07/15/2021] [Accepted: 07/19/2021] [Indexed: 02/06/2023]
Abstract
PURPOSE Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder that frequently coexists with obesity, metabolic syndrome, and type 2 diabetes. The NAFLD spectrum, ranging from hepatic steatosis to nonalcoholic steatohepatitis, fibrosis, and cirrhosis, can be associated with long-term hepatic (hepatic decompensation and hepatocellular carcinoma) and extrahepatic complications. Diagnosis of NAFLD requires detection of liver steatosis with exclusion of other causes of chronic liver disease. Screening for NAFLD and identification of individuals at risk of end-stage liver disease represent substantial challenges that have yet to be met. NAFLD affects up to 25% of adults, yet only a small proportion will progress beyond steatosis to develop advanced disease (steatohepatitis and fibrosis) associated with increased morbidity and mortality. Identification of this cohort has required the gold standard liver biopsy, which is both invasive and expensive. The use of serum biomarkers and noninvasive imaging techniques is an area of significant clinical relevance. This narrative review outlines current and emerging technologies for the diagnosis of NAFLD, nonalcoholic steatohepatitis, and hepatic fibrosis. METHODS We reviewed the literature using PubMed and reviewed national and international guidelines and conference proceedings to provide a comprehensive overview of the evidence. FINDINGS Significant advances have been made during the past 2 decades that have enhanced noninvasive assessment of NAFLD without the need for liver biopsy. For the detection of steatosis, abdominal ultrasonography remains the first-line investigation, although a controlled attenuation parameter using transient elastography is more sensitive. For detecting fibrosis, noninvasive serum markers of fibrosis and algorithms based on routine biochemistry are available, in addition to transient elastography. These techniques are well validated and have been incorporated into national and international screening guidelines. These approaches have facilitated more judicious use of liver biopsy but are yet to entirely replace it. Although serum biomarkers present a pragmatic and widely available screening approach for NAFLD in large population-based studies, magnetic resonance imaging techniques offer the benefit of achieving high degrees of accuracy in disease grading, tumor staging, and assessing therapeutic response. IMPLICATIONS This diagnostic clinical and research field is rapidly evolving; increasingly combined applications of biomarkers and transient elastography or imaging of selective (intermediate or high risk) cases are being used for clinical and research purposes. Liver biopsy remains the gold standard investigation, particularly in the context of clinical trials, but noninvasive options are emerging, using multimodality assessment, that are quicker, more tolerable, more widely available and have greater patient acceptability.
Collapse
Affiliation(s)
- T Hydes
- Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom.
| | - E Brown
- Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom
| | - A Hamid
- Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom
| | - A C Bateman
- Department of Cellular Pathology, Southampton General Hospital, Southampton, United Kingdom
| | - D J Cuthbertson
- Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom
| |
Collapse
|
20
|
Galetti I, Brown E, Kennedy A, Riggs RJ, Roennow A, Sauvé M, Welling J, Finnern H, Gilbert A, Gahlemann M, Sauter W. POS1497-PARE POST-TRIAL SURVEY OF PARTICIPANTS OF A PHASE 3 CLINICAL TRIAL IN SSC-ILD. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1847] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:The SENSCIS® trial (2015–18) was a large clinical trial (n=576) investigating the efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease.1 The clinical research sponsors (CRS) collaborated with the scleroderma patient community advisory board (CAB) regarding the design, implementation and conduct of the trial.2 As part of this collaboration, the CRS and CAB developed a post-trial survey for SENSCIS® participants. The use of the developed patient-centric materials was optional for the sites.Objectives:The objectives of the SENSCIS® post-trial survey were to gain experience in collecting real-world information and trial satisfaction data from patients to inform and improve future patient centric clinical research.Methods:SENSCIS® trial participants who were involved in the extension trial SENSCIS®-ON completed a post-trial survey covering nine multiple-choice questions about three main topics:[1]Recruitment – Where do patients usually search for clinical trials and how did they become aware of SENSCIS®?[2]Motivation & Retention – What motivated patients to start and continue participation in SENSCIS®?[3]Challenges & Wishes – What were the challenges during trial participation and how can future clinical trials be improved regarding patient centricity?Results:A total of 125 participants completed all survey questions. Participants could select more than one option. A total of 51 patients reported that they are usually not actively looking for trials. For those actively searching, the most common sources to learn about trials were specialists/general practitioners (GPs) (46 patients) and internet search engines (20 patients), followed by patient organisations (12 patients). Of note, 78 patients would pay attention to printed materials, such as a card/flyer/poster in a doctor’s office and get in touch with a trial/study site.Back in 2015–2017, during recruitment for the SENSCIS® trial, the majority of the patients who answered the survey were made aware via their specialist/GP (116 patients), whereas 5 were made aware via patient organisations and 4 via the internet.The most frequent motivations to join the trial were ‘hope to receive an improved therapy’ (98 patients), to help other patients (64 patients), and on the recommendation of their specialist/GP (81 patients). Similarly, the most liked aspects of the trial were the ‘opportunity to receive an improved therapy’ (92 patients) and ‘to support the development of an improved therapy for my illness’ (90 patients). More than half of patients reported ‘continuous observation of general health’ (72 patients) and ‘advice from GPs/specialists’ (71 patients) as motivation to stay in the trial (Figure 1).‘Concerns about side effects’ (72 patients) and ‘not knowing whether the trial medication will work for me’ (63 patients) were reported as the least liked aspects of the trial. Travel to the site was reported as a challenge by 21 patients.To improve clinical trials, patients requested more patient-friendly information (50 patients) and multiple formats of information material (46 patients). Finally, 48 patients expressed the desire to communicate with other trial participants.Conclusion:The SENSCIS® post-trial survey is a unique approach to receive real-world feedback from trial participants, and these pilot data will help improve future clinical trials and communication. The results highlight the importance of reaching patients who may not be actively looking for clinical trials.Figure 1.Motivation to stay in the SENSCIS® trial1,21More than one option could be selected.2Data collected on 9th January 2021References:[1]Distler O et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076.[2]Roennow A et al. BMJ Open. 2020 Dec 16;10(12):e039473. doi: 10.1136/bmjopen-2020-039473.Acknowledgements:Sue Farrington (Federation of European Scleroderma Associations [FESCA] Belgium), Luke Evnin (Scleroderma Research Foundation, United States), Beatriz Garcia (Asociacion Espanola de Esclerodermia, Spain), Catarina Leite (Associacao Portuguesa de Doentes com Esclerodermia, Portugal), Alison Zheng (Chinese Organisation for Scleroderma), Matea Perković Popović (Hrvatska udruga oboljelih od sklerodermije, Croatia), Tina Ampudia (Asociacion Mexicana de Orientacion Apoyo y Lucha Contra la Esclerodermia, AC, Mexico), Stephanie Munoz (Norsk Revmatikerforbund, Diagnosegruppen for Systemisk Sklerose, Norway), Monica Holmner (Reumatikerförbundet Riksföreningen för systemisk skleros, Sweden).Disclosure of Interests:Ilaria Galetti: None declared, EDITH BROWN: None declared, Ann Kennedy Consultant of: I have been a member of the CAB (Community Patient Advisory Board) described in the accompanying abstract under discussion. My patient organisation has been paid for its participation in the CAB., Grant/research support from: It is not myself personally, but FESCA (Federation of European Scleroderma Associations) aisbl., that has received project grants for awareness raising and education. I was President of this Federation., Robert J Riggs: None declared, Annelise Roennow: None declared, Maureen Sauvé: None declared, Joep Welling Speakers bureau: BI MIDI and BI International, Sanofi, Henrik Finnern Employee of: I am employee of Boehringer Ingelheim International GmbH, Annie Gilbert Consultant of: I am a paid consultant for Bohringer Ingelheim since 2016, Martina Gahlemann Employee of: I am employed by Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland, Wiebke Sauter Employee of: I am employer of Boehringer-Ingelheim
Collapse
|
21
|
Maltez N, Hughes M, Brown E, Hickey V, Park H, Shea B, Herrick AL, Pauling JD, Proudman S, Merkel PA. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020. Semin Arthritis Rheum 2021; 51:640-643. [PMID: 33947582 DOI: 10.1016/j.semarthrit.2021.04.005] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2021] [Accepted: 04/09/2021] [Indexed: 12/16/2022]
Abstract
Raynaud's phenomenon (RP) and digital ulcers (DUs) are important disease manifestations of systemic sclerosis (SSc) that can lead to significant pain and disability. It is essential when studying these disease features to utilize outcome measures that fully evaluate the complexities of RP and DUs . The Outcome Measures in Rheumatology (OMERACT) Vascular Disease in SSc Working Group is applying the OMERACT filter 2.1 to identify a core set of disease domains that encompass the full burden of SSc-related RP and DUs. Progress to date and future research plans were presented during a Special Interest Group held in December 2020.
Collapse
Affiliation(s)
- Nancy Maltez
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
| | - Michael Hughes
- Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| | | | | | - Heiyoung Park
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Health, USA
| | - Beverley Shea
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Ariane L Herrick
- The University of Manchester and Salford Royal NHS Foundation Trust, UK
| | - John D Pauling
- Royal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath, Bath, UK
| | - Susanna Proudman
- Discipline of Medicine, University of Adelaide and Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia
| | - Peter A Merkel
- Division of Rheumatology, Department of Medicine, Division of Clinical Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
22
|
Aprile E, Aalbers J, Agostini F, Alfonsi M, Althueser L, Amaro FD, Antochi VC, Angelino E, Angevaare JR, Arneodo F, Barge D, Baudis L, Bauermeister B, Bellagamba L, Benabderrahmane ML, Berger T, Breur PA, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Cimmino B, Clark M, Coderre D, Colijn AP, Conrad J, Cussonneau JP, Decowski MP, Depoian A, Di Gangi P, Di Giovanni A, Di Stefano R, Diglio S, Elykov A, Eurin G, Ferella AD, Fulgione W, Gaemers P, Gaior R, Rosso AG, Galloway M, Gao F, Grandi L, Garbini M, Hasterok C, Hils C, Hiraide K, Hoetzsch L, Hogenbirk E, Howlett J, Iacovacci M, Itow Y, Joerg F, Kato N, Kazama S, Kobayashi M, Koltman G, Kopec A, Landsman H, Lang RF, Levinson L, Lin Q, Lindemann S, Lindner M, Lombardi F, Lopes JAM, López Fune E, Macolino C, Mahlstedt J, Manenti L, Manfredini A, Marignetti F, Undagoitia TM, Martens K, Masbou J, Masson D, Mastroianni S, Messina M, Miuchi K, Molinario A, Morå K, Moriyama S, Mosbacher Y, Murra M, Naganoma J, Ni K, Oberlack U, Odgers K, Palacio J, Pelssers B, Peres R, Pienaar J, Pizzella V, Plante G, Qin J, Qiu H, García DR, Reichard S, Rocchetti A, Rupp N, Santos JMFD, Sartorelli G, Šarčević N, Scheibelhut M, Schindler S, Schreiner J, Schulte D, Schumann M, Lavina LS, Selvi M, Semeria F, Shagin P, Shockley E, Silva M, Simgen H, Takeda A, Therreau C, Thers D, Toschi F, Trinchero G, Tunnell C, Vargas M, Volta G, Wack O, Wang H, Wei Y, Weinheimer C, Weiss M, Wenz D, Westermann J, Wittweg C, Wulf J, Xu Z, Yamashita M, Ye J, Zavattini G, Zhang Y, Zhu T, Zopounidis JP. 222 Rn emanation measurements for the XENON1T experiment. Eur Phys J C Part Fields 2021; 81:337. [PMID: 34720714 PMCID: PMC8550029 DOI: 10.1140/epjc/s10052-020-08777-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Accepted: 12/17/2020] [Indexed: 06/13/2023]
Abstract
The selection of low-radioactive construction materials is of utmost importance for the success of low-energy rare event search experiments. Besides radioactive contaminants in the bulk, the emanation of radioactive radon atoms from material surfaces attains increasing relevance in the effort to further reduce the background of such experiments. In this work, we present the 222 Rn emanation measurements performed for the XENON1T dark matter experiment. Together with the bulk impurity screening campaign, the results enabled us to select the radio-purest construction materials, targeting a 222 Rn activity concentration of 10 μ Bq / kg in 3.2 t of xenon. The knowledge of the distribution of the 222 Rn sources allowed us to selectively eliminate problematic components in the course of the experiment. The predictions from the emanation measurements were compared to data of the 222 Rn activity concentration in XENON1T. The final 222 Rn activity concentration of ( 4.5 ± 0.1 ) μ Bq / kg in the target of XENON1T is the lowest ever achieved in a xenon dark matter experiment.
Collapse
Affiliation(s)
| | - E. Aprile
- Physics Department, Columbia University, New York, NY 10027 USA
| | - J. Aalbers
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - F. Agostini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M. Alfonsi
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L. Althueser
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - F. D. Amaro
- Department of Physics, LIBPhys, University of Coimbra, 3004-516 Coimbra, Portugal
| | - V. C. Antochi
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - E. Angelino
- Department of Physics, INAF-Astrophysical Observatory of Torino, University of Torino and INFN-Torino, 10125 Turin, Italy
| | - J. R. Angevaare
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
| | - F. Arneodo
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - D. Barge
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - L. Baudis
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - B. Bauermeister
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - L. Bellagamba
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | | | - T. Berger
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, NY 12180 USA
| | - P. A. Breur
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
| | - A. Brown
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - E. Brown
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, NY 12180 USA
| | - S. Bruenner
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
| | - G. Bruno
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - R. Budnik
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
- Simons Center for Geometry and Physics and C. N. Yang Institute for Theoretical Physics, SUNY, Stony Brook, NY USA
| | - C. Capelli
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - J. M. R. Cardoso
- Department of Physics, LIBPhys, University of Coimbra, 3004-516 Coimbra, Portugal
| | - D. Cichon
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - B. Cimmino
- Department of Physics “Ettore Pancini”, University of Napoli and INFN-Napoli, 80126 Naples, Italy
| | - M. Clark
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN 47907 USA
| | - D. Coderre
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A. P. Colijn
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
- Institute for Subatomic Physics, Utrecht University, Utrecht, Netherlands
| | - J. Conrad
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - J. P. Cussonneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, 44307 Nantes, France
| | - M. P. Decowski
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
| | - A. Depoian
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN 47907 USA
| | - P. Di Gangi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - A. Di Giovanni
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - R. Di Stefano
- Department of Physics “Ettore Pancini”, University of Napoli and INFN-Napoli, 80126 Naples, Italy
| | - S. Diglio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, 44307 Nantes, France
| | - A. Elykov
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G. Eurin
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - A. D. Ferella
- Department of Physics and Chemistry, University of L’Aquila, 67100 L’Aquila, Italy
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L’Aquila, Italy
| | - W. Fulgione
- Department of Physics, INAF-Astrophysical Observatory of Torino, University of Torino and INFN-Torino, 10125 Turin, Italy
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L’Aquila, Italy
| | - P. Gaemers
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
| | - R. Gaior
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| | - A. Gallo Rosso
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L’Aquila, Italy
| | - M. Galloway
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - F. Gao
- Physics Department, Columbia University, New York, NY 10027 USA
| | - L. Grandi
- Department of Physics, Kavli Institute for Cosmological Physics, University of Chicago, Chicago, IL 60637 USA
| | - M. Garbini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - C. Hasterok
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C. Hils
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K. Hiraide
- Kamioka Observatory, Institute for Cosmic Ray Research, Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205 Japan
| | - L. Hoetzsch
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - E. Hogenbirk
- Nikhef and the University of Amsterdam, Science Park, 1098 XG Amsterdam, The Netherlands
| | - J. Howlett
- Physics Department, Columbia University, New York, NY 10027 USA
| | - M. Iacovacci
- Department of Physics “Ettore Pancini”, University of Napoli and INFN-Napoli, 80126 Naples, Italy
| | - Y. Itow
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, and Institute for Space-Earth Environmental Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602 Japan
| | - F. Joerg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - N. Kato
- Kamioka Observatory, Institute for Cosmic Ray Research, Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205 Japan
| | - S. Kazama
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, and Institute for Space-Earth Environmental Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602 Japan
- Institute for Advanced Research, Nagoya University, Nagoya, Aichi, 464-8601 Japan
| | - M. Kobayashi
- Physics Department, Columbia University, New York, NY 10027 USA
| | - G. Koltman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
| | - A. Kopec
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN 47907 USA
| | - H. Landsman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
| | - R. F. Lang
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN 47907 USA
| | - L. Levinson
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
| | - Q. Lin
- Physics Department, Columbia University, New York, NY 10027 USA
| | - S. Lindemann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M. Lindner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - F. Lombardi
- Department of Physics, LIBPhys, University of Coimbra, 3004-516 Coimbra, Portugal
| | - J. A. M. Lopes
- Department of Physics, LIBPhys, University of Coimbra, 3004-516 Coimbra, Portugal
- Coimbra Polytechnic - ISEC, Coimbra, Portugal
| | - E. López Fune
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| | - C. Macolino
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - J. Mahlstedt
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - L. Manenti
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - A. Manfredini
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - F. Marignetti
- Department of Physics “Ettore Pancini”, University of Napoli and INFN-Napoli, 80126 Naples, Italy
| | | | - K. Martens
- Kamioka Observatory, Institute for Cosmic Ray Research, Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205 Japan
| | - J. Masbou
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, 44307 Nantes, France
| | - D. Masson
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S. Mastroianni
- Department of Physics “Ettore Pancini”, University of Napoli and INFN-Napoli, 80126 Naples, Italy
| | - M. Messina
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L’Aquila, Italy
| | - K. Miuchi
- Department of Physics, Kobe University, Kobe, Hyogo 657-8501 Japan
| | - A. Molinario
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L’Aquila, Italy
| | - K. Morå
- Physics Department, Columbia University, New York, NY 10027 USA
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - S. Moriyama
- Kamioka Observatory, Institute for Cosmic Ray Research, Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205 Japan
| | - Y. Mosbacher
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
| | - M. Murra
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J. Naganoma
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L’Aquila, Italy
| | - K. Ni
- Department of Physics, University of California San Diego, La Jolla, CA 92093 USA
| | - U. Oberlack
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K. Odgers
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, NY 12180 USA
| | - J. Palacio
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, 44307 Nantes, France
| | - B. Pelssers
- Department of Physics, Oskar Klein Centre, Stockholm University, AlbaNova, 10691 Stockholm, Sweden
| | - R. Peres
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - J. Pienaar
- Department of Physics, Kavli Institute for Cosmological Physics, University of Chicago, Chicago, IL 60637 USA
| | - V. Pizzella
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G. Plante
- Physics Department, Columbia University, New York, NY 10027 USA
| | - J. Qin
- Department of Physics and Astronomy, Purdue University, West Lafayette, IN 47907 USA
| | - H. Qiu
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
| | - D. Ramírez García
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S. Reichard
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - A. Rocchetti
- Department of Physics, University of California San Diego, La Jolla, CA 92093 USA
| | - N. Rupp
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J. M. F. dos Santos
- Department of Physics, LIBPhys, University of Coimbra, 3004-516 Coimbra, Portugal
| | - G. Sartorelli
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - N. Šarčević
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M. Scheibelhut
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S. Schindler
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J. Schreiner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D. Schulte
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M. Schumann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L. Scotto Lavina
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| | - M. Selvi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - F. Semeria
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - P. Shagin
- Department of Physics and Astronomy, Rice University, Houston, TX 77005 USA
| | - E. Shockley
- Department of Physics, Kavli Institute for Cosmological Physics, University of Chicago, Chicago, IL 60637 USA
| | - M. Silva
- Department of Physics, LIBPhys, University of Coimbra, 3004-516 Coimbra, Portugal
| | - H. Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - A. Takeda
- Kamioka Observatory, Institute for Cosmic Ray Research, Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205 Japan
| | - C. Therreau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, 44307 Nantes, France
| | - D. Thers
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, 44307 Nantes, France
| | - F. Toschi
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G. Trinchero
- Department of Physics, INAF-Astrophysical Observatory of Torino, University of Torino and INFN-Torino, 10125 Turin, Italy
| | - C. Tunnell
- Department of Physics and Astronomy, Rice University, Houston, TX 77005 USA
| | - M. Vargas
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - G. Volta
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - O. Wack
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - H. Wang
- Physics and Astronomy Department, University of California, Los Angeles, CA 90095 USA
| | - Y. Wei
- Department of Physics, University of California San Diego, La Jolla, CA 92093 USA
| | - C. Weinheimer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M. Weiss
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot, 7610001 Israel
| | - D. Wenz
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J. Westermann
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C. Wittweg
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J. Wulf
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - Z. Xu
- Physics Department, Columbia University, New York, NY 10027 USA
| | - M. Yamashita
- Kamioka Observatory, Institute for Cosmic Ray Research, Kavli Institute for the Physics and Mathematics of the Universe (WPI), The University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205 Japan
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, and Institute for Space-Earth Environmental Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602 Japan
| | - J. Ye
- Department of Physics, University of California San Diego, La Jolla, CA 92093 USA
| | - G. Zavattini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
- INFN, Sez. di Ferrara and Dip. di Fisica e Scienze della Terra, Università di Ferrara, via G. Saragat 1, Edificio C, I-44122, Ferrara (FE), Italy
| | - Y. Zhang
- Physics Department, Columbia University, New York, NY 10027 USA
| | - T. Zhu
- Physics Department, Columbia University, New York, NY 10027 USA
| | - J. P. Zopounidis
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| |
Collapse
|
23
|
Aprile E, Aalbers J, Agostini F, Ahmed Maouloud S, Alfonsi M, Althueser L, Amaro FD, Andaloro S, Antochi VC, Angelino E, Angevaare JR, Arneodo F, Baudis L, Bauermeister B, Bellagamba L, Benabderrahmane ML, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Cimmino B, Clark M, Coderre D, Colijn AP, Conrad J, Cuenca J, Cussonneau JP, Decowski MP, Depoian A, Di Gangi P, Di Giovanni A, Di Stefano R, Diglio S, Elykov A, Ferella AD, Fulgione W, Gaemers P, Gaior R, Galloway M, Gao F, Grandi L, Hils C, Hiraide K, Hoetzsch L, Howlett J, Iacovacci M, Itow Y, Joerg F, Kato N, Kazama S, Kobayashi M, Koltman G, Kopec A, Landsman H, Lang RF, Levinson L, Liang S, Lindemann S, Lindner M, Lombardi F, Long J, Lopes JAM, Ma Y, Macolino C, Mahlstedt J, Mancuso A, Manenti L, Manfredini A, Marignetti F, Marrodán Undagoitia T, Martens K, Masbou J, Masson D, Mastroianni S, Messina M, Miuchi K, Mizukoshi K, Molinario A, Morå K, Moriyama S, Mosbacher Y, Murra M, Naganoma J, Ni K, Oberlack U, Odgers K, Palacio J, Pelssers B, Peres R, Pierre M, Pienaar J, Pizzella V, Plante G, Qi J, Qin J, Ramírez García D, Reichard S, Rocchetti A, Rupp N, Dos Santos JMF, Sartorelli G, Schreiner J, Schulte D, Schulze Eißing H, Schumann M, Scotto Lavina L, Selvi M, Semeria F, Shagin P, Shockley E, Silva M, Simgen H, Takeda A, Therreau C, Thers D, Toschi F, Trinchero G, Tunnell C, Valerius K, Vargas M, Volta G, Wei Y, Weinheimer C, Weiss M, Wenz D, Wittweg C, Wolf T, Xu Z, Yamashita M, Ye J, Zavattini G, Zhang Y, Zhu T, Zopounidis JP. Search for Coherent Elastic Scattering of Solar ^{8}B Neutrinos in the XENON1T Dark Matter Experiment. Phys Rev Lett 2021; 126:091301. [PMID: 33750173 DOI: 10.1103/physrevlett.126.091301] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2020] [Revised: 01/17/2021] [Accepted: 01/27/2021] [Indexed: 06/12/2023]
Abstract
We report on a search for nuclear recoil signals from solar ^{8}B neutrinos elastically scattering off xenon nuclei in XENON1T data, lowering the energy threshold from 2.6 to 1.6 keV. We develop a variety of novel techniques to limit the resulting increase in backgrounds near the threshold. No significant ^{8}B neutrinolike excess is found in an exposure of 0.6 t×y. For the first time, we use the nondetection of solar neutrinos to constrain the light yield from 1-2 keV nuclear recoils in liquid xenon, as well as nonstandard neutrino-quark interactions. Finally, we improve upon world-leading constraints on dark matter-nucleus interactions for dark matter masses between 3 and 11 GeV c^{-2} by as much as an order of magnitude.
Collapse
Affiliation(s)
- E Aprile
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Aalbers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - F Agostini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - S Ahmed Maouloud
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| | - M Alfonsi
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L Althueser
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - F D Amaro
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - S Andaloro
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - V C Antochi
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - E Angelino
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
| | - J R Angevaare
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - F Arneodo
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - L Baudis
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - B Bauermeister
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - L Bellagamba
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | | | - A Brown
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - E Brown
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - S Bruenner
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - G Bruno
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - R Budnik
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - C Capelli
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - J M R Cardoso
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - D Cichon
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - B Cimmino
- Department of Physics "Ettore Pancini", University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - M Clark
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - D Coderre
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A P Colijn
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Conrad
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - J Cuenca
- Institute for Astroparticle Physics, Karlsruhe Institute of Technology, 76021 Karlsruhe, Germany
| | - J P Cussonneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - M P Decowski
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Depoian
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - P Di Gangi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - A Di Giovanni
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - R Di Stefano
- Department of Physics "Ettore Pancini", University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - S Diglio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - A Elykov
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A D Ferella
- Department of Physics and Chemistry, University of L'Aquila, 67100 L'Aquila, Italy
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - W Fulgione
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - P Gaemers
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - R Gaior
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| | - M Galloway
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - F Gao
- Physics Department, Columbia University, New York, New York 10027, USA
- Department of Physics & Center for High Energy Physics, Tsinghua University, Beijing 100084, China
| | - L Grandi
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - C Hils
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Hiraide
- Kamioka Observatory, Institute for Cosmic Ray Research, and Kavli Institute for the Physics and Mathematics of the Universe (WPI), the University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205, Japan
| | - L Hoetzsch
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J Howlett
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Iacovacci
- Department of Physics "Ettore Pancini", University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - Y Itow
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, and Institute for Space-Earth Environmental Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan
| | - F Joerg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - N Kato
- Kamioka Observatory, Institute for Cosmic Ray Research, and Kavli Institute for the Physics and Mathematics of the Universe (WPI), the University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205, Japan
| | - S Kazama
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, and Institute for Space-Earth Environmental Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan
| | - M Kobayashi
- Physics Department, Columbia University, New York, New York 10027, USA
| | - G Koltman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - A Kopec
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Landsman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - R F Lang
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - L Levinson
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - S Liang
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - S Lindemann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Lindner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - F Lombardi
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - J Long
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - J A M Lopes
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - Y Ma
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - C Macolino
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - J Mahlstedt
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Mancuso
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - L Manenti
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates
| | - A Manfredini
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - F Marignetti
- Department of Physics "Ettore Pancini", University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | | | - K Martens
- Kamioka Observatory, Institute for Cosmic Ray Research, and Kavli Institute for the Physics and Mathematics of the Universe (WPI), the University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205, Japan
| | - J Masbou
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Masson
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S Mastroianni
- Department of Physics "Ettore Pancini", University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - M Messina
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Miuchi
- Department of Physics, Kobe University, Kobe, Hyogo 657-8501, Japan
| | - K Mizukoshi
- Department of Physics, Kobe University, Kobe, Hyogo 657-8501, Japan
| | - A Molinario
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Morå
- Physics Department, Columbia University, New York, New York 10027, USA
| | - S Moriyama
- Kamioka Observatory, Institute for Cosmic Ray Research, and Kavli Institute for the Physics and Mathematics of the Universe (WPI), the University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205, Japan
| | - Y Mosbacher
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - M Murra
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Naganoma
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Ni
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - U Oberlack
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Odgers
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - J Palacio
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - B Pelssers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - R Peres
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - M Pierre
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - J Pienaar
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - V Pizzella
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Plante
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Qi
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - J Qin
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - D Ramírez García
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S Reichard
- Institute for Astroparticle Physics, Karlsruhe Institute of Technology, 76021 Karlsruhe, Germany
| | - A Rocchetti
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - N Rupp
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J M F Dos Santos
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - G Sartorelli
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - J Schreiner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Schulte
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - H Schulze Eißing
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M Schumann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L Scotto Lavina
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| | - M Selvi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - F Semeria
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - P Shagin
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - E Shockley
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - M Silva
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - H Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - A Takeda
- Kamioka Observatory, Institute for Cosmic Ray Research, and Kavli Institute for the Physics and Mathematics of the Universe (WPI), the University of Tokyo, Higashi-Mozumi, Kamioka, Hida, Gifu 506-1205, Japan
| | - C Therreau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Thers
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - F Toschi
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Trinchero
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
| | - C Tunnell
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - K Valerius
- Institute for Astroparticle Physics, Karlsruhe Institute of Technology, 76021 Karlsruhe, Germany
| | - M Vargas
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - G Volta
- Physik-Institut, University of Zürich, 8057 Zürich, Switzerland
| | - Y Wei
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - C Weinheimer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M Weiss
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - D Wenz
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - C Wittweg
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - T Wolf
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - Z Xu
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Yamashita
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, and Institute for Space-Earth Environmental Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan
| | - J Ye
- Physics Department, Columbia University, New York, New York 10027, USA
- Department of Physics, University of California San Diego, La Jolla, California 92093, USA
| | - G Zavattini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - Y Zhang
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Zhu
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J P Zopounidis
- LPNHE, Sorbonne Université, Université de Paris, CNRS/IN2P3, Paris, France
| |
Collapse
|
24
|
Walsh C, Tafforeau P, Wagner WL, Jafree DJ, Bellier A, Werlein C, Kühnel MP, Boller E, Walker-Samuel S, Robertus JL, Long DA, Jacob J, Marussi S, Brown E, Holroyd N, Jonigk DD, Ackermann M, Lee PD. Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography. bioRxiv 2021:2021.02.03.429481. [PMID: 33564772 PMCID: PMC7872374 DOI: 10.1101/2021.02.03.429481] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Human organs are complex, three-dimensional and multiscale systems. Spatially mapping the human body down through its hierarchy, from entire organs to their individual functional units and specialised cells, is a major obstacle to fully understanding health and disease. To meet this challenge, we developed hierarchical phase-contrast tomography (HiP-CT), an X-ray phase propagation technique utilising the European Synchrotron Radiation Facility's Extremely Brilliant Source: the world's first high-energy 4 th generation X-ray source. HiP-CT enabled three-dimensional and non-destructive imaging at near-micron resolution in soft tissues at one hundred thousand times the voxel size whilst maintaining the organ's structure. We applied HiP-CT to image five intact human parenchymal organs: brain, lung, heart, kidney and spleen. These were hierarchically assessed with HiP-CT, providing a structural overview of the whole organ alongside detail of the organ's individual functional units and cells. The potential applications of HiP-CT were demonstrated through quantification and morphometry of glomeruli in an intact human kidney, and identification of regional changes to the architecture of the air-tissue interface and alveolar morphology in the lung of a deceased COVID-19 patient. Overall, we show that HiP-CT is a powerful tool which can provide a comprehensive picture of structural information for whole intact human organs, encompassing precise details on functional units and their constituent cells to better understand human health and disease.
Collapse
Affiliation(s)
- C Walsh
- Centre for Advanced Biomedical Imaging, University College London, U.K
| | - P Tafforeau
- European Synchrotron Radiation Facility, Grenoble, France
| | - Willi L Wagner
- Dept of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany Translational Lung Research Centre Heidelberg (TLRC), German Lung Research Centre (DZL), Heidelberg, Germany
| | - D J Jafree
- Developmental Biology and Cancer Programme, Great Ormond Street Institute of Child Health, University College London, UK
- UCL MB/PhD Programme, Faculty of Medical Sciences, University College London, UK
| | - A Bellier
- French Alps Laboratory of Anatomy (LADAF), Grenoble Alpes University, Grenoble, France
| | - C Werlein
- Institute of Pathology, Hannover Medical School, Hannover, Germany (Carl-Neuberg-Straße 1, 30625 Hannover)
| | - M P Kühnel
- Institute of Pathology, Hannover Medical School, Hannover, Germany (Carl-Neuberg-Straße 1, 30625 Hannover)
- Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH)
| | - E Boller
- European Synchrotron Radiation Facility, Grenoble, France
| | - S Walker-Samuel
- Centre for Advanced Biomedical Imaging, University College London, U.K
| | - J L Robertus
- Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London, UK
- National Heart & Lung Institute, Imperial College London, London, UK
| | - D A Long
- Developmental Biology and Cancer Programme, Great Ormond Street Institute of Child Health, University College London, UK
| | - J Jacob
- Centre for Medical Image Computing, University College London, London, UK
- Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK
| | - S Marussi
- Department of Mechanical Engineering University College London, U.K
| | - E Brown
- Centre for Advanced Biomedical Imaging, University College London, U.K
| | - N Holroyd
- Centre for Advanced Biomedical Imaging, University College London, U.K
| | - D D Jonigk
- Institute of Pathology, Hannover Medical School, Hannover, Germany (Carl-Neuberg-Straße 1, 30625 Hannover)
- Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH)
| | - M Ackermann
- Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg University Mainz, Mainz
| | - P D Lee
- Department of Mechanical Engineering University College London, U.K
| |
Collapse
|
25
|
Roennow A, Sauvé M, Welling J, Riggs RJ, Kennedy AT, Galetti I, Brown E, Leite C, Gonzalez A, Portales Guiraud AP, Houÿez F, Camp R, Gilbert A, Gahlemann M, Moros L, Luna Flores JL, Schmidt F, Sauter W, Finnern H. Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations. BMJ Open 2020; 10:e039473. [PMID: 33328257 PMCID: PMC7745690 DOI: 10.1136/bmjopen-2020-039473] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Introduction Transparent collaborations between patient organisations (POs) and clinical research sponsors (CRS) can identify and address the unmet needs of patients and caregivers. These insights can improve clinical trial participant experience and delivery of medical innovations necessary to advance health outcomes and standards of care. We share our experiences from such a collaboration undertaken surrounding the SENSCIS® clinical trial (NCT02597933), and discuss its impact during, and legacy beyond, the trial.Summary We describe the establishment of a community advisory board (CAB): a transparent, multiyear collaboration between the scleroderma patient community and a CRS. We present shared learnings from the collaboration, which is split into three main areas: (1) the implementation and conduct of the clinical trial; (2) analysis and dissemination of the results; and (3) aspects of the collaboration not related to the trial.1. The scleroderma CAB reviewed and provided advice on trial conduct and reporting. This led to the improvement and optimisation of trial procedures; meaningful, patient-focused adaptations were made to address challenges relevant to scleroderma-associated interstitial lung disease patients.2. To ensure that results of the trial were accessible to lay audiences and patients, written lay summaries were developed by the trial sponsor with valuable input from the CAB to ensure that language and figures were understandable.3. The CAB and the CRS also collaborated to co-develop opening tools for medication blister packs and bottles. In addition, to raise disease awareness among physicians, patients and caregivers, educational materials to improve diagnosis and management of scleroderma were co-created and delivered by the CAB and CRS.Conclusions This collaboration between POs and a CRS, in a rare disease condition, led to meaningful improvements in patient safety, comfort and self-management and addressed information needs. This collaboration may serve as a template of best practice for future collaborations between POs, research sponsors and other healthcare stakeholders.
Collapse
Affiliation(s)
- Annelise Roennow
- Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium
- Sklerodermiforening, Rødovre, Denmark
| | | | - Joep Welling
- Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium
| | - Robert J Riggs
- Scleroderma Foundation, Inc, Danvers, Massachusetts, USA
| | | | - Ilaria Galetti
- Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium
- Gruppo Italiano per la Lotta alla Sclerodermia, Milan, Italy
| | | | - Catarina Leite
- Portuguese Association of Patients with Scleroderma, Monção, Portugal
| | - Alex Gonzalez
- Scleroderma Research Foundation, San Francisco, California, USA
| | | | | | - Rob Camp
- EURORDIS-Rare Diseases Europe, Barcelona, Spain
| | | | | | - Lizette Moros
- Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany
| | - Jose Luis Luna Flores
- Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany
| | - Friedrich Schmidt
- Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany
| | - Wiebke Sauter
- Boehringer Ingelheim Pharma GmbH and Co KG Biberach, Biberach, Baden-Württemberg, Germany
| | - Henrik Finnern
- Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Rheinland-Pfalz, Germany
| |
Collapse
|
26
|
Hydes TJ, Summers N, Brown E, Alam U, Thomaides-Brears H, Wilding JPH, Cuthbertson DJ. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. Diabet Med 2020; 37:1793-1806. [PMID: 32619031 DOI: 10.1111/dme.14356] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/26/2020] [Indexed: 12/14/2022]
Abstract
Non-alcoholic fatty liver disease (NAFLD) exists as a spectrum of disease ranging from excessive accumulation of fat within the liver (simple steatosis), inflammation (non-alcoholic steatohepatitis) through to fibrosis, cirrhosis and end-stage liver disease. There is also an increased risk of hepatocellular carcinoma. The principal risk factor for NAFLD is overweight or obesity, along with type 2 diabetes, and NAFLD itself is also a risk factor for incident type 2 diabetes. Overweight/obesity is synergistic with alcohol consumption in causing progressive and insidious liver damage. Recent consensus advocates a change in nomenclature from NAFLD to 'metabolic associated fatty liver disease' (MAFLD), reflective of the associated metabolic abnormalities (insulin resistance/type 2 diabetes and metabolic syndrome components). Additional extra-hepatic manifestations of NAFLD include cardiovascular disease, chronic kidney disease and certain cancers. Unlike other micro- and macrovascular complications of type 2 diabetes, systematic screening or surveillance protocols have not been widely adopted in routine diabetes care to assess for presence/severity of NAFLD. Various screening tools are available (non-invasive tests and biochemical indices) combined with imaging techniques (e.g. transient elastography) to detect steatosis and more importantly advanced fibrosis/cirrhosis to facilitate appropriate surveillance. Liver biopsy may be sometimes necessary. Treatment options for type 2 diabetes, including lifestyle interventions (dietary change and physical activity), glucose-lowering therapies and metabolic surgery, can modulate hepatic steatosis and to a lesser extent fibrosis. Awareness of the impact of liver disease on the choice of glucose-lowering medications in individuals with type 2 diabetes is also critical.
Collapse
Affiliation(s)
- T J Hydes
- Department of Gastroenterology and Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - N Summers
- Liverpool University Hospitals NHS Foundation Trust, University Hospital Aintree, Liverpool, UK
| | - E Brown
- Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK
- Metabolism and Nutrition Research Group, Clinical Sciences Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| | - U Alam
- Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK
- Metabolism and Nutrition Research Group, Clinical Sciences Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
- Division of Diabetes, Endocrinology and Gastroenterology, Institute of Human Development, University of Manchester, Manchester, UK
| | | | - J P H Wilding
- Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK
- Metabolism and Nutrition Research Group, Clinical Sciences Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| | - D J Cuthbertson
- Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK
- Metabolism and Nutrition Research Group, Clinical Sciences Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| |
Collapse
|
27
|
Visram S, Brown E. What is the role of community fridges in the UK? An exploratory mixed methods study. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
More than one-quarter of the world's population is experiencing severe or moderate food insecurity, yet one-third of all food produced is lost or wasted. In response to this paradox, countries such as Spain, Germany and the UK have introduced community fridges: 'a public space where organisations and households can make perishable foods that would have been wasted available to the community'. The UK is home to the world's first national community fridge network, comprising 90 operational fridges that have so far redistributed 780 tonnes of surplus food. Other fridges exist outside of this network but little is known about what they do or who they serve. The objective of this study was to explore the role of community fridges in the UK.
Methods
A mixed methods approach was used, involving an online survey of community fridge organisers and telephone interviews with a purposively selected sample of respondents. The survey was piloted before being distributed via email and social media. Forty-seven responses were received from individuals representing 42 community fridges, and in-depth interviews were conducted with eight respondents. Data were analysed using thematic analysis.
Results
Three main roles fulfilled by community fridges were identified: reducing food waste; helping those in need; and building a sense of community. Some participants were reluctant to describe their work as being linked to food insecurity, citing the potential for stigmatisation. Others indicated that their primary goal was to tackle hunger in a non-stigmatising way, by providing free access to nutritious foods. A minor theme involved creating opportunities to build community cohesion.
Conclusions
Community fridges may form part of efforts to reduce food waste and tackle growing levels of food insecurity in the UK. This is an area ripe further for research, given the potential to promote sharing and social cohesion but also the risks in terms of stigma, hygiene and food safety.
Key messages
The UK is home to the world's first national community fridge network, but little is currently known about what these fridges do or who they serve. Community fridges have a role in reducing food waste, addressing food insecurity and building community cohesion, although stigma remains a concern.
Collapse
Affiliation(s)
- S Visram
- Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK
- Fuse: the Centre for Translational Research in Public Health, Newcastle University, Newcastle-upon-Tyne, UK
| | - E Brown
- Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK
| |
Collapse
|
28
|
Welling J, Roennow A, Sauvé M, Brown E, Galetti I, Gonzalez A, Portales Guiraud AP, Kennedy A, Leite C, Riggs RJ, Zheng A, Perkovic Popovic M, Gilbert A, Moros L, Sroka-Saidi K, Schindler T, Finnern H. PARE0009 COMMUNITY ADVISORY BOARD INPUT CAN MAKE LAY SUMMARIES OF CLINICAL TRIAL RESULTS MORE UNDERSTANDABLE. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Under European Union (EU) Clinical Trial regulations,1clinical research sponsors (CRSs) must ensure all studies performed in the EU are accompanied by a trial summary for laypersons, published within 1 year of study completion. These lay summaries should disseminate clinical trial results in an easy-to-understand way for trial participants, patient and caregiver communities, and the general public. The European Patients Forum (EPF)2and European Patients’ Academy on Therapeutic Innovation (EUPATI)3encourage CRSs to engage with patient organisations (POs) in the development of lay summaries. This recognises the patients’ contribution to clinical research and supports the development of patient-focused material.Objectives:We share learnings from a collaboration between scleroderma POs and a CRS to create the SENSCIS® trial (NCT02597933) written and video lay summaries.Methods:A community advisory board (CAB), comprising representatives from 11 scleroderma POs covering a range of countries/regions, was formed based on the EURORDIS charter for collaboration in clinical research.4Through three structured meetings, over a seven-month period, the CAB provided advice on lay summary materials (written and video) drafted by the CRS’ Lay Summary Group (Fig. 1). At each review cycle, the CAB advice was addressed to make content more understandable and more relevant for patients and the general public.Results:The CAB advised that the existence of lay summaries is not well known in the patient community and also recommended the development of trial-specific lay summary videos to further improve understandability of the clinical trial results for the general public. Videos are a key channel of communication, enabling access to information for people with specific health needs and lower literacy levels. Following CAB advice, the CRS developed a stand-alone video entitled“What are lay summaries?”and a trial-specific lay summary video. Revisions to lay summary content (written and video) included colour schemes, iconography and language changes to make content more understandable. For videos, adjustments to animation speed, script and voiceover were implemented to improve clarity and flow of information (Fig. 2). Approved final versions of lay summary materials are publicly available on the CRS website. Translation into languages representing trial-site countries is in progress to widen access to non-English speakers and, where possible, local versions are being reviewed by the patient community.Conclusion:Structured collection and implementation of CAB advice can make lay summary materials more understandable for the patient community and wider general public.References:[1]EU. Summaries of clinical trial results for laypersons. 2018[2]EPF. EPF position: clinical trial results – communication of the lay summary. 2015[3]EUPATI. Guidance for patient involvement in ethical review of clinical trials. 2018[4]EURORDIS. Charter for Collaboration in Clinical Research in Rare Diseases. 2009Disclosure of Interests:Joep Welling Speakers bureau: Four times as a patient advocate for employees of BII and BI MIDI with a fixed amount of € 150,00 per occasion., Annelise Roennow: None declared, Maureen Sauvé Grant/research support from: Educational grants from Boehringer Ingelheim and Janssen., EDITH BROWN: None declared, Ilaria Galetti: None declared, Alex Gonzalez Consultant of: Payment made to the patient organisation (Scleroderma Research Foundation) for participation in advisory boards, Alexandra Paula Portales Guiraud: None declared, Ann Kennedy Grant/research support from: AS FESCA aisbl, Catarina Leite: None declared, Robert J. Riggs: None declared, Alison Zheng Grant/research support from: We get grants from Lorem Vascular; BI China,; Jianke Pharmaceutical Co., Ltd.; Kangjing Biological Co., Ltd.; COFCO Coca-Cola to organize national scleroderma meetings, offer patients service, holding academic meetings and other public activities, there is also a small part of the grants used to pay the workers in our organization., Consultant of: I worked as a paid consultant for BI. Pay-per-job., Speakers bureau: I was invited once to be a speaker at BI China’s internal meeting and they paid me., Matea Perkovic Popovic: None declared, Annie Gilbert Consultant of: I have worked as a paid consultant with BI International for over 3 years, since Sept 2016., Lizette Moros Employee of: Lizette Moros is an employee of Boehringer Ingelheim, Kamila Sroka-Saidi Employee of: Paid employee of Boehringer Ingelheim., Thomas Schindler Employee of: Employee of Boehringer Ingelheim Pharma, Henrik Finnern Employee of: Paid employee of Boehringer Ingelheim.
Collapse
|
29
|
Galdos MV, Brown E, Rosolem CA, Pires LF, Hallett PD, Mooney SJ. Brachiaria species influence nitrate transport in soil by modifying soil structure with their root system. Sci Rep 2020; 10:5072. [PMID: 32193510 PMCID: PMC7081357 DOI: 10.1038/s41598-020-61986-0] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2019] [Accepted: 03/05/2020] [Indexed: 11/15/2022] Open
Abstract
Leaching of nitrate from fertilisers diminishes nitrogen use efficiency (the portion of nitrogen used by a plant) and is a major source of agricultural pollution. To improve nitrogen capture, grasses such as brachiaria are increasingly used, especially in South America and Africa, as a cover crop, either via intercropping or in rotation. However, the complex interactions between soil structure, nitrogen and the root systems of maize and different species of forage grasses remain poorly understood. This study explored how soil structure modification by the roots of maize (Zea maize), palisade grass (Brachiaria brizantha cv. Marandu) and ruzigrass (Brachiaria ruziziensis) affected nitrate leaching and retention, measured via chemical breakthrough curves. All plants were found to increase the rate of nitrate transport suggesting root systems increase the tendency for preferential flow. The greater density of fine roots produced by palisade grass, subtly decreased nitrate leaching potential through increased complexity of the soil pore network assessed with X-ray Computed Tomography. A dominance of larger roots in ruzigrass and maize increased nitrate loss through enhanced solute flow bypassing the soil matrix. These results suggest palisade grass could be a more efficient nitrate catch crop than ruzigrass (the most extensively used currently in countries such as Brazil) due to retardation in solute flow associated with the fine root system and the complex pore network.
Collapse
Affiliation(s)
- M V Galdos
- Institute for Climate and Atmospheric Science, School of Earth and Environment, University of Leeds, Leeds, LS2 9JT, UK.,Division of Agricultural & Environmental Science, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Loughborough, LE12 5RD, UK
| | - E Brown
- Division of Agricultural & Environmental Science, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Loughborough, LE12 5RD, UK
| | - C A Rosolem
- Department of Crop Science, São Paulo State University, Botucatu, Brazil
| | - L F Pires
- Department of Physics, State University of Ponta Grossa, Ponta Grossa, Brazil
| | - P D Hallett
- School of Biological Sciences, University of Aberdeen, Aberdeen, UK
| | - S J Mooney
- Division of Agricultural & Environmental Science, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Loughborough, LE12 5RD, UK.
| |
Collapse
|
30
|
Brown EA, Davies SJ, Heimbürger O, Meeus F, Mellotte G, Rosman J, Rutherford P, Van Bree M, Borras M, Brown E, Caillette–Beaudoin A, Clutterbuck E, Davies S, D'Auzac C, Ekstrand A, Frandsen N, Freida P, Heimbürger O, Kuypers+ D, Gasthuisberg+ A, Mactier R, MacNamara E, Malmsten G, Mastrangelo F, Meeus F, Melotte G, Perez–Contreras J, Riegel W, Rodrigues A, Rodriguez–Carmona A, Rosman J, Rutherford P, Scanziani R, Vega Diaz N, Vychytil A, Weinreich T. Adequacy Targets Can be Met in Anuric Patients by Automated Peritoneal Dialysis: Baseline Data from Eapos. Perit Dial Int 2020. [DOI: 10.1177/089686080102103s19] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
♦ Objective Conventional continuous ambulatory peritoneal dialysis (CAPD) in patients without residual renal function and with high solute transport is associated with worse clinical outcomes. Automated peritoneal dialysis (APD) has the potential to improve both solute clearance and ultrafiltration in these circumstances, but its efficacy as a treatment modality is unknown. The European Automated Peritoneal Dialysis Outcomes Study (EAPOS) is a 2-year, prospective, European multi-center study designed to determine APD feasibility and clinical outcomes in anuric patients. The present article describes the baseline data for patients recruited into the study. ♦ Design All PD patients treated in the participating centers were screened for inclusion criteria [urinary output < 100 mL/24 h, or residual renal function (RRF) < 1 mL/min, or both]. After enrollment, changes were made to the dialysis prescription to achieve a weekly creatinine clearance above 60 L per 1.73 m2 and an ultrafiltration rate above 750 mL in 24 hours. ♦ Setting The study is being conducted in 26 dialysis centers in 13 European countries. ♦ Baseline Data Collection The information collected includes patient demographics, dialysis prescription, achieved weekly creatinine clearance, and 24-hour ultra-filtration (UF). ♦ Results The study enrolled 177 anuric patients. Median dialysis duration before enrollment was 22.5 months (range: 0 – 285 months). Mean solute transport measured as the dialysate-to-plasma ratio of creatinine (D/PCr) was 0.74 ± 0.12. Patients received APD for a median of 9.0 hours overnight (range: 7 – 12 hours) using a median of 11.0 L of fluid (range: 6 – 28.75 L). Median daytime volume was 4.0 L (range: 0.0 – 9.0 L). Tidal dialysis was used in 26 patients, and icodextrin in 86 patients. At baseline, before treatment optimization, the weekly mean total creatinine clearance was 65.2 ± 14.4 L/1.73 m2, with 105 patients (60%) achieving the target of more than 60 L/1.73 m2. At baseline, 81% of patients with high transport, 69% with high-average transport, and 40% with low-average transport met the target. At baseline, 70% of patients with a body surface area (BSA) below 1.7 m2, 60% with a BSA of 1.7 – 2.0 m2, and 56% with a BSA above 2.0 m2 achieved 60 L/1.73 m2 weekly. Median UF was 1090 mL/24 h, and 75% of patients achieved the UF target of more than 750 mL/24 h. ♦ Conclusion This baseline analysis of anuric patients recruited into the EAPOS study demonstrates that a high proportion of anuric patients on APD can achieve dialysis and ultrafiltration targets using a variety of regimes. This 2-year follow-up study aims to optimize APD prescription to reach predefined clearance and ultrafiltration targets, and to observe the resulting clinical outcomes.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - M. Borras
- Hospital Amau de Vilanova, Lerida, Spain
| | - E. Brown
- Charing Cross Hospital, London, U.K
| | | | | | - S. Davies
- North Staffordshire Hospital, Stoke-on-Trent, U.K
| | - C. D'Auzac
- Hôpital Européen Georges Pompidou, Paris, France
| | - A. Ekstrand
- Helsinki University Hospital, Helsinki, Finland
| | | | - P. Freida
- Centre Hospitalier Louis Pasteur, Cherbourg, France
| | | | | | | | - R. Mactier
- Stobhill Hospital NHS Trust, Glasgow, Scotland, U.K
| | - E. MacNamara
- Centre Hospitalier Germon et Gauthier, Bethune, France
| | - G. Malmsten
- Orebro Medical Center Hospital, Orebro, Sweden
| | | | - F. Meeus
- Centre Hospitalier Louise Michel Evry, Evry, France
| | | | | | - W. Riegel
- Klinikum Darmstadt, Darmstadt, Germany
| | | | | | - J. Rosman
- Westeinde Hospital, The Hague, Netherlands
| | | | | | - N. Vega Diaz
- Hospital Nuestra Senora del Pino, Las Palmas, Spain
| | - A. Vychytil
- Universitat Klinik für Innere Medezin III, Vienna, Austria
| | - T. Weinreich
- Dialyse Institüt Villingen– Schwenningen, Schwenningen, Germany
| | | |
Collapse
|
31
|
Cooker LA, Luneburg P, Holmes CJ, Jones S, Topley N, O'Donoghue D, Frenken L, Brown E, Walls J, Pedersen F, Freese P, Heimbürger O, Gokal R, Junor B, Maiorca R, Weiss L, Farrington K, Kristiensen J, Ahlmén J, Struijk D, Brouwer R, Ryckelynck J, Williams J, Hopwood A. Interleukin-6 Levels Decrease in Effluent from Patients Dialyzed with Bicarbonate/Lactate–Based Peritoneal Dialysis Solutions. Perit Dial Int 2020. [DOI: 10.1177/089686080102103s17] [Citation(s) in RCA: 50] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
♦ Objective Conventional lactate-buffered peritoneal dialysis (PD) solutions have several bioincompatible characteristics, including acidic pH, lactate buffer, and the presence of glucose degradation products (GDPs). These characteristics, along with inflammation, are believed to contribute to membrane dysfunction in peritoneal dialysis patients. A new PD solution containing a bicarbonate/ lactate buffer system with physiologic pH and low GDPs has shown improved biocompatibility in both in vitro and ex vivo studies. In the present study, the concentrations of cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNFα), and vascular endothelial growth factor (VEGF), were measured in timed overnight effluents from PD patients continuously dialyzed with either lactate-based control solution (C) or bicarbonate/lactate–based solution (B/L) for 6 months. ♦ Methods Effluents from 92 continuous ambulatory peritoneal dialysis (CAPD) patients were collected when the patients were entered into the study (baseline, all patients on C for more than 3 months), and at 3 and 6 months following randomization to C ( n = 31) or to B/L ( n = 61). Effluent samples were filtered, stored frozen, and then assayed for IL-6, TNFα, and VEGF by ELISA. ♦ Results A significant decrease in effluent IL-6 was seen at 3 months and at 6 months in the B/L-treated patients. Levels of VEGF were significantly reduced at 3 months. No changes in the levels of IL-6 or VEGF were seen in the C-treated patients, and no changes in TNFα were seen in either group over time. ♦ Conclusions Treatment with B/L is associated with decreased IL-6 synthesis and decreased VEGF secretion. The data suggest that the use of B/L solution is associated with reduced intraperitoneal inflammation and potential for angiogenesis. The use of B/L solution may, over time, help to restore peritoneal homeostasis and therefore preserve the function of the membrane in peritoneal dialysis.
Collapse
Affiliation(s)
- Laurinda A. Cooker
- Baxter Healthcare Corporation, Renal Division, McGaw Park, Illinois, U.S.A
| | - Patricia Luneburg
- Baxter Healthcare Corporation, Renal Division, McGaw Park, Illinois, U.S.A
| | - Clifford J. Holmes
- Baxter Healthcare Corporation, Renal Division, McGaw Park, Illinois, U.S.A
| | - Suzanne Jones
- Institute of Nephrology, University of Wales College of Medicine, Cardiff, U.K
| | - Nicholas Topley
- Institute of Nephrology, University of Wales College of Medicine, Cardiff, U.K
| | | | - L. Frenken
- De Wever Ziekenhuis, Heerlen, Netherlands
| | - E. Brown
- Charing Cross Hospital, London, U.K
| | - J. Walls
- Leicester General Hospital, Leicester, U.K
| | | | - P. Freese
- Odense Universitetshospital, Odense, Denmark
| | | | - R. Gokal
- Manchester Royal Infirmary, Manchester, U.K
| | | | - R. Maiorca
- Ospedale Regionale “Spedali Civili,” Brescia, Italy
| | - L. Weiss
- Central Sjukhuset, Karlstad, Sweden
| | | | | | | | - D. Struijk
- Academisch Medisch Centrum, Amsterdam, Netherlands
| | - R. Brouwer
- Medisch Spectrum Twente, Enchede, Netherlands
| | | | - J.D. Williams
- University of Wales College of Medicine, Cardiff, U.K
| | | | | |
Collapse
|
32
|
Aprile E, Aalbers J, Agostini F, Alfonsi M, Althueser L, Amaro FD, Antochi VC, Angelino E, Arneodo F, Barge D, Baudis L, Bauermeister B, Bellagamba L, Benabderrahmane ML, Berger T, Breur PA, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Coderre D, Colijn AP, Conrad J, Cussonneau JP, Decowski MP, de Perio P, Depoian A, Di Gangi P, Di Giovanni A, Diglio S, Elykov A, Eurin G, Fei J, Ferella AD, Fieguth A, Fulgione W, Gaemers P, Gallo Rosso A, Galloway M, Gao F, Garbini M, Grandi L, Greene Z, Hasterok C, Hils C, Hogenbirk E, Howlett J, Iacovacci M, Itay R, Joerg F, Kazama S, Kish A, Kobayashi M, Koltman G, Kopec A, Landsman H, Lang RF, Levinson L, Lin Q, Lindemann S, Lindner M, Lombardi F, Lopes JAM, López Fune E, Macolino C, Mahlstedt J, Manfredini A, Marignetti F, Marrodán Undagoitia T, Masbou J, Mastroianni S, Messina M, Micheneau K, Miller K, Molinario A, Morå K, Mosbacher Y, Murra M, Naganoma J, Ni K, Oberlack U, Odgers K, Palacio J, Pelssers B, Peres R, Pienaar J, Pizzella V, Plante G, Podviianiuk R, Qin J, Qiu H, Ramírez García D, Reichard S, Riedel B, Rocchetti A, Rupp N, Dos Santos JMF, Sartorelli G, Šarčević N, Scheibelhut M, Schindler S, Schreiner J, Schulte D, Schumann M, Scotto Lavina L, Selvi M, Shagin P, Shockley E, Silva M, Simgen H, Therreau C, Thers D, Toschi F, Trinchero G, Tunnell C, Upole N, Vargas M, Volta G, Wack O, Wang H, Wei Y, Weinheimer C, Wenz D, Wittweg C, Wulf J, Ye J, Zhang Y, Zhu T, Zopounidis JP. Light Dark Matter Search with Ionization Signals in XENON1T. Phys Rev Lett 2019; 123:251801. [PMID: 31922764 DOI: 10.1103/physrevlett.123.251801] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2019] [Revised: 11/07/2019] [Indexed: 06/10/2023]
Abstract
We report constraints on light dark matter (DM) models using ionization signals in the XENON1T experiment. We mitigate backgrounds with strong event selections, rather than requiring a scintillation signal, leaving an effective exposure of (22±3) tonne day. Above ∼0.4 keV_{ee}, we observe <1 event/(tonne day keV_{ee}), which is more than 1000 times lower than in similar searches with other detectors. Despite observing a higher rate at lower energies, no DM or CEvNS detection may be claimed because we cannot model all of our backgrounds. We thus exclude new regions in the parameter spaces for DM-nucleus scattering for DM masses m_{χ} within 3-6 GeV/c^{2}, DM-electron scattering for m_{χ}>30 MeV/c^{2}, and absorption of dark photons and axionlike particles for m_{χ} within 0.186-1 keV/c^{2}.
Collapse
Affiliation(s)
- E Aprile
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Aalbers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - F Agostini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M Alfonsi
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L Althueser
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - F D Amaro
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - V C Antochi
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - E Angelino
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
| | - F Arneodo
- New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates
| | - D Barge
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - L Baudis
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Bauermeister
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - L Bellagamba
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M L Benabderrahmane
- New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates
| | - T Berger
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - P A Breur
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Brown
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - E Brown
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - S Bruenner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Bruno
- New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates
| | - R Budnik
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - C Capelli
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J M R Cardoso
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - D Cichon
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Coderre
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A P Colijn
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Conrad
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - J P Cussonneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - M P Decowski
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - P de Perio
- Physics Department, Columbia University, New York, New York 10027, USA
| | - A Depoian
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - P Di Gangi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - A Di Giovanni
- New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates
| | - S Diglio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - A Elykov
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Eurin
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J Fei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - A D Ferella
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Fieguth
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - W Fulgione
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - P Gaemers
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Gallo Rosso
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - M Galloway
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - F Gao
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Garbini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - L Grandi
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - Z Greene
- Physics Department, Columbia University, New York, New York 10027, USA
| | - C Hasterok
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C Hils
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - E Hogenbirk
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Howlett
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Iacovacci
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - R Itay
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Joerg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - S Kazama
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan
| | - A Kish
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - M Kobayashi
- Physics Department, Columbia University, New York, New York 10027, USA
| | - G Koltman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - A Kopec
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Landsman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - R F Lang
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - L Levinson
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - Q Lin
- Physics Department, Columbia University, New York, New York 10027, USA
| | - S Lindemann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Lindner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - F Lombardi
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
- Department of Physics, University of California, San Diego, California 92093, USA
| | - J A M Lopes
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - E López Fune
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - C Macolino
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91405 Orsay, France
| | - J Mahlstedt
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Manfredini
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Marignetti
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | | | - J Masbou
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - S Mastroianni
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - M Messina
- New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Micheneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - K Miller
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Molinario
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Morå
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - Y Mosbacher
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - M Murra
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Naganoma
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - K Ni
- Department of Physics, University of California, San Diego, California 92093, USA
| | - U Oberlack
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Odgers
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - J Palacio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - B Pelssers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - R Peres
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Pienaar
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - V Pizzella
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Plante
- Physics Department, Columbia University, New York, New York 10027, USA
| | - R Podviianiuk
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - J Qin
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Qiu
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - D Ramírez García
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S Reichard
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Riedel
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Rocchetti
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - N Rupp
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J M F Dos Santos
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - G Sartorelli
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - N Šarčević
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Scheibelhut
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Schindler
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Schreiner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Schulte
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M Schumann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L Scotto Lavina
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - M Selvi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - P Shagin
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - E Shockley
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Silva
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - H Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C Therreau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Thers
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - F Toschi
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Trinchero
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
| | - C Tunnell
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - N Upole
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Vargas
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - G Volta
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - O Wack
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - H Wang
- Physics and Astronomy Department, University of California, Los Angeles, California 90095, USA
| | - Y Wei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - C Weinheimer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - D Wenz
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - C Wittweg
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Wulf
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Ye
- Department of Physics, University of California, San Diego, California 92093, USA
| | - Y Zhang
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Zhu
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J P Zopounidis
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| |
Collapse
|
33
|
Aprile E, Aalbers J, Agostini F, Alfonsi M, Althueser L, Amaro FD, Antochi VC, Angelino E, Arneodo F, Barge D, Baudis L, Bauermeister B, Bellagamba L, Benabderrahmane ML, Berger T, Breur PA, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Coderre D, Colijn AP, Conrad J, Cussonneau JP, Decowski MP, de Perio P, Depoian A, Di Gangi P, Di Giovanni A, Diglio S, Elykov A, Eurin G, Fei J, Ferella AD, Fieguth A, Fulgione W, Gaemers P, Gallo Rosso A, Galloway M, Gao F, Garbini M, Grandi L, Greene Z, Hasterok C, Hils C, Hogenbirk E, Howlett J, Iacovacci M, Itay R, Joerg F, Kazama S, Kish A, Kobayashi M, Koltman G, Kopec A, Landsman H, Lang RF, Levinson L, Lin Q, Lindemann S, Lindner M, Lombardi F, Lopes JAM, López Fune E, Macolino C, Mahlstedt J, Manenti M, Manfredini A, Marignetti F, Marrodán Undagoitia T, Masbou J, Mastroianni S, Messina M, Micheneau K, Miller K, Molinario A, Morå K, Mosbacher Y, Murra M, Naganoma J, Ni K, Oberlack U, Odgers K, Palacio J, Pelssers B, Peres R, Pienaar J, Pizzella V, Plante G, Podviianiuk R, Qin J, Qiu H, Ramírez García D, Reichard S, Riedel B, Rocchetti A, Rupp N, Dos Santos JMF, Sartorelli G, Šarčević N, Scheibelhut M, Schindler S, Schreiner J, Schulte D, Schumann M, Scotto Lavina L, Selvi M, Shagin P, Shockley E, Silva M, Simgen H, Therreau C, Thers D, Toschi F, Trinchero G, Tunnell C, Upole N, Vargas M, Volta G, Wack O, Wang H, Wei Y, Weinheimer C, Wenz D, Wittweg C, Wulf J, Ye J, Zhang Y, Zhu T, Zopounidis JP. Search for Light Dark Matter Interactions Enhanced by the Migdal Effect or Bremsstrahlung in XENON1T. Phys Rev Lett 2019; 123:241803. [PMID: 31922867 DOI: 10.1103/physrevlett.123.241803] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Revised: 10/15/2019] [Indexed: 06/10/2023]
Abstract
Direct dark matter detection experiments based on a liquid xenon target are leading the search for dark matter particles with masses above ∼5 GeV/c^{2}, but have limited sensitivity to lighter masses because of the small momentum transfer in dark matter-nucleus elastic scattering. However, there is an irreducible contribution from inelastic processes accompanying the elastic scattering, which leads to the excitation and ionization of the recoiling atom (the Migdal effect) or the emission of a bremsstrahlung photon. In this Letter, we report on a probe of low-mass dark matter with masses down to about 85 MeV/c^{2} by looking for electronic recoils induced by the Migdal effect and bremsstrahlung using data from the XENON1T experiment. Besides the approach of detecting both scintillation and ionization signals, we exploit an approach that uses ionization signals only, which allows for a lower detection threshold. This analysis significantly enhances the sensitivity of XENON1T to light dark matter previously beyond its reach.
Collapse
Affiliation(s)
- E Aprile
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Aalbers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - F Agostini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M Alfonsi
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L Althueser
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - F D Amaro
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - V C Antochi
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - E Angelino
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
| | - F Arneodo
- New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates
| | - D Barge
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - L Baudis
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Bauermeister
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - L Bellagamba
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M L Benabderrahmane
- New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates
| | - T Berger
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - P A Breur
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Brown
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - E Brown
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - S Bruenner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Bruno
- New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates
| | - R Budnik
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - C Capelli
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J M R Cardoso
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - D Cichon
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Coderre
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A P Colijn
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Conrad
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - J P Cussonneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - M P Decowski
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - P de Perio
- Physics Department, Columbia University, New York, New York 10027, USA
| | - A Depoian
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - P Di Gangi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - A Di Giovanni
- New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates
| | - S Diglio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - A Elykov
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Eurin
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J Fei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - A D Ferella
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Fieguth
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - W Fulgione
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - P Gaemers
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Gallo Rosso
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - M Galloway
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - F Gao
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Garbini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - L Grandi
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - Z Greene
- Physics Department, Columbia University, New York, New York 10027, USA
| | - C Hasterok
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C Hils
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - E Hogenbirk
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Howlett
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Iacovacci
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - R Itay
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Joerg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - S Kazama
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan
| | - A Kish
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - M Kobayashi
- Physics Department, Columbia University, New York, New York 10027, USA
| | - G Koltman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - A Kopec
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Landsman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - R F Lang
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - L Levinson
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - Q Lin
- Physics Department, Columbia University, New York, New York 10027, USA
| | - S Lindemann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Lindner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - F Lombardi
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
- Department of Physics, University of California, San Diego, California 92093, USA
| | - J A M Lopes
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - E López Fune
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - C Macolino
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91405 Orsay, France
| | - J Mahlstedt
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - M Manenti
- New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates
| | - A Manfredini
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Marignetti
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | | | - J Masbou
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - S Mastroianni
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - M Messina
- New York University Abu Dhabi, P.O. Box 129188, Abu Dhabi, United Arab Emirates
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Micheneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - K Miller
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Molinario
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Morå
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - Y Mosbacher
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - M Murra
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Naganoma
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - K Ni
- Department of Physics, University of California, San Diego, California 92093, USA
| | - U Oberlack
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Odgers
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - J Palacio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - B Pelssers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - R Peres
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Pienaar
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - V Pizzella
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Plante
- Physics Department, Columbia University, New York, New York 10027, USA
| | - R Podviianiuk
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - J Qin
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Qiu
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - D Ramírez García
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S Reichard
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Riedel
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Rocchetti
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - N Rupp
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J M F Dos Santos
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - G Sartorelli
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - N Šarčević
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Scheibelhut
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Schindler
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Schreiner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Schulte
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M Schumann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L Scotto Lavina
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - M Selvi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - P Shagin
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - E Shockley
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Silva
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - H Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C Therreau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Thers
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - F Toschi
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Trinchero
- INAF-Astrophysical Observatory of Torino, Department of Physics, University of Torino and INFN-Torino, 10125 Torino, Italy
| | - C Tunnell
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - N Upole
- Department of Physics and Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Vargas
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - G Volta
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - O Wack
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - H Wang
- Physics and Astronomy Department, University of California, Los Angeles, California 90095, USA
| | - Y Wei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - C Weinheimer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - D Wenz
- Institut für Physik and Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - C Wittweg
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Wulf
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Ye
- Department of Physics, University of California, San Diego, California 92093, USA
| | - Y Zhang
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Zhu
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J P Zopounidis
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| |
Collapse
|
34
|
Jugé L, Yeung J, Knapman F, Burke P, Brown E, Butler J, Eckert D, Ngiam J, Sutherland K, Cistulli P, Bilston L. How mandibular advancement splints alter genioglossus airway dilation patterns during inspiration in awake people with obstructive sleep apnoea may help predict treatment outcomes. Sleep Med 2019. [DOI: 10.1016/j.sleep.2019.11.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
35
|
Stalter R, Onono M, Scarsi K, Brown E, Adeojo L, Bukusi E, Patel R. Characterizing condomless sex among new contraceptive implant users who are living with or at risk for HIV in Kenya. Am J Obstet Gynecol 2019. [DOI: 10.1016/j.ajog.2019.10.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Ferreira JL, Maslanka S, Johnson E, Goodnough M, Barash J, Boersma T, Brown E, Dykes J, Eliasberg S, Inami G, Lau D, Lindsey C, Ludwig G, Minor E, Parker T, Reddy R, Skinner G, Solomon H, Tepp B, Tetzloff R. Detection of Botulinal Neurotoxins A, B, E, and F by Amplified Enzyme-Linked Immunosorbent Assay: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/86.2.314] [Citation(s) in RCA: 59] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
An amplified enzyme-linked immunosorbent assay (amp-ELISA) was compared with the AOAC Official Method 977.26 for detection of Clostridium botulinum and its toxins in foods. Eleven laboratories participated and the results of 10 laboratories were used in the study. Two anaerobic culture media, tryptone peptone glucose yeast extract (TPGY) and cooked meat medium (CMM) were used to generate toxic samples with types A, B, E, and F botulinal strains. Nonbotulinal clostridia were also tested. The toxicity of each botulinal culture was determined by the AOAC method, and the cultures were then diluted, if necessary, to high (about 10 000 minimal lethal dose [MLD]/mL) and low (about 100 MLD/mL) test samples. The overall sensitivity of detection in TPGY and CMM cultures with the amp-ELISA was 94.7% at about 100 MLD/mL and 99.6% for samples with ≥10 000 MLD/mL toxicity. The amp-ELISA detection sensitivity for low toxin samples was 92.3% in TPGY and 99.4% in CMM. The false-positive rate ranged from 1.5% for type A to 28.6% for type F in TPGY, and from 2.4% for type A to 11.4% for type F in CMM. Most of the cross-reactivity was due to detection of other botulinal types, especially in high toxin samples. The amp-ELISA could be used to screen suspect cultures for botulinal toxins. Positive amp-ELISA samples would be confirmed by the AOAC reference method.
Collapse
Affiliation(s)
| | - Susan Maslanka
- Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333
| | - Eric Johnson
- University of Wisconsin–Madison, Department of Food Microbiology and Toxicology, 1925 Willow Dr, Madison, WI 53706
| | - Mike Goodnough
- Present address: Metabiologics, Inc., 505 S. Rosa Rd, Madison, WI 53719
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Rosero S, Machet F, Kowarz M, Brown E, Lopes-Vicente J, Sharp J, Rader W. P6308Use of cell-embedded fully implantable biosensor system for real-time, in-vivo monitoring of NF-Kappa B inflammatory pathway. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
21st century health care remains anchored to sporadic measurements of traditional physiologic variables such as heart rate, blood pressure, weight, physical exam findings and general biochemical values. Currently there is no sensor capable of monitoring in intra-cellular protein and gene level signaling in real-time and in-vivo. This gap between biological signaling and its translation into clinically relevant therapeutics targeting the individual has limited precision medicine approaches to heart and vascular diseases. Inflammatory processes have been implicated in numerous cardiovascular diseases providing an ideal target for using Biologically based-Implantable Electronic Devices (BIED) approaches.
Objective
We aimed to test an implantable electro-photonic biosensor system in which living cells are integrated within the BIED and 1) serve as the primary sensor element providing in-vivo, real-time monitoring of intra-cellular processes such as gene expression, protein signaling, and target pathway activation, and 2) provide intelligent biologically based-processing in which the the output reflects biological response to an event. The engineered sensor cells provide real-time monitoring and respond to prespecified biologic signals using green fluorescence protein (GFP). The fluorescence is then detected via the BIED's photonic system and the cellular response data transmitted providing remote monitoring capabilities to facilitate the development of innovative personalized therapeutics.
Methods
A biologically-based implantable biosensor (BIED) platform which provides fluorescence detection, data acquisition and transmission from living cells integrated within the device was tested. The sensor cells communicate with the surrounding implant environment via a biomembrane. NRK rat cells engineered to express GFP in response to NF-κB pathway activation were cultured and housed within the sensor. Prior implant studies confirmed NRK sensor cells remained viable for 21 days in-vivo as part of a fully functional implanted BIED hardware system. Ex-vivo experiments characterized the expected magnitude and time course of NRK response to TNF-α and Lipopolysaccharide (LPS) exposure used to elicit a proinflammatory inflammatory response. The biosensor was implanted in the subcutaneous space of male Sprague Dawley rats (n=2) for a total of 11 days consisting of a baseline post-surgical recovery period of 7 days, with subsequent challenge with intraperitoneal LPS on Day 8 and 96 hours of post LPS monitoring.
Results
Rats implanted with the Biological based sensor and challenged with intraperitoneal LPS showed real-time expression of GFP under NF-κB transcriptional control following time course similar to ex-vivo experiments (p<0.05) (Figure 1).
Figure 1. Implantable Cell-Embedded Biosensor
Conclusion
We present the first in-vivo use of a new class of BIEDs to detect biological cell response which may herald real-time personalize health management at the molecular and cellular level.
Acknowledgement/Funding
Clinical and Translational Sciences Institute-University of Rochester, Efferent Labs
Collapse
Affiliation(s)
- S Rosero
- University of Rochester, Clinical Cardiovascular Research Center, Rochester, United States of America
| | | | - M Kowarz
- Efferent Labs, Research Unit, Buffalo, United States of America
| | - E Brown
- University of Rochester, Biomedical Engineering, Rochester, United States of America
| | | | - J Sharp
- University of Rochester, Rochester, United States of America
| | | |
Collapse
|
38
|
Stephenson R, Sharma A, Mimiaga MJ, Garofalo R, Brown E, Bratcher A, Wimbly T, Hidalgo MA, Hoehnle S, Thai J, Sullivan PS, Suarez NA. Concordance in the reporting of intimate partner violence among male-male couples. J Fam Violence 2019; 34:677-686. [PMID: 32773962 PMCID: PMC7413602 DOI: 10.1007/s10896-019-00076-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
Intimate partner violence (IPV) among male couples is increasingly recognized as a public health concern. Research on IPV in opposite sex couples indicates frequent underreporting of IPV and high levels of discordance in reporting among dyads. Concordance studies inform refinement methods to measure the experience of IPV among dyads; however the lack of dyadic studies of male couples impedes our understanding of the extent to which IPV is differentially reported in male-male dyads. This study utilized baseline data from a randomized controlled trial of a behavioral intervention to optimize antiretroviral therapy (ART) adherence among 160 sero-discordant male couples in three US cities and provides the first analysis of concordance in reporting IPV among male couples. Low degrees of concordance in the reporting of IPV were identified among male dyads, with a greater proportion of men reporting violence perpetration than experiencing violence. The greater reporting of IPV perpetration may be linked to adherence to concepts of masculinity. The results underscore the unique experiences of IPV among male couples and the need to reexamine current IPV measurement and intervention strategies.
Collapse
Affiliation(s)
- R Stephenson
- Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, USA
- Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI, USA
| | - A Sharma
- Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, USA
- Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI, USA
| | - M J Mimiaga
- Center for Health Equity Research, Brown University, Providence, RI, USA
- Departments of Behavioral and Social Health Sciences and Epidemiology, Brown University School of Public Health, Providence, RI, USA
- Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, RI, USA
- The Fenway Institute, Fenway Health, Boston, MA, USA
| | - R Garofalo
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
- Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
| | - E Brown
- The Fenway Institute, Fenway Health, Boston, MA, USA
| | - A Bratcher
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - T Wimbly
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - M A Hidalgo
- Center for Trans Youth Health and Development, Children's Hospital Los Angeles, Los Angeles, CA, USA
- Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - S Hoehnle
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
- Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
| | - J Thai
- Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
| | - P S Sullivan
- Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA
| | - N A Suarez
- Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, MI, USA
- The Center for Sexuality and Health Disparities, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
39
|
Robin G, Brown E, Davis C, Bird L, Wilson L, Halperin R, Brundage M, Croke J, Caissie A. A Pan-Canadian Initiative to Increase Patient Engagement Within Radiation Oncology Programs. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.2117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
40
|
Williams EM, Dismuke CL, Faith TD, Smalls BL, Brown E, Oates JC, Egede LE. Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study. Lupus 2019; 28:937-944. [PMID: 31166867 DOI: 10.1177/0961203319851559] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
OBJECTIVE The Peer Approaches to Lupus Self-management (PALS) program was developed as a peer mentoring tool to improve health behaviors, beliefs, and outcomes in African American women with systemic lupus erythematosus (SLE). This study aims to assess the cost of the PALS intervention and determine its effectiveness when compared to existing treatments. METHODS Peer mentors and mentees were paired on shared criteria such as life stage, marital status, or whether they were mothers. This 12-week program consisted of a weekly peer mentoring session by telephone. Cost of healthcare utilization was evaluated by assessing the healthcare costs pre- and post-intervention. Validated measures of quality of life, self-management, disease activity, depression, and anxiety were collected. Total direct program costs per participant were totaled and used to determine average per unit improvement in outcome measures. The benefit-cost ratio and pre- versus post-intervention hospital charges were examined. RESULTS A total of 20 mentees and 7 mentors were enrolled in the PALS program. All PALS pairs completed 12 sessions lasting an average of 54 minutes. Mentees reported statistically significant decreases in patient-reported disease activity, depression, and anxiety, with improved trends in patient activation or patient engagement in their disease and management. The total cost per patient was $1291.50, which was $107.62 per patient per week. There was a savings of $23,417 per individual receiving the intervention with a benefit-cost ratio of 18.13 per patient. CONCLUSION These findings suggest that the PALS intervention was effective in improving patient-level factors and was cost-effective. Future research will need to validate these findings in a larger sample.
Collapse
Affiliation(s)
- E M Williams
- 1 Department of Public Health Sciences, Medical University of South Carolina, Charleston, USA
| | - C L Dismuke
- 2 Veterans Health Administration, Charleston Health Equity and Rural Outreach Innovation Center, Ralph H Johnson Department of Veterans Affairs Medical Center, Charleston, USA.,3 College of Medicine, Center for Health Disparities Research, Medical University of South Carolina, Charleston, USA
| | - T D Faith
- 1 Department of Public Health Sciences, Medical University of South Carolina, Charleston, USA
| | - B L Smalls
- 4 Center for Health Services Research, College of Medicine, University of Kentucky, Lexington, USA
| | - E Brown
- 5 Division of Healthcare Studies, Department of Health Professions, College of Health Professions, Medical University of South Carolina, Charleston, USA
| | - J C Oates
- 6 Division of Rheumatology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, USA
| | - L E Egede
- 7 Division of General Internal Medicine, Center for Patient Care and Outcomes Research, Medical College of Wisconsin, Milwaukee, USA
| |
Collapse
|
41
|
Aprile E, Aalbers J, Agostini F, Alfonsi M, Althueser L, Amaro FD, Anthony M, Antochi VC, Arneodo F, Baudis L, Bauermeister B, Benabderrahmane ML, Berger T, Breur PA, Brown A, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Coderre D, Colijn AP, Conrad J, Cussonneau JP, Decowski MP, de Perio P, Di Gangi P, Di Giovanni A, Diglio S, Elykov A, Eurin G, Fei J, Ferella AD, Fieguth A, Fulgione W, Gallo Rosso A, Galloway M, Gao F, Garbini M, Grandi L, Greene Z, Hasterok C, Hogenbirk E, Howlett J, Iacovacci M, Itay R, Joerg F, Kazama S, Kish A, Koltman G, Kopec A, Landsman H, Lang RF, Levinson L, Lin Q, Lindemann S, Lindner M, Lombardi F, Lopes JAM, López Fune E, Macolino C, Mahlstedt J, Manfredini A, Marignetti F, Marrodán Undagoitia T, Masbou J, Masson D, Mastroianni S, Messina M, Micheneau K, Miller K, Molinario A, Morå K, Mosbacher Y, Murra M, Naganoma J, Ni K, Oberlack U, Odgers K, Pelssers B, Piastra F, Pienaar J, Pizzella V, Plante G, Podviianiuk R, Priel N, Qiu H, Ramírez García D, Reichard S, Riedel B, Rizzo A, Rocchetti A, Rupp N, Dos Santos JMF, Sartorelli G, Šarčević N, Scheibelhut M, Schindler S, Schreiner J, Schulte D, Schumann M, Scotto Lavina L, Selvi M, Shagin P, Shockley E, Silva M, Simgen H, Therreau C, Thers D, Toschi F, Trinchero G, Tunnell C, Upole N, Vargas M, Wack O, Wang H, Wang Z, Wei Y, Weinheimer C, Wenz D, Wittweg C, Wulf J, Xu Z, Ye J, Zhang Y, Zhu T, Zopounidis JP. Constraining the Spin-Dependent WIMP-Nucleon Cross Sections with XENON1T. Phys Rev Lett 2019; 122:141301. [PMID: 31050482 DOI: 10.1103/physrevlett.122.141301] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 03/07/2019] [Indexed: 06/09/2023]
Abstract
We report the first experimental results on spin-dependent elastic weakly interacting massive particle (WIMP) nucleon scattering from the XENON1T dark matter search experiment. The analysis uses the full ton year exposure of XENON1T to constrain the spin-dependent proton-only and neutron-only cases. No significant signal excess is observed, and a profile likelihood ratio analysis is used to set exclusion limits on the WIMP-nucleon interactions. This includes the most stringent constraint to date on the WIMP-neutron cross section, with a minimum of 6.3×10^{-42} cm^{2} at 30 GeV/c^{2} and 90% confidence level. The results are compared with those from collider searches and used to exclude new parameter space in an isoscalar theory with an axial-vector mediator.
Collapse
Affiliation(s)
- E Aprile
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Aalbers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - F Agostini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M Alfonsi
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L Althueser
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - F D Amaro
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - M Anthony
- Physics Department, Columbia University, New York, New York 10027, USA
| | - V C Antochi
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - F Arneodo
- New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates
| | - L Baudis
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Bauermeister
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | | | - T Berger
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - P A Breur
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Brown
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - A Brown
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - E Brown
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - S Bruenner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Bruno
- New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates
| | - R Budnik
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - C Capelli
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J M R Cardoso
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - D Cichon
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Coderre
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A P Colijn
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Conrad
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - J P Cussonneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - M P Decowski
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - P de Perio
- Physics Department, Columbia University, New York, New York 10027, USA
| | - P Di Gangi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - A Di Giovanni
- New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates
| | - S Diglio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - A Elykov
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Eurin
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J Fei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - A D Ferella
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Fieguth
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - W Fulgione
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
- INFN-Torino and Osservatorio Astrofisico di Torino, 10125 Torino, Italy
| | - A Gallo Rosso
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - M Galloway
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - F Gao
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Garbini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - L Grandi
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - Z Greene
- Physics Department, Columbia University, New York, New York 10027, USA
| | - C Hasterok
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - E Hogenbirk
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Howlett
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Iacovacci
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - R Itay
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Joerg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - S Kazama
- Kobayashi-Maskawa Institute for the Origin of Particles and the Universe, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8602, Japan
| | - A Kish
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - G Koltman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - A Kopec
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Landsman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - R F Lang
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - L Levinson
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - Q Lin
- Physics Department, Columbia University, New York, New York 10027, USA
| | - S Lindemann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Lindner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - F Lombardi
- Department of Physics, University of California, San Diego, California 92093, USA
| | - J A M Lopes
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - E López Fune
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - C Macolino
- LAL, Université Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, F-91405 Orsay, France
| | - J Mahlstedt
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Manfredini
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Marignetti
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | | | - J Masbou
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Masson
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - S Mastroianni
- Department of Physics "Ettore Pancini," University of Napoli and INFN-Napoli, 80126 Napoli, Italy
| | - M Messina
- New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Micheneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - K Miller
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Molinario
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Morå
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - Y Mosbacher
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - M Murra
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Naganoma
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - K Ni
- Department of Physics, University of California, San Diego, California 92093, USA
| | - U Oberlack
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - K Odgers
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - B Pelssers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - F Piastra
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Pienaar
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - V Pizzella
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Plante
- Physics Department, Columbia University, New York, New York 10027, USA
| | - R Podviianiuk
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - N Priel
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - H Qiu
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - D Ramírez García
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S Reichard
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Riedel
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Rizzo
- Physics Department, Columbia University, New York, New York 10027, USA
| | - A Rocchetti
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - N Rupp
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J M F Dos Santos
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - G Sartorelli
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - N Šarčević
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Scheibelhut
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Schindler
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Schreiner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Schulte
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M Schumann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L Scotto Lavina
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - M Selvi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - P Shagin
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - E Shockley
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Silva
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - H Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - C Therreau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Thers
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - F Toschi
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Trinchero
- INFN-Torino and Osservatorio Astrofisico di Torino, 10125 Torino, Italy
| | - C Tunnell
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - N Upole
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Vargas
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - O Wack
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - H Wang
- Physics & Astronomy Department, University of California, Los Angeles, California 90095, USA
| | - Z Wang
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - Y Wei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - C Weinheimer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - D Wenz
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - C Wittweg
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Wulf
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - Z Xu
- Department of Physics, University of California, San Diego, California 92093, USA
| | - J Ye
- Department of Physics, University of California, San Diego, California 92093, USA
| | - Y Zhang
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Zhu
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J P Zopounidis
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| |
Collapse
|
42
|
Aprile E, Aalbers J, Agostini F, Alfonsi M, Althueser L, Amaro FD, Anthony M, Antochi VC, Arneodo F, Baudis L, Bauermeister B, Benabderrahmane ML, Berger T, Breur PA, Brown A, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Coderre D, Colijn AP, Conrad J, Cussonneau JP, Decowski MP, de Perio P, Di Gangi P, Di Giovanni A, Diglio S, Elykov A, Eurin G, Fei J, Ferella AD, Fieguth A, Fulgione W, Gallo Rosso A, Galloway M, Gao F, Garbini M, Grandi L, Greene Z, Hasterok C, Hogenbirk E, Howlett J, Iacovacci M, Itay R, Joerg F, Kaminsky B, Kazama S, Kish A, Koltman G, Kopec A, Landsman H, Lang RF, Levinson L, Lin Q, Lindemann S, Lindner M, Lombardi F, Lopes JAM, López Fune E, Macolino C, Mahlstedt J, Manfredini A, Marignetti F, Marrodán Undagoitia T, Masbou J, Masson D, Mastroianni S, Messina M, Micheneau K, Miller K, Molinario A, Morå K, Murra M, Naganoma J, Ni K, Oberlack U, Odgers K, Pelssers B, Piastra F, Pienaar J, Pizzella V, Plante G, Podviianiuk R, Priel N, Qiu H, Ramírez García D, Reichard S, Riedel B, Rizzo A, Rocchetti A, Rupp N, Dos Santos JMF, Sartorelli G, Šarčević N, Scheibelhut M, Schindler S, Schreiner J, Schulte D, Schumann M, Scotto Lavina L, Selvi M, Shagin P, Shockley E, Silva M, Simgen H, Therreau C, Thers D, Toschi F, Trinchero G, Tunnell C, Upole N, Vargas M, Wack O, Wang H, Wang Z, Wei Y, Weinheimer C, Wenz D, Wittweg C, Wulf J, Ye J, Zhang Y, Zhu T, Zopounidis JP, Hoferichter M, Klos P, Menéndez J, Schwenk A. First Results on the Scalar WIMP-Pion Coupling, Using the XENON1T Experiment. Phys Rev Lett 2019; 122:071301. [PMID: 30848617 DOI: 10.1103/physrevlett.122.071301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Indexed: 06/09/2023]
Abstract
We present first results on the scalar coupling of weakly interacting massive particles (WIMPs) to pions from 1 t yr of exposure with the XENON1T experiment. This interaction is generated when the WIMP couples to a virtual pion exchanged between the nucleons in a nucleus. In contrast to most nonrelativistic operators, these pion-exchange currents can be coherently enhanced by the total number of nucleons and therefore may dominate in scenarios where spin-independent WIMP-nucleon interactions are suppressed. Moreover, for natural values of the couplings, they dominate over the spin-dependent channel due to their coherence in the nucleus. Using the signal model of this new WIMP-pion channel, no significant excess is found, leading to an upper limit cross section of 6.4×10^{-46} cm^{2} (90% confidence level) at 30 GeV/c^{2} WIMP mass.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - M Hoferichter
- Institute for Nuclear Theory, University of Washington, Seattle, Washington 98195-1550, USA
| | - P Klos
- Institut für Kernphysik, Technische Universität Darmstadt, 64289 Darmstadt, Germany
- Extreme Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| | - J Menéndez
- Center for Nuclear Study, The University of Tokyo, 113-0033 Tokyo, Japan
| | - A Schwenk
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
- Institut für Kernphysik, Technische Universität Darmstadt, 64289 Darmstadt, Germany
- Extreme Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291 Darmstadt, Germany
| |
Collapse
|
43
|
Beitsch P, Whitworth P, Baron P, Rosen B, Compagnoni G, Simmons R, Smith LA, Holmes D, Brown E, Gold L, Clark P, Coomer C, Grady I, Barbosa K, Riley L, Kinney M, Lyons S, MacDonald H, Kahn S, Ruiz A, Patel R, Curcio L, Esplin E, Yang S. Abstract P5-09-06: Underdiagnosis of HBOC in breast cancer patients: Are genetic testing guidelines a tool or an obstacle? Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-09-06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Pathogenic genetic variants are estimated to occur in 10-15% of all breast cancer patients, with BRCA 1/2 accounting for 40-50% of pathogenic/likely pathogenic (P/LP) variants. However, it is estimated that <30% of breast cancer patients harboring a BRCA 1/2 variant have been identified, with the percentage being much less for ˜20 other breast cancer associated genes. Reasons for this are multifactorial and include complicated and restrictive testing guidelines developed at a time when the cost of testing was high and guidelines for management were limited. Today, cost has plummeted and there are definitive management guidelines for a broader range of genes. We created a community based Registry to determine the incidence of P/LP variants in breast cancer patients who meet and who do not meet the NCCN 2017 genetic testing criteria.
Methods: An IRB-approved multicenter prospective registry was initiated with 20 community and academic sites experienced incancer genetic testing and counseling.
Eligibility criteria included patients with a breast cancer diagnosis who had not been previously tested. Consecutive patients aged 18-90 were consented and underwent an 80 gene panel test (Invitae –Multi-Cancer Panel). The non-inferiority study was powered to detect a difference in P/LP variant rate of 4 percentage points with statistical significance (p<0.05, Fisher's exact test).
HIPAA compliant electronic case report forms collected information on patient diagnosis, test results, and physician recommendations made after test results were received.
Results: Over 1000 patients were enrolled and data from 910 subjects analyzed to date. 50.4% met NCCN criteria and 49.5% did not. Median age for the enrolled patients is 60.5 and ranged from 22-93. 56.0% of patients were recently diagnosed with breast cancer. 10.9% of patients had a history of a prior non breast cancer. Overall, 8.9% of patients had a pathogenicvariant. 9.6% of patients who met NCCN criteria with test results had a P/LP variant. 8.2% of patients who did not meet criteria had a P/LP variant. The difference of positive cases among the two groups is not statistically significant (P = 0.49)
4.9% of patients had pathogenic variants if only an 11 gene standard breast cancer panel was considered.
The spectrum of mutated genes varied between the two groups, with some overlap.
Conclusions:
There was no statistically significant difference in the number of pathogenic/likely pathogenic variants between those patients who met and those who did not meet NCCN guidelines. Expanded panel testing yields more medically actionable P/LP variants than testing BRCA 1/2 alone or breast cancer panels with 11 genes. This study demonstrates that there will be a significant number of patients with P/LP variants are missed if NCCN guidelines are required for genetic testing. Current NCCN guidelines for the genetic testing of breast cancer patients are an obstacle to identifying patients with P/LP variants and should be removed.
Universal BC Genetic Testing RegistryNCCN Criteria (910 patients analyzed)#/% who have P/LP variants#/% who do not have P/LP variantsPatients who meet guidelines44/459 (9.6%)415/459 (90.4%)Patients who do not meet guidelines37/451 (8.2%)414/451 (91.8%)
Citation Format: Beitsch P, Whitworth P, Baron P, Rosen B, Compagnoni G, Simmons R, Smith LA, Holmes D, Brown E, Gold L, Clark P, Coomer C, Grady I, Barbosa K, Riley L, Kinney M, Lyons S, MacDonald H, Kahn S, Ruiz A, Patel R, Curcio L, Esplin E, Yang S. Underdiagnosis of HBOC in breast cancer patients: Are genetic testing guidelines a tool or an obstacle? [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-09-06.
Collapse
Affiliation(s)
- P Beitsch
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - P Whitworth
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - P Baron
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - B Rosen
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - G Compagnoni
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - R Simmons
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - LA Smith
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - D Holmes
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - E Brown
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - L Gold
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - P Clark
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - C Coomer
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - I Grady
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - K Barbosa
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - L Riley
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - M Kinney
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Lyons
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - H MacDonald
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Kahn
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - A Ruiz
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - R Patel
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - L Curcio
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - E Esplin
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Yang
- TME Dallas, Dallas, TX; TME Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical Care, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albuquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St. Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, VA; Good Samaritin, Los Gatos, CA; Breast Link, Laguna Hills, CA; Invitae, San Francisco, CA
| |
Collapse
|
44
|
Beitsch P, Whitworth P, Baron P, Rosen B, Compagnoni G, Simmons R, Smith LA, Holmes D, Brown E, Gold L, Clark P, Coomer C, Grady I, Barbosa K, Riley L, Kinney M, Lyons S, MacDonald H, Kahn S, Ruiz A, Patel R, Curcio L, Esplin E, Yang S, Michalski S. Abstract P5-09-03: Expanded panel testing superior to BRCA1/2 and breast cancer panel in patients with breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-09-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The testing of hereditary breast and ovarian cancer (HBOC) patients for BRCA1/2 only was established years ago to identify patients with clinically actionable variants and limit the economic burden. However, the cost of genetic testing has plummeted, and the number of breast cancer-risk genes with management guidelines has expanded. We created a community-based registry to test all breast cancer patients. A primary objective of this registry included accruing and comparing patients who did and did not meet NCCN guidelines and determining if providing all breast cancer patients with comprehensive multi-gene panel testing yields additional clinical value than testing BRCA1/2 alone.
Methods: An IRB-approved multicenter prospective registry was initiated with 20 community-based and academic breast sites, selected to insure geographic and ethnic diversity. Consecutive patients ages 18-90 with current or prior breast cancer were offered testing with an 80-gene panel (Invitae, San Francisco, CA). HIPAA-compliant case report forms collected patient diagnosis, test results, and physician recommendations made after test results.
Results: Over 1,000 patients were enrolled and data on 911 have been analyzed to date. Median age of patients is 60.5 (range 22 to 93). 56.0% were recently diagnosed with breast cancer. Of these patients, 50.54% met NCCN criteria, and 49.5% did not. 10.9% had history of a prior non-breast cancer. The pathogenic/likely pathogenic (P/LP) variant rate for patients on a comprehensive 80-gene panel was 8.9%. When restricted to a guidelines-based 11-gene breast cancer panel (BRCA1/2, ATM, CDH1, CHEK2, NBN, NF1, PTEN, STK11, TP53, PALB2), 4.9% had P/LP variants; when limited to BRCA1/2, 1.6% had P/LP variants. Of all patients with P/LP findings, 93% had variants in cancer-risk genes with established management recommendations (Table 1) and 80% had germline variants conferring eligibility for precision medicine-based cancer treatments, such as PARP inhibitors, through actively enrolling clinical trials.
Conclusions: This study demonstrates that comprehensive panel testing of breast cancer patients provides a higher yield of clinically actionable P/LP variants than BRCA1/2 testing alone. Limited panels may miss clinically relevant P/LP variants, leaving risk for preventable cancers undiscovered and unnecessarily restricting patients' treatment options. These results also suggest that variants in tumor suppressor genes, not previously thought related to breast cancer, may contribute to its etiology. A comprehensive panel strategy reveals untapped clinical utility and can impact breast cancer patient care by informing implementation of precision medicine treatment interventions and guiding long-term medical management and surveillance for patients and their family members.
PatientsVariantsWith breast cancer management guidelines (including variants ATM*, BRCA1*, BRCA2*, CHEK2*, NBN*, NF1, PALB2*, TP53*)45 (56%)46 (55%)With cancer guidelines and clinical management implications (including variants BARD1*, FH, MITF, MSH6*, MUTYH*, PTCH1, RAD50*, RAD51C*, RAD51D*, RB1, RET, VHL)31 (38%)33 (39%)Evidence of actionability accruing (including variants BLM, DIS3L2, RECQL4)5 (6%)5 (6%)Totals8184*P/LP variants in these genes confer potential clinical trial eligibility, e.g. NCT02401347.
Citation Format: Beitsch P, Whitworth P, Baron P, Rosen B, Compagnoni G, Simmons R, Smith LA, Holmes D, Brown E, Gold L, Clark P, Coomer C, Grady I, Barbosa K, Riley L, Kinney M, Lyons S, MacDonald H, Kahn S, Ruiz A, Patel R, Curcio L, Esplin E, Yang S, Michalski S. Expanded panel testing superior to BRCA1/2 and breast cancer panel in patients with breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-09-03.
Collapse
Affiliation(s)
- P Beitsch
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - P Whitworth
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - P Baron
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - B Rosen
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - G Compagnoni
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - R Simmons
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - LA Smith
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - D Holmes
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - E Brown
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - L Gold
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - P Clark
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - C Coomer
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - I Grady
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - K Barbosa
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - L Riley
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - M Kinney
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Lyons
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - H MacDonald
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Kahn
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - A Ruiz
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - R Patel
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - L Curcio
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - E Esplin
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Yang
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| | - S Michalski
- TME-Dallas, Dallas, TX; TM- Nashville, Nashville, TN; Roper St. Francis, Charleston, SC; Advocate Health, Barrington, IL; Advanced Surgical, Barrington, IL; Weill Cornell, New York, NY; Linda Ann Smith MD, Albaquerque, NM; Dennis Holmes MD, Los Angeles, CA; Comprehensive Breast Care, Troy, MI; Ironwood Cancer Centers, Phoenix, AZ; Staten Island University, Staten Island, NY; North Valley Breast Clinic, Redding, CA; Alaska Breast Care Specialists, Anchorage, AK; St Lukes, Allentown, PA; Center for Advanced Breast Care, Arlington Heights, IL; Lyons Care Associates, Wailuku, HI; Hoag Memorial Hospital, Newport Beach, CA; The Breast Center at Chesapeake Regional, Chesapeake, Va; Good Samaritan-Los Gatos, Los Gatos, CA; Breastlink, Laguna Hills, CA; Invitae, San Francisco, CA
| |
Collapse
|
45
|
McLean K, Glasbey J, Borakati A, Brooks T, Chang H, Choi S, Goodson R, Nielsen M, Pronin S, Salloum N, Sewart E, Vanniasegaram D, Drake T, Gillies M, Harrison E, Chapman S, Khatri C, Kong C, Claireaux H, Bath M, Mohan M, McNamee L, Kelly M, Mitchell H, Fitzgerald J, Bhangu A, Nepogodiev D, Antoniou I, Dean R, Davies N, Trecarten S, Henderson I, Holmes C, Wylie J, Shuttleworth R, Jindal A, Hughes F, Gouda P, Fleck R, Hanrahan M, Karunakaran P, Chen J, Sykes M, Sethi R, Suresh S, Patel P, Patel M, Varma R, Mushtaq J, Gundogan B, Bolton W, Khan T, Burke J, Morley R, Favero N, Adams R, Thirumal V, Kennedy E, Ong K, Tan Y, Gabriel J, Bakhsh A, Low J, Yener A, Paraoan V, Preece R, Tilston T, Cumber E, Dean S, Ross T, McCance E, Amin H, Satterthwaite L, Clement K, Gratton R, Mills E, Chiu S, Hung G, Rafiq N, Hayes J, Robertson K, Dynes K, Huang H, Assadullah S, Duncumb J, Moon R, Poo S, Mehta J, Joshi K, Callan R, Norris J, Chilvers N, Keevil H, Jull P, Mallick S, Elf D, Carr L, Player C, Barton E, Martin A, Ratu S, Roberts E, Phan P, Dyal A, Rogers J, Henson A, Reid N, Burke D, Culleton G, Lynne S, Mansoor S, Brennan C, Blessed R, Holloway C, Hill A, Goldsmith T, Mackin S, Kim S, Woin E, Brent G, Coffin J, Ziff O, Momoh Z, Debenham R, Ahmed M, Yong C, Wan J, Copley H, Raut P, Chaudhry F, Nixon G, Dorman C, Tan R, Kanabar S, Canning N, Dolaghan M, Bell N, McMenamin M, Chhabra A, Duke K, Turner L, Patel T, Chew L, Mirza M, Lunawat S, Oremule B, Ward N, Khan M, Tan E, Maclennan D, McGregor R, Chisholm E, Griffin E, Bell L, Hughes B, Davies J, Haq H, Ahmed H, Ungcharoen N, Whacha C, Thethi R, Markham R, Lee A, Batt E, Bullock N, Francescon C, Davies J, Shafiq N, Zhao J, Vivekanantham S, Barai I, Allen J, Marshall D, McIntyre C, Wilson H, Ashton A, Lek C, Behar N, Davis-Hall M, Seneviratne N, Esteve L, Sirakaya M, Ali S, Pope S, Ahn J, Craig-McQuaide A, Gatfield W, Leong S, Demetri A, Kerr A, Rees C, Loveday J, Liu S, Wijesekera M, Maru D, Attalla M, Smith N, Brown D, Sritharan P, Shah A, Charavanamuttu V, Heppenstall-Harris G, Ng K, Raghvani T, Rajan N, Hulley K, Moody N, Williams M, Cotton A, Sharifpour M, Lwin K, Bright M, Chitnis A, Abdelhadi M, Semana A, Morgan F, Reid R, Dickson J, Anderson L, McMullan R, Ahern N, Asmadi A, Anderson L, Boon Xuan JL, Crozier L, McAleer S, Lees D, Adebayo A, Das M, Amphlett A, Al-Robeye A, Valli A, Khangura J, Winarski A, Ali A, Woodward H, Gouldthrope C, Turner M, Sasapu K, Tonkins M, Wild J, Robinson M, Hardie J, Heminway R, Narramore R, Ramjeeawon N, Hibberd A, Winslow F, Ho W, Chong B, Lim K, Ho S, Crewdson J, Singagireson S, Kalra N, Koumpa F, Jhala H, Soon W, Karia M, Rasiah M, Xylas D, Gilbert H, Sundar-Singh M, Wills J, Akhtar S, Patel S, Hu L, Brathwaite-Shirley C, Nayee H, Amin O, Rangan T, Turner E, McCrann C, Shepherd R, Patel N, Prest-Smith J, Auyoung E, Murtaza A, Coates A, Prys-Jones O, King M, Gaffney S, Dewdney C, Nehikhare I, Lavery J, Bassett J, Davies K, Ahmad K, Collins A, Acres M, Egerton C, Cheng K, Chen X, Chan N, Sheldon A, Khan S, Empey J, Ingram E, Malik A, Johnstone M, Goodier R, Shah J, Giles J, Sanders J, McLure S, Pal S, Rangedara A, Baker A, Asbjoernsen C, Girling C, Gray L, Gauntlett L, Joyner C, Qureshi S, Mogan Y, Ng J, Kumar A, Park J, Tan D, Choo K, Raman K, Buakuma P, Xiao C, Govinden S, Thompson O, Charalambos M, Brown E, Karsan R, Dogra T, Bullman L, Dawson P, Frank A, Abid H, Tung L, Qureshi U, Tahmina A, Matthews B, Harris R, O'Connor A, Mazan K, Iqbal S, Stanger S, Thompson J, Sullivan J, Uppal E, MacAskill A, Bamgbose F, Neophytou C, Carroll A, Rookes C, Datta U, Dhutia A, Rashid S, Ahmed N, Lo T, Bhanderi S, Blore C, Ahmed S, Shaheen H, Abburu S, Majid S, Abbas Z, Talukdar S, Burney L, Patel J, Al-Obaedi O, Roberts A, Mahboob S, Singh B, Sheth S, Karia P, Prabhudesai A, Kow K, Koysombat K, Wang S, Morrison P, Maheswaran Y, Keane P, Copley P, Brewster O, Xu G, Harries P, Wall C, Al-Mousawi A, Bonsu S, Cunha P, Ward T, Paul J, Nadanakumaran K, Tayeh S, Holyoak H, Remedios J, Theodoropoulou K, Luhishi A, Jacob L, Long F, Atayi A, Sarwar S, Parker O, Harvey J, Ross H, Rampal R, Thomas G, Vanmali P, McGowan C, Stein J, Robertson V, Carthew L, Teng V, Fong J, Street A, Thakker C, O'Reilly D, Bravo M, Pizzolato A, Khokhar H, Ryan M, Cheskes L, Carr R, Salih A, Bassiony S, Yuen R, Chrastek D, Rosen O'Sullivan H, Amajuoyi A, Wang A, Sitta O, Wye J, Qamar M, Major C, Kaushal A, Morgan C, Petrarca M, Allot R, Verma K, Dutt S, Chilima C, Peroos S, Kosasih S, Chin H, Ashken L, Pearse R, O'Loughlin R, Menon A, Singh K, Norton J, Sagar R, Jathanna N, Rothwell L, Watson N, Harding F, Dube P, Khalid H, Punjabi N, Sagmeister M, Gill P, Shahid S, Hudson-Phillips S, George D, Ashwood J, Lewis T, Dhar M, Sangal P, Rhema I, Kotecha D, Afzal Z, Syeed J, Prakash E, Jalota P, Herron J, Kimani L, Delport A, Shukla A, Agarwal V, Parthiban S, Thakur H, Cymes W, Rinkoff S, Turnbull J, Hayat M, Darr S, Khan U, Lim J, Higgins A, Lakshmipathy G, Forte B, Canning E, Jaitley A, Lamont J, Toner E, Ghaffar A, McDowell M, Salmon D, O'Carroll O, Khan A, Kelly M, Clesham K, Palmer C, Lyons R, Bell A, Chin R, Waldron R, Trimble A, Cox S, Ashfaq U, Campbell J, Holliday R, McCabe G, Morris F, Priestland R, Vernon O, Ledsam A, Vaughan R, Lim D, Bakewell Z, Hughes R, Koshy R, Jackson H, Narayan P, Cardwell A, Jubainville C, Arif T, Elliott L, Gupta V, Bhaskaran G, Odeleye A, Ahmed F, Shah R, Pickard J, Suleman Y, North A, McClymont L, Hussain N, Ibrahim I, Ng G, Wong V, Lim A, Harris L, Tharmachandirar T, Mittapalli D, Patel V, Lakhani M, Bazeer H, Narwani V, Sandhu K, Wingfield L, Gentry S, Adjei H, Bhatti M, Braganza L, Barnes J, Mistry S, Chillarge G, Stokes S, Cleere J, Wadanamby S, Bucko A, Meek J, Boxall N, Heywood E, Wiltshire J, Toh C, Ward A, Shurovi B, Horth D, Patel B, Ali B, Spencer T, Axelson T, Kretzmer L, Chhina C, Anandarajah C, Fautz T, Horst C, Thevathasan A, Ng J, Hirst F, Brewer C, Logan A, Lockey J, Forrest P, Keelty N, Wood A, Springford L, Avery P, Schulz T, Bemand T, Howells L, Collier H, Khajuria A, Tharakan R, Parsons S, Buchan A, McGalliard R, Mason J, Cundy O, Li N, Redgrave N, Watson R, Pezas T, Dennis Y, Segall E, Hameed M, Lynch A, Chamberlain M, Peck F, Neo Y, Russell G, Elseedawy M, Lee S, Foster N, Soo Y, Puan L, Dennis R, Goradia H, Qureshi A, Osman S, Reeves T, Dinsmore L, Marsden M, Lu Q, Pitts-Tucker T, Dunn C, Walford R, Heathcote E, Martin R, Pericleous A, Brzyska K, Reid K, Williams M, Wetherall N, McAleer E, Thomas D, Kiff R, Milne S, Holmes M, Bartlett J, Lucas de Carvalho J, Bloomfield T, Tongo F, Bremner R, Yong N, Atraszkiewicz B, Mehdi A, Tahir M, Sherliker G, Tear A, Pandey A, Broyd A, Omer H, Raphael M, Chaudhry W, Shahidi S, Jawad A, Gill C, Fisher IH, Adeleja I, Clark I, Aidoo-Micah G, Stather P, Salam G, Glover T, Deas G, Sim N, Obute R, Wynell-Mayow W, Sait M, Mitha N, de Bernier G, Siddiqui M, Shaunak R, Wali A, Cuthbert G, Bhudia R, Webb E, Shah S, Ansari N, Perera M, Kelly N, McAllister R, Stanley G, Keane C, Shatkar V, Maxwell-Armstrong C, Henderson L, Maple N, Manson R, Adams R, Semple E, Mills M, Daoub A, Marsh A, Ramnarine A, Hartley J, Malaj M, Jewell P, Whatling E, Hitchen N, Chen M, Goh B, Fern J, Rogers S, Derbyshire L, Robertson D, Abuhussein N, Deekonda P, Abid A, Harrison P, Aildasani L, Turley H, Sherif M, Pandey G, Filby J, Johnston A, Burke E, Mohamud M, Gohil K, Tsui A, Singh R, Lim S, O'Sullivan K, McKelvey L, O'Neill S, Roberts H, Brown F, Cao Y, Buckle R, Liew Y, Sii S, Ventre C, Graham C, Filipescu T, Yousif A, Dawar R, Wright A, Peters M, Varley R, Owczarek S, Hartley S, Khattak M, Iqbal A, Ali M, Durrani B, Narang Y, Bethell G, Horne L, Pinto R, Nicholls K, Kisyov I, Torrance H, English W, Lakhani S, Ashraf S, Venn M, Elangovan V, Kazmi Z, Brecher J, Sukumar S, Mastan A, Mortimer A, Parker J, Boyle J, Elkawafi M, Beckett J, Mohite A, Narain A, Mazumdar E, Sreh A, Hague A, Weinberg D, Fletcher L, Steel M, Shufflebotham H, Masood M, Sinha Y, Jenvey C, Kitt H, Slade R, Craig A, Deall C, Reakes T, Chervenkoff J, Strange E, O'Bryan M, Murkin C, Joshi D, Bergara T, Naqib S, Wylam D, Scotcher S, Hewitt C, Stoddart M, Kerai A, Trist A, Cole S, Knight C, Stevens S, Cooper G, Ingham R, Dobson J, O'Kane A, Moradzadeh J, Duffy A, Henderson C, Ashraf S, McLaughin C, Hoskins T, Reehal R, Bookless L, McLean R, Stone E, Wright E, Abdikadir H, Roberts C, Spence O, Srikantharajah M, Ruiz E, Matthews J, Gardner E, Hester E, Naran P, Simpson R, Minhas M, Cornish E, Semnani S, Rojoa D, Radotra A, Eraifej J, Eparh K, Smith D, Mistry B, Hickling S, Din W, Liu C, Mithrakumar P, Mirdavoudi V, Rashid M, Mcgenity C, Hussain O, Kadicheeni M, Gardner H, Anim-Addo N, Pearce J, Aslanyan A, Ntala C, Sorah T, Parkin J, Alizadeh M, White A, Edozie F, Johnston J, Kahar A, Navayogaarajah V, Patel B, Carter D, Khonsari P, Burgess A, Kong C, Ponweera A, Cody A, Tan Y, Ng A, Croall A, Allan C, Ng S, Raghuvir V, Telfer R, Greenhalgh A, McKerr C, Edison M, Patel B, Dear K, Hardy M, Williams P, Hassan S, Sajjad U, O'Neill E, Lopes S, Healy L, Jamal N, Tan S, Lazenby D, Husnoo S, Beecroft S, Sarvanandan T, Weston C, Bassam N, Rabinthiran S, Hayat U, Ng L, Varma D, Sukkari M, Mian A, Omar A, Kim J, Sellathurai J, Mahmood J, O'Connell C, Bose R, Heneghan H, Lalor P, Matheson J, Doherty C, Cullen C, Cooper D, Angelov S, Drislane C, Smith A, Kreibich A, Palkhi E, Durr A, Lotfallah A, Gold D, Mckean E, Dhanji A, Anilkumar A, Thacoor A, Siddiqui Z, Lim S, Piquet A, Anderson S, McCormack D, Gulati J, Ibrahim A, Murray S, Walsh S, McGrath A, Ziprin P, Chua E, Lou C, Bloomer J, Paine H, Osei-Kuffour D, White C, Szczap A, Gokani S, Patel K, Malys M, Reed A, Torlot G, Cumber E, Charania A, Ahmad S, Varma N, Cheema H, Austreng L, Petra H, Chaudhary M, Zegeye M, Cheung F, Coffey D, Heer R, Singh S, Seager E, Cumming S, Suresh R, Verma S, Ptacek I, Gwozdz A, Yang T, Khetarpal A, Shumon S, Fung T, Leung W, Kwang P, Chew L, Loke W, Curran A, Chan C, McGarrigle C, Mohan K, Cullen S, Wong E, Toale C, Collins D, Keane N, Traynor B, Shanahan D, Yan A, Jafree D, Topham C, Mitrasinovic S, Omara S, Bingham G, Lykoudis P, Miranda B, Whitehurst K, Kumaran G, Devabalan Y, Aziz H, Shoa M, Dindyal S, Yates J, Bernstein I, Rattan G, Coulson R, Stezaker S, Isaac A, Salem M, McBride A, McFarlane H, Yow L, MacDonald J, Bartlett R, Turaga S, White U, Liew W, Yim N, Ang A, Simpson A, McAuley D, Craig E, Murphy L, Shepherd P, Kee J, Abdulmajid A, Chung A, Warwick H, Livesey A, Holton P, Theodoreson M, Jenkin S, Turner J, Entwisle J, Marchal S, O'Connor S, Blege H, Aithie J, Sabine L, Stewart G, Jackson S, Kishore A, Lankage C, Acquaah F, Joyce H, McKevitt K, Coffey C, Fawaz A, Dolbec K, O'Sullivan D, Geraghty J, Lim E, Bolton L, FitzPatrick D, Robinson C, Ramtoola T, Collinson S, Grundy L, McEnhill P, Harbhajan Singh G, Loughran D, Golding D, Keeling R, Williams R, Whitham R, Yoganathan S, Nachiappan R, Egan R, Owasil R, Kwan M, He A, Goh R, Bhome R, Wilson H, Teoh P, Raji K, Jayakody N, Matthams J, Chong J, Luk C, Greig R, Trail M, Charalambous G, Rocke A, Gardiner N, Bulley F, Warren N, Brennan E, Fergurson P, Wilson R, Whittingham H, Brown E, Khanijau R, Gandhi K, Morris S, Boulton A, Chandan N, Barthorpe A, Maamari R, Sandhu S, McCann M, Higgs L, Balian V, Reeder C, Diaper C, Sale T, Ali H, Archer C, Clarke A, Heskin J, Hurst P, Farmer J, O'Flynn L, Doan L, Shuker B, Stott G, Vithanage N, Hoban K, Nesargikar P, Kennedy H, Grossart C, Tan E, Roy C, Sim P, Leslie K, Sim D, Abul M, Cody N, Tay A, Woon E, Sng S, Mah J, Robson J, Shakweh E, Wing V, Mills H, Li M, Barrow T, Balaji S, Jordan H, Phillips C, Naveed H, Hirani S, Tai A, Ratnakumaran R, Sahathevan A, Shafi A, Seedat M, Weaver R, Batho A, Punj R, Selvachandran H, Bhatt N, Botchey S, Khonat Z, Brennan K, Morrison C, Devlin E, Linton A, Galloway E, McGarvie S, Ramsay N, McRobbie H, Whewell H, Dean W, Nelaj S, Eragat M, Mishra A, Kane T, Zuhair M, Wells M, Wilkinson D, Woodcock N, Sun E, Aziz N, Ghaffar MKA. Critical care usage after major gastrointestinal and liver surgery: a prospective, multicentre observational study. Br J Anaesth 2019; 122:42-50. [PMID: 30579405 DOI: 10.1016/j.bja.2018.07.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2018] [Revised: 07/19/2018] [Accepted: 07/23/2018] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND Patient selection for critical care admission must balance patient safety with optimal resource allocation. This study aimed to determine the relationship between critical care admission, and postoperative mortality after abdominal surgery. METHODS This prespecified secondary analysis of a multicentre, prospective, observational study included consecutive patients enrolled in the DISCOVER study from UK and Republic of Ireland undergoing major gastrointestinal and liver surgery between October and December 2014. The primary outcome was 30-day mortality. Multivariate logistic regression was used to explore associations between critical care admission (planned and unplanned) and mortality, and inter-centre variation in critical care admission after emergency laparotomy. RESULTS Of 4529 patients included, 37.8% (n=1713) underwent planned critical care admissions from theatre. Some 3.1% (n=86/2816) admitted to ward-level care subsequently underwent unplanned critical care admission. Overall 30-day mortality was 2.9% (n=133/4519), and the risk-adjusted association between 30-day mortality and critical care admission was higher in unplanned [odds ratio (OR): 8.65, 95% confidence interval (CI): 3.51-19.97) than planned admissions (OR: 2.32, 95% CI: 1.43-3.85). Some 26.7% of patients (n=1210/4529) underwent emergency laparotomies. After adjustment, 49.3% (95% CI: 46.8-51.9%, P<0.001) were predicted to have planned critical care admissions, with 7% (n=10/145) of centres outside the 95% CI. CONCLUSIONS After risk adjustment, no 30-day survival benefit was identified for either planned or unplanned postoperative admissions to critical care within this cohort. This likely represents appropriate admission of the highest-risk patients. Planned admissions in selected, intermediate-risk patients may present a strategy to mitigate the risk of unplanned admission. Substantial inter-centre variation exists in planned critical care admissions after emergency laparotomies.
Collapse
|
46
|
Aprile E, Aalbers J, Agostini F, Alfonsi M, Althueser L, Amaro FD, Anthony M, Arneodo F, Baudis L, Bauermeister B, Benabderrahmane ML, Berger T, Breur PA, Brown A, Brown A, Brown E, Bruenner S, Bruno G, Budnik R, Capelli C, Cardoso JMR, Cichon D, Coderre D, Colijn AP, Conrad J, Cussonneau JP, Decowski MP, de Perio P, Di Gangi P, Di Giovanni A, Diglio S, Elykov A, Eurin G, Fei J, Ferella AD, Fieguth A, Fulgione W, Gallo Rosso A, Galloway M, Gao F, Garbini M, Geis C, Grandi L, Greene Z, Qiu H, Hasterok C, Hogenbirk E, Howlett J, Itay R, Joerg F, Kaminsky B, Kazama S, Kish A, Koltman G, Landsman H, Lang RF, Levinson L, Lin Q, Lindemann S, Lindner M, Lombardi F, Lopes JAM, Mahlstedt J, Manfredini A, Marrodán Undagoitia T, Masbou J, Masson D, Messina M, Micheneau K, Miller K, Molinario A, Morå K, Murra M, Naganoma J, Ni K, Oberlack U, Pelssers B, Piastra F, Pienaar J, Pizzella V, Plante G, Podviianiuk R, Priel N, Ramírez García D, Rauch L, Reichard S, Reuter C, Riedel B, Rizzo A, Rocchetti A, Rupp N, Dos Santos JMF, Sartorelli G, Scheibelhut M, Schindler S, Schreiner J, Schulte D, Schumann M, Scotto Lavina L, Selvi M, Shagin P, Shockley E, Silva M, Simgen H, Thers D, Toschi F, Trinchero G, Tunnell C, Upole N, Vargas M, Wack O, Wang H, Wang Z, Wei Y, Weinheimer C, Wittweg C, Wulf J, Ye J, Zhang Y, Zhu T. Dark Matter Search Results from a One Ton-Year Exposure of XENON1T. Phys Rev Lett 2018; 121:111302. [PMID: 30265108 DOI: 10.1103/physrevlett.121.111302] [Citation(s) in RCA: 177] [Impact Index Per Article: 29.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2018] [Revised: 08/14/2018] [Indexed: 06/08/2023]
Abstract
We report on a search for weakly interacting massive particles (WIMPs) using 278.8 days of data collected with the XENON1T experiment at LNGS. XENON1T utilizes a liquid xenon time projection chamber with a fiducial mass of (1.30±0.01) ton, resulting in a 1.0 ton yr exposure. The energy region of interest, [1.4,10.6] keV_{ee} ([4.9,40.9] keV_{nr}), exhibits an ultralow electron recoil background rate of [82_{-3}^{+5}(syst)±3(stat)] events/(ton yr keV_{ee}). No significant excess over background is found, and a profile likelihood analysis parametrized in spatial and energy dimensions excludes new parameter space for the WIMP-nucleon spin-independent elastic scatter cross section for WIMP masses above 6 GeV/c^{2}, with a minimum of 4.1×10^{-47} cm^{2} at 30 GeV/c^{2} and a 90% confidence level.
Collapse
Affiliation(s)
- E Aprile
- Physics Department, Columbia University, New York, New York 10027, USA
| | - J Aalbers
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - F Agostini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M Alfonsi
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L Althueser
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - F D Amaro
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - M Anthony
- Physics Department, Columbia University, New York, New York 10027, USA
| | - F Arneodo
- New York University Abu Dhabi, PO Box 129188,Abu Dhabi, United Arab Emirates
| | - L Baudis
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - B Bauermeister
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - M L Benabderrahmane
- New York University Abu Dhabi, PO Box 129188,Abu Dhabi, United Arab Emirates
| | - T Berger
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - P A Breur
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Brown
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - A Brown
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - E Brown
- Department of Physics, Applied Physics and Astronomy, Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - S Bruenner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Bruno
- New York University Abu Dhabi, PO Box 129188,Abu Dhabi, United Arab Emirates
| | - R Budnik
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - C Capelli
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J M R Cardoso
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - D Cichon
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Coderre
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - A P Colijn
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Conrad
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - J P Cussonneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - M P Decowski
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - P de Perio
- Physics Department, Columbia University, New York, New York 10027, USA
| | - P Di Gangi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - A Di Giovanni
- New York University Abu Dhabi, PO Box 129188,Abu Dhabi, United Arab Emirates
| | - S Diglio
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - A Elykov
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Eurin
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J Fei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - A D Ferella
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Fieguth
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - W Fulgione
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
- INFN-Torino and Osservatorio Astrofisico di Torino, 10125 Torino, Italy
| | - A Gallo Rosso
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - M Galloway
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - F Gao
- Physics Department, Columbia University, New York, New York 10027, USA
| | - M Garbini
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - C Geis
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - L Grandi
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - Z Greene
- Physics Department, Columbia University, New York, New York 10027, USA
| | - H Qiu
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - C Hasterok
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - E Hogenbirk
- Nikhef and the University of Amsterdam, Science Park, 1098XG Amsterdam, Netherlands
| | - J Howlett
- Physics Department, Columbia University, New York, New York 10027, USA
| | - R Itay
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - F Joerg
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - B Kaminsky
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - S Kazama
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - A Kish
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - G Koltman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - H Landsman
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - R F Lang
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - L Levinson
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - Q Lin
- Physics Department, Columbia University, New York, New York 10027, USA
| | - S Lindemann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - M Lindner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - F Lombardi
- Department of Physics, University of California, San Diego, California 92093, USA
| | - J A M Lopes
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - J Mahlstedt
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - A Manfredini
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | | | - J Masbou
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - D Masson
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - M Messina
- New York University Abu Dhabi, PO Box 129188,Abu Dhabi, United Arab Emirates
| | - K Micheneau
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - K Miller
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Molinario
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - K Morå
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - M Murra
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Naganoma
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - K Ni
- Department of Physics, University of California, San Diego, California 92093, USA
| | - U Oberlack
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - B Pelssers
- Oskar Klein Centre, Department of Physics, Stockholm University, AlbaNova, Stockholm SE-10691, Sweden
| | - F Piastra
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Pienaar
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - V Pizzella
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - G Plante
- Physics Department, Columbia University, New York, New York 10027, USA
| | - R Podviianiuk
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - N Priel
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 7610001, Israel
| | - D Ramírez García
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L Rauch
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - S Reichard
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - C Reuter
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - B Riedel
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - A Rizzo
- Physics Department, Columbia University, New York, New York 10027, USA
| | - A Rocchetti
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - N Rupp
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - J M F Dos Santos
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - G Sartorelli
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - M Scheibelhut
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Schindler
- Institut für Physik & Exzellenzcluster PRISMA, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - J Schreiner
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Schulte
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - M Schumann
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - L Scotto Lavina
- LPNHE, Université Pierre et Marie Curie, Université Paris Diderot, CNRS/IN2P3, Paris 75252, France
| | - M Selvi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
| | - P Shagin
- Department of Physics and Astronomy, Rice University, Houston, Texas 77005, USA
| | - E Shockley
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Silva
- LIBPhys, Department of Physics, University of Coimbra, 3004-516 Coimbra, Portugal
| | - H Simgen
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - D Thers
- SUBATECH, IMT Atlantique, CNRS/IN2P3, Université de Nantes, Nantes 44307, France
| | - F Toschi
- Department of Physics and Astronomy, University of Bologna and INFN-Bologna, 40126 Bologna, Italy
- Physikalisches Institut, Universität Freiburg, 79104 Freiburg, Germany
| | - G Trinchero
- INFN-Torino and Osservatorio Astrofisico di Torino, 10125 Torino, Italy
| | - C Tunnell
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - N Upole
- Department of Physics & Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - M Vargas
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - O Wack
- Max-Planck-Institut für Kernphysik, 69117 Heidelberg, Germany
| | - H Wang
- Physics & Astronomy Department, University of California, Los Angeles, California 90095, USA
| | - Z Wang
- INFN-Laboratori Nazionali del Gran Sasso and Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - Y Wei
- Department of Physics, University of California, San Diego, California 92093, USA
| | - C Weinheimer
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - C Wittweg
- Institut für Kernphysik, Westfälische Wilhelms-Universität Münster, 48149 Münster, Germany
| | - J Wulf
- Physik-Institut, University of Zurich, 8057 Zurich, Switzerland
| | - J Ye
- Department of Physics, University of California, San Diego, California 92093, USA
| | - Y Zhang
- Physics Department, Columbia University, New York, New York 10027, USA
| | - T Zhu
- Physics Department, Columbia University, New York, New York 10027, USA
| |
Collapse
|
47
|
Frojmovic M, Brown E, Kasirer-Friede A, Liu Q. Limitations and Warnings in Use of Labelled (Fibrinogen) Ligands to Cell Receptors. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1650534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Frojmovic
- The Physiology Department, McGill University, Montreal, Quebec, Canada
| | - E Brown
- The Physiology Department, McGill University, Montreal, Quebec, Canada
| | - A Kasirer-Friede
- The Physiology Department, McGill University, Montreal, Quebec, Canada
| | - Q Liu
- The Physiology Department, McGill University, Montreal, Quebec, Canada
| |
Collapse
|
48
|
Kreuzaler P, Clarke M, Brown E, Wilson C, Fisher J, Evan G. 1 Obligatory tumour heterogeneity driven by Myc overexpression: mechanistic insights and therapeutic strategies. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
49
|
Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology (Oxford) 2018; 57:370-381. [PMID: 29207002 PMCID: PMC5850714 DOI: 10.1093/rheumatology/kex410] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Indexed: 11/21/2022] Open
Abstract
Objectives Our aim was to describe the burden of early dcSSc in terms of disability, fatigue and pain in the European Scleroderma Observational Study cohort, and to explore associated clinical features. Methods Patients completed questionnaires at study entry, 12 and 24 months, including the HAQ disability index (HAQ-DI), the Cochin Hand Function Scale (CHFS), the Functional Assessment of Chronic Illness Therapy-fatigue and the Short Form 36 (SF36). Associates examined included the modified Rodnan skin score (mRSS), current digital ulcers and internal organ involvement. Correlations between 12-month changes were also examined. Results The 326 patients recruited (median disease duration 11.9 months) displayed high levels of disability [mean (s.d.) HAQ-DI 1.1 (0.83)], with ‘grip’ and ‘activity’ being most affected. Of the 18 activities assessed in the CHFS, those involving fine finger movements were most affected. High HAQ-DI and CHFS scores were both associated with high mRSS (ρ = 0.34, P < 0.0001 and ρ = 0.35, P < 0.0001, respectively). HAQ-DI was higher in patients with digital ulcers (P = 0.004), pulmonary fibrosis (P = 0.005), cardiac (P = 0.005) and muscle involvement (P = 0.002). As anticipated, HAQ-DI, CHFS, the Functional Assessment of Chronic Illness Therapy and SF36 scores were all highly correlated, in particular the HAQ-DI with the CHFS (ρ = 0.84, P < 0.0001). Worsening HAQ-DI over 12 months was strongly associated with increasing mRSS (ρ = 0.40, P < 0.0001), decreasing hand function (ρ = 0.57, P < 0.0001) and increasing fatigue (ρ = −0.53, P < 0.0001). Conclusion The European Scleroderma Observational Study highlights the burden of disability in early dcSSc, with high levels of disability and fatigue, associating with the degree of skin thickening (mRSS). Impaired hand function is a major contributor to overall disability.
Collapse
Affiliation(s)
- Sébastien Peytrignet
- Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - Christopher P Denton
- Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, Royal Free Campus, London, UK
| | - Mark Lunt
- Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | | | - Luc Mouthon
- Service de Médecine Interne, Hôpital Cochin, Centre de Référence pour les Vascularités Nécrosantes et la Sclérodermie Systémique, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Alan Silman
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
| | - Xiaoyan Pan
- Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - Edith Brown
- Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - László Czirják
- Department of Rheumatology and Immunology, Medical Center, University of Pécs, Pécs, Hungary, Erlangen, Germany
| | - Jörg H W Distler
- Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Oliver Distler
- Department of Rheumatology, University of Zurich, Zurich, Switzerland
| | - Kim Fligelstone
- Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, Royal Free Campus, London, UK
| | - William J Gregory
- Rehabilitation Services, Salford Royal NHS Foundation Trust, Salford, UK
| | - Rachel Ochiel
- Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, Royal Free Campus, London, UK
| | - Madelon Vonk
- Department of the Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | - Codrina Ancuta
- Rheumatology 2 Department, Clinical Rehabilitation Hospital, 'Grigore T. Popa' University of Medicine and Pharmacy, Iasi, Romania
| | - Voon H Ong
- Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, Royal Free Campus, London, UK
| | - Dominique Farge
- Unité Clinique de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire, Hôpital Saint-Louis, Paris, France
| | - Marie Hudson
- Lady Davis Institute, Jewish General Hospital, Montreal, Canada.,Department of Medicine, McGill University, Montreal, Canada
| | - Marco Matucci-Cerinic
- Department Experimental and Clinical Medicine, Division Rheumatology AOUC, University of Florence, Florence, Italy
| | - Alexandra Balbir-Gurman
- B. Shine Rheumatology Unit, Rambam Heath Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel
| | - Øyvind Midtvedt
- Rheumatology Unit, Oslo University Hospital Rikshospitalet, Oslo, Norway
| | - Alison C Jordan
- Queen Elizabeth Hospital Birmingham, UHB Foundation Trust, Birmingham, UK
| | - Wendy Stevens
- Rheumatology Unit, St Vincent's Hospital, Melbourne, Australia
| | - Pia Moinzadeh
- Department for Dermatology, University of Cologne, Köln, Germany
| | - Frances C Hall
- Department of Clinical Medicine, Cambridge University NHS Hospital Foundation Trust, Cambridge, UK
| | - Christian Agard
- Department of Internal Medicine, Hôtel-Dieu Hospital, University of Nantes, Nantes, France
| | | | - Elisabeth Diot
- Service de Médecine Interne, Hôpital Bretonneau Tours, Tours, France
| | - Rajan Madhok
- Centre for Rheumatic Diseases, Royal Infirmary, Glasgow, UK
| | - Mohammed Akil
- Department of Rheumatology, Sheffield Teaching Hospitals, Sheffield, UK
| | - Maya H Buch
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.,NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - Lorinda Chung
- Division of Immunology and Rheumatology, Stanford University, Stanford, CA, USA
| | - Nemanja Damjanov
- Institute of Rheumatology, University of Belgrade School of Medicine, Belgrade, Serbia
| | - Harsha Gunawardena
- Clinical and Academic Rheumatology, North Bristol NHS Trust, Bristol, UK
| | - Peter Lanyon
- Rheumatology, Nottingham University Hospitals NHS Trust, Nottingham, UK.,Rheumatology, Nottingham NHS Treatment Centre, Nottingham, UK
| | - Yasmeen Ahmad
- Peter Maddison Rheumatology Centre, Llandudno Hospital, Llandudno, UK
| | | | - Søren Jacobsen
- Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
| | - Alexander J MacGregor
- Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, UK
| | - Neil McHugh
- Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK
| | - Ulf Müller-Ladner
- Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Kerckhoff Klinik, Bad Nauheim, Germany
| | | | - Michael Becker
- Department of Rheumatology and Clinical Immunology, University Hospital Charité Berlin, Berlin, Germany
| | - Janet Roddy
- Department of Rheumatology, Royal Perth Hospital, Perth, Australia
| | - Patricia E Carreira
- Servicio de Reumatologia, Hospital Universitario 12 de Octubre, Madrid, Spain
| | | | - Eric Hachulla
- Centre National de Référence Maladies Systémiques et Auto-immunes Rares, Département de Médecine Interne et Immunologie Clinique, Université de Lille, Lille, France
| | - Jennifer Hamilton
- Department of Rheumatology, Gateshead Hospitals Foundation Trust, Gateshead, UK
| | - Murat Inanç
- Department of Internal Medicine, Division of Rheumatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
| | - John S McLaren
- Fife Rheumatic Diseases Unit, Whyteman's Brae Hospital, Kirkcaldy, Scotland, UK
| | - Jacob M van Laar
- Department of Rheumatology and Clinical Immunology, UMC Utrecht, Utrecht, the Netherlands
| | - Sanjay Pathare
- Rheumatology, James Cook University Hospital, Middlesbrough, UK
| | - Susanna Proudman
- Rheumatology Unit, Royal Adelaide Hospital.,Discipline of Medicine, University of Adelaide, Adelaide, Australia
| | - Anna Rudin
- Department of Rheumatology and Inflammation Research, The Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden
| | - Joanne Sahhar
- Monash Centre for Inflammatory Diseases, Monash University, Melbourne, Australia
| | - Brigitte Coppere
- Department of Internal Medicine, Hôpital Edouard Herriot, Lyon, France
| | - Christine Serratrice
- Department of Internal Medicine, Foundation Hospital Saint Joseph, Marseille, France
| | - Tom Sheeran
- Department of Rheumatology, Cannock Chase Hospital, Cannock, UK
| | - Douglas J Veale
- Rheumatology, St Vincent's University Hospital, Dublin, Ireland
| | - Claire Grange
- Department of Internal Medicine 69310, Centre Hospitalier Lyon Sud, Pierre-Bénite, Lyon, France
| | - Georges-Selim Trad
- Internal Medecine, Ambroise Paré Hospital, Boulogne, Billancourt, France
| | - Ariane L Herrick
- Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.,Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.,NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
| |
Collapse
|
50
|
Tang WW, McGee P, Lachin JM, Li DY, Hoogwerf B, Hazen SL, Nathan D, Zinman B, Crofford O, Genuth S, Brown‐Friday J, Crandall J, Engel H, Engel S, Martinez H, Phillips M, Reid M, Shamoon H, Sheindlin J, Gubitosi‐Klug R, Mayer L, Pendegast S, Zegarra H, Miller D, Singerman L, Smith‐Brewer S, Novak M, Quin J, Genuth S, Palmert M, Brown E, McConnell J, Pugsley P, Crawford P, Dahms W, Gregory N, Lackaye M, Kiss S, Chan R, Orlin A, Rubin M, Brillon D, Reppucci V, Lee T, Heinemann M, Chang S, Levy B, Jovanovic L, Richardson M, Bosco B, Dwoskin A, Hanna R, Barron S, Campbell R, Bhan A, Kruger D, Jones J, Edwards P, Bhan A, Carey J, Angus E, Thomas A, Galprin A, McLellan M, Whitehouse F, Bergenstal R, Johnson M, Gunyou K, Thomas L, Laechelt J, Hollander P, Spencer M, Kendall D, Cuddihy R, Callahan P, List S, Gott J, Rude N, Olson B, Franz M, Castle G, Birk R, Nelson J, Freking D, Gill L, Mestrezat W, Etzwiler D, Morgan K, Aiello L, Golden E, Arrigg P, Asuquo V, Beaser R, Bestourous L, Cavallerano J, Cavicchi R, Ganda O, Hamdy O, Kirby R, Murtha T, Schlossman D, Shah S, Sharuk G, Silva P, Silver P, Stockman M, Sun J, Weimann E, Wolpert H, Aiello L, Jacobson A, Rand L, Rosenzwieg J, Nathan D, Larkin M, Christofi M, Folino K, Godine J, Lou P, Stevens C, Anderson E, Bode H, Brink S, Cornish C, Cros D, Delahanty L, eManbey ., Haggan C, Lynch J, McKitrick C, Norman D, Moore D, Ong M, Taylor C, Zimbler D, Crowell S, Fritz S, Hansen K, Gauthier‐Kelly C, Service F, Ziegler G, Barkmeier A, Schmidt L, French B, Woodwick R, Rizza R, Schwenk W, Haymond M, Pach J, Mortenson J, Zimmerman B, Lucas A, Colligan R, Luttrell L, Lopes‐Virella M, Caulder S, Pittman C, Patel N, Lee K, Nutaitis M, Fernandes J, Hermayer K, Kwon S, Blevins A, Parker J, Colwell J, Lee D, Soule J, Lindsey P, Bracey M, Farr A, Elsing S, Thompson T, Selby J, Lyons T, Yacoub‐Wasef S, Szpiech M, Wood D, Mayfield R, Molitch M, Adelman D, Colson S, Jampol L, Lyon A, Gill M, Strugula Z, Kaminski L, Mirza R, Simjanoski E, Ryan D, Johnson C, Wallia A, Ajroud‐Driss S, Astelford P, Leloudes N, Degillio A, Schaefer B, Mudaliar S, Lorenzi G, Goldbaum M, Jones K, Prince M, Swenson M, Grant I, Reed R, Lyon R, Kolterman O, Giotta M, Clark T, Friedenberg G, Sivitz W, Vittetoe B, Kramer J, Bayless M, Zeitler R, Schrott H, Olson N, Snetselaar L, Hoffman R, MacIndoe J, Weingeist T, Fountain C, Miller R, Johnsonbaugh S, Patronas M, Carney M, Mendley S, Salemi P, Liss R, Hebdon M, Counts D, Donner T, Gordon J, Hemady R, Kowarski A, Ostrowski D, Steidl S, Jones B, Herman W, Martin C, Pop‐Busui R, Greene D, Stevens M, Burkhart N, Sandford T, Floyd J, Bantle J, Flaherty N, Terry J, Koozekanani D, Montezuma S, Wimmergren N, Rogness B, Mech M, Strand T, Olson J, McKenzie L, Kwong C, Goetz F, Warhol R, Hainsworth D, Goldstein D, Hitt S, Giangiacomo J, Schade D, Canady J, Burge M, Das A, Avery R, Ketai L, Chapin J, Schluter M, Rich J, Johannes C, Hornbeck D, Schutta M, Bourne P, Brucker A, Braunstein S, Schwartz S, Maschak‐Carey B, Baker L, Orchard T, Cimino L, Songer T, Doft B, Olson S, Becker D, Rubinstein D, Bergren R, Fruit J, Hyre R, Palmer C, Silvers N, Lobes L, Rath PP, Conrad P, Yalamanchi S, Wesche J, Bratkowksi M, Arslanian S, Rinkoff J, Warnicki J, Curtin D, Steinberg D, Vagstad G, Harris R, Steranchak L, Arch J, Kelly K, Ostrosaka P, Guiliani M, Good M, Williams T, Olsen K, Campbell A, Shipe C, Conwit R, Finegold D, Zaucha M, Drash A, Morrison A, Malone J, Bernal M, Pavan P, Grove N, Tanaka E, McMillan D, Vaccaro‐Kish J, Babbione L, Solc H, DeClue T, Dagogo‐Jack S, Wigley C, Ricks H, Kitabchi A, Chaum E, Murphy M, Moser S, Meyer D, Iannacone A, Yoser S, Bryer‐Ash M, Schussler S, Lambeth H, Raskin P, Strowig S, Basco M, Cercone S, Zinman B, Barnie A, Devenyi R, Mandelcorn M, Brent M, Rogers S, Gordon A, Bakshi N, Perkins B, Tuason L, Perdikaris F, Ehrlich R, Daneman D, Perlman K, Ferguson S, Palmer J, Fahlstrom R, de Boer I, Kinyoun J, Van Ottingham L, Catton S, Ginsberg J, McDonald C, Harth J, Driscoll M, Sheidow T, Mahon J, Canny C, Nicolle D, Colby P, Dupre J, Hramiak I, Rodger N, Jenner M, Smith T, Brown W, May M, Lipps Hagan J, Agarwal A, Adkins T, Lorenz R, Feman S, Survant L, White N, Levandoski L, Grand G, Thomas M, Joseph D, Blinder K, Shah G, Burgess D, Boniuk I, Santiago J, Tamborlane W, Gatcomb P, Stoessel K, Ramos P, Fong K, Ossorio P, Ahern J, Gubitosi‐Klug R, Meadema‐Mayer L, Beck C, Farrell K, Genuth S, Quin J, Gaston P, Palmert M, Trail R, Dahms W, Lachin J, Backlund J, Bebu I, Braffett B, Diminick L, Gao X, Hsu W, Klumpp K, Pan H, Trapani V, Cleary P, McGee P, Sun W, Villavicencio S, Anderson K, Dews L, Younes N, Rutledge B, Chan K, Rosenberg D, Petty B, Determan A, Kenny D, Williams C, Cowie C, Siebert C, Steffes M, Arends V, Bucksa J, Nowicki M, Chavers B, O'Leary D, Polak J, Harrington A, Funk L, Crow R, Gloeb B, Thomas S, O'Donnell C, Soliman E, Zhang Z, Li Y, Campbell C, Keasler L, Hensley S, Hu J, Barr M, Taylor T, Prineas R, Feldman E, Albers J, Low P, Sommer C, Nickander K, Speigelberg T, Pfiefer M, Schumer M, Moran M, Farquhar J, Ryan C, Sandstrom D, Williams T, Geckle M, Cupelli E, Thoma F, Burzuk B, Woodfill T, Danis R, Blodi B, Lawrence D, Wabers H, Gangaputra S, Neill S, Burger M, Dingledine J, Gama V, Sussman R, Davis M, Hubbard L, Budoff M, Darabian S, Rezaeian P, Wong N, Fox M, Oudiz R, Kim L, Detrano R, Cruickshanks K, Dalton D, Bainbridge K, Lima J, Bluemke D, Turkbey E, der Geest ., Liu C, Malayeri A, Jain A, Miao C, Chahal H, Jarboe R, Nathan D, Monnier V, Sell D, Strauch C, Hazen S, Pratt A, Tang W, Brunzell J, Purnell J, Natarajan R, Miao F, Zhang L, Chen Z, Paterson A, Boright A, Bull S, Sun L, Scherer S, Lopes‐Virella M, Lyons T, Jenkins A, Klein R, Virella G, Jaffa A, Carter R, Stoner J, Garvey W, Lackland D, Brabham M, McGee D, Zheng D, Mayfield R, Maynard J, Wessells H, Sarma A, Jacobson A, Dunn R, Holt S, Hotaling J, Kim C, Clemens Q, Brown J, McVary K. Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study. J Am Heart Assoc 2018. [PMCID: PMC6015340 DOI: 10.1161/jaha.117.008368] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background
Hyperglycemia leading to increased oxidative stress is implicated in the increased risk for the development of macrovascular and microvascular complications in patients with type 1 diabetes mellitus.
Methods and Results
A random subcohort of 349 participants was selected from the
DCCT
/
EDIC
(Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) cohort. This included 320 controls and 29 cardiovascular disease cases that were augmented with 98 additional known cases to yield a case cohort of 447 participants (320 controls, 127 cases). Biosamples from
DCCT
baseline, year 1, and closeout of
DCCT
, and 1 to 2 years post‐
DCCT
(
EDIC
years 1 and 2) were measured for markers of oxidative stress, including plasma myeloperoxidase, paraoxonase activity, urinary F
2α
isoprostanes, and its metabolite, 2,3 dinor‐8
iso
prostaglandin F
2α
. Following adjustment for glycated hemoblobin and weighting the observations inversely proportional to the sampling selection probabilities, higher paraoxonase activity, reflective of antioxidant activity, and 2,3 dinor‐8
iso
prostaglandin F
2α
, an oxidative marker, were significantly associated with lower risk of cardiovascular disease (−4.5% risk for 10% higher paraoxonase,
P
<0.003; −5.3% risk for 10% higher 2,3 dinor‐8
iso
prostaglandin F
2α
,
P
=0.0092). In contrast, the oxidative markers myeloperoxidase and F
2α
isoprostanes were not significantly associated with cardiovascular disease after adjustment for glycated hemoblobin. There were no significant differences between
DCCT
intensive and conventional treatment groups in the change in all biomarkers across time segments.
Conclusions
Heightened antioxidant activity (rather than diminished oxidative stress markers) is associated with lower cardiovascular disease risk in type 1 diabetes mellitus, but these biomarkers did not change over time with intensification of glycemic control.
Clinical Trial Registration
URL
:
https://www.clinicaltrials.gov
. Unique identifiers:
NCT
00360815 and
NCT
00360893.
Collapse
Affiliation(s)
- W.H. Wilson Tang
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | - Paula McGee
- The Biostatistics Center, George Washington University, Rockville, MD
| | - John M. Lachin
- The Biostatistics Center, George Washington University, Rockville, MD
| | - Daniel Y. Li
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
| | | | - Stanley L. Hazen
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|